Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",A1BG,Alpha-1B-glycoprotein,24239,135,1.22 [0.49-3.08],0.6678039464217881
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AAMDC,Mth938 domain-containing protein,23568,133,1.27 [0.94-1.71],0.1220820707638081
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AARSD1,Alanyl-tRNA editing protein Aarsd1,27629,155,1.25 [0.98-1.60],0.0700675524107682
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ABCA2,ATP-binding cassette sub-family A member 2,23424,129,1.27 [0.84-1.94],0.2615587470334254
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ABHD14B,Protein ABHD14B,27469,152,1.00 [0.78-1.27],0.9854170637502048
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ABL1,Tyrosine-protein kinase ABL1,27629,155,1.23 [1.02-1.49],0.0328144199975262
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ABO,Histo-blood group ABO system transferase,24205,134,1.01 [0.90-1.13],0.8384166012090544
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ABRAXAS2,BRISC complex subunit Abraxas 2,23424,129,1.17 [0.91-1.49],0.2175001897038078
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",27102,151,1.11 [0.94-1.32],0.2272805348806179
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",23740,131,1.13 [0.93-1.38],0.2146703164821748
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24191,134,1.03 [0.85-1.24],0.7592570867809247
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACAN,Aggrecan core protein,27507,154,1.08 [0.66-1.79],0.7529528706260356
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACE,Angiotensin-converting enzyme,24205,134,0.88 [0.46-1.67],0.694628409948048
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACE2,Angiotensin-converting enzyme 2,27243,152,1.04 [0.77-1.40],0.820682373890947
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACHE,Acetylcholinesterase,23679,128,0.59 [0.34-1.03],0.0637898780059995
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACOT13,Acyl-coenzyme A thioesterase 13,24066,134,1.05 [0.91-1.22],0.5065951832272503
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,27752,155,1.03 [0.77-1.37],0.8364385333559253
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACP1,Low molecular weight phosphotyrosine protein phosphatase,23508,131,0.97 [0.66-1.42],0.8759391374671672
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACP5,Tartrate-resistant acid phosphatase type 5,27878,152,1.24 [0.80-1.91],0.3317785946747364
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACP6,Lysophosphatidic acid phosphatase type 6,27936,155,1.08 [0.87-1.35],0.4967542703848826
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACRBP,Acrosin-binding protein,24054,130,1.08 [0.71-1.67],0.7138154844343638
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACRV1,Acrosomal protein SP-10,23508,131,0.85 [0.52-1.39],0.5171448602081379
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACSL1,Long-chain-fatty-acid--CoA ligase 1,23424,129,0.88 [0.55-1.42],0.609276507833451
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACTA2,"Actin, aortic smooth muscle",27243,152,0.89 [0.63-1.25],0.4972397608520312
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACTN2,Alpha-actinin-2,23424,129,1.14 [0.86-1.51],0.3496511767128879
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACTN4,Alpha-actinin-4,27198,150,1.20 [0.80-1.80],0.3853708222002138
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACVRL1,Serine/threonine-protein kinase receptor R3,27517,152,1.36 [0.76-2.43],0.3061003891478571
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACY1,Aminoacylase-1,27752,155,1.05 [0.83-1.33],0.6868972829865576
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,23424,129,0.96 [0.71-1.30],0.7999071955135246
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ACYP1,Acylphosphatase-1,23583,127,1.07 [0.83-1.38],0.5913987377563356
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADA,Adenosine deaminase,28040,156,1.08 [0.73-1.60],0.6883563491806715
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADA2,Adenosine deaminase 2,27573,153,0.94 [0.66-1.33],0.7279691378539003
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,23508,131,1.16 [0.82-1.64],0.3955967893779561
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,27243,152,0.90 [0.56-1.45],0.6700268962220388
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,27559,153,0.96 [0.64-1.46],0.8659301708950746
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,28040,156,0.96 [0.64-1.43],0.827073170677511
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,27944,155,0.68 [0.41-1.11],0.1260705148408042
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24066,134,0.94 [0.54-1.65],0.8401025524544059
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,23508,131,1.32 [0.83-2.09],0.2453896857572023
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,28090,154,1.16 [0.62-2.17],0.6423788822656059
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,27629,155,1.51 [1.08-2.11],0.0167521906512492
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,27243,152,1.06 [0.69-1.63],0.7923793689122332
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,23508,131,1.01 [0.63-1.60],0.976941523658944
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,27849,154,0.81 [0.59-1.11],0.1886765860235728
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADAMTSL2,ADAMTS-like protein 2,24190,135,0.85 [0.49-1.47],0.555675940390402
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADAMTSL4,ADAMTS-like protein 4,23568,133,1.36 [0.68-2.72],0.3848381514484832
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADAMTSL5,ADAMTS-like protein 5,24191,134,0.73 [0.48-1.11],0.1459946587678545
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,27102,151,1.07 [0.74-1.54],0.7257628079136091
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADD1,Alpha-adducin,23679,128,1.13 [0.89-1.45],0.3194827944943685
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADGRB3,Adhesion G protein-coupled receptor B3,27517,152,0.79 [0.51-1.22],0.2880410190044371
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADGRD1,Adhesion G-protein coupled receptor D1,23679,128,1.08 [0.68-1.70],0.7541205756913552
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADGRE1,Adhesion G protein-coupled receptor E1,24066,134,0.80 [0.59-1.09],0.1539666838697142
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADGRE2,Adhesion G protein-coupled receptor E2,27889,155,0.77 [0.46-1.28],0.3086455500357954
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADGRE5,Adhesion G protein-coupled receptor E5,27953,154,0.69 [0.42-1.13],0.1430080194250389
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADGRF5,Adhesion G protein-coupled receptor F5,24191,134,1.05 [0.60-1.82],0.874730623694499
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADGRG1,Adhesion G-protein coupled receptor G1,27629,155,0.89 [0.64-1.22],0.469924917869247
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADGRG2,Adhesion G-protein coupled receptor G2,27752,155,0.92 [0.54-1.56],0.7605252595686651
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADGRV1,Adhesion G-protein coupled receptor V1,23410,130,0.80 [0.60-1.06],0.1155687289683076
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADH1B,All-trans-retinol dehydrogenase,23679,128,0.94 [0.74-1.19],0.608207195736322
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,27243,152,0.90 [0.76-1.07],0.2437073037924362
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADIPOQ,Adiponectin,24239,135,0.90 [0.71-1.15],0.4145684845866787
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADM,Pro-adrenomedullin,27985,155,1.77 [1.06-2.96],0.0296868169880786
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ADRA2A,Alpha-2A adrenergic receptor,23424,129,1.15 [0.94-1.40],0.1731382963669603
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AFAP1,Actin filament-associated protein 1,23679,128,1.02 [0.83-1.24],0.8751152804456954
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AFM,Afamin,24239,135,0.90 [0.37-2.17],0.8151824737625698
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AFP,Alpha-fetoprotein,27477,152,1.13 [0.92-1.39],0.2332960151091125
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AGBL2,Cytosolic carboxypeptidase 2,23410,130,1.02 [0.85-1.23],0.8261872051867046
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AGER,Advanced glycosylation end product-specific receptor,27704,153,1.04 [0.73-1.48],0.8306064452752051
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AGR2,Anterior gradient protein 2 homolog,26835,150,0.95 [0.82-1.09],0.438796814870186
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AGR3,Anterior gradient protein 3,27054,151,1.13 [0.89-1.44],0.3058967048006255
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AGRN,Agrin,27889,155,1.34 [0.89-2.03],0.1661302766488158
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AGRP,Agouti-related protein,28040,156,1.15 [0.89-1.48],0.3005090251136969
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AGT,Angiotensinogen,24205,134,1.40 [0.74-2.66],0.2967326467280847
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AGXT,Serine--pyruvate aminotransferase,27752,155,0.98 [0.82-1.18],0.866308372753831
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AHCY,Adenosylhomocysteinase,27752,155,1.04 [0.84-1.27],0.7264569245297294
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AHNAK,Neuroblast differentiation-associated protein AHNAK,23568,133,0.56 [0.32-0.98],0.0412346391848569
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AHNAK2,Protein AHNAK2,23568,133,0.78 [0.43-1.43],0.4302462634581842
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24054,130,1.10 [0.88-1.37],0.3981530811922512
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AHSG,Alpha-2-HS-glycoprotein,24205,134,1.07 [0.58-1.96],0.8252032637773289
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AHSP,Alpha-hemoglobin-stabilizing protein,27715,155,1.15 [0.99-1.35],0.0712905845371722
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AIDA,"Axin interactor, dorsalization-associated protein",23514,134,1.02 [0.84-1.23],0.8431151795217148
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AIF1,Allograft inflammatory factor 1,27102,151,1.14 [0.87-1.49],0.3579114335765245
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AIF1L,Allograft inflammatory factor 1-like,23568,133,0.76 [0.54-1.07],0.1206019749802894
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",27578,155,1.04 [0.91-1.19],0.5714468314887274
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AK1,Adenylate kinase isoenzyme 1,27752,155,1.12 [0.91-1.39],0.286694828850294
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AK2,"Adenylate kinase 2, mitochondrial",24136,133,1.09 [0.93-1.28],0.2703535749856867
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AKAP12,A-kinase anchor protein 12,23679,128,0.81 [0.35-1.85],0.6124041999660875
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AKR1B1,Aldo-keto reductase family 1 member B1,27102,151,1.14 [0.95-1.36],0.1624470542653272
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AKR1B10,Aldo-keto reductase family 1 member B10,23514,134,0.78 [0.58-1.07],0.1208874523826789
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AKR1C4,Aldo-keto reductase family 1 member C4,27243,152,0.95 [0.72-1.25],0.7039078457943369
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AKR7L,Aflatoxin B1 aldehyde reductase member 4,23508,131,0.97 [0.77-1.23],0.8101856738066059
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AKT1S1,Proline-rich AKT1 substrate 1,27073,151,1.14 [0.92-1.41],0.237418477664313
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AKT2,RAC-beta serine/threonine-protein kinase,24152,133,1.10 [0.96-1.25],0.1776534546204152
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AKT3,RAC-gamma serine/threonine-protein kinase,26971,151,1.19 [0.93-1.53],0.1670645547249449
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ALCAM,CD166 antigen,28090,154,0.66 [0.32-1.40],0.2811612325718624
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ALDH1A1,Retinal dehydrogenase 1,27756,156,1.03 [0.79-1.34],0.8211737212787756
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ALDH2,"Aldehyde dehydrogenase, mitochondrial",24054,130,1.09 [0.81-1.47],0.5773666381720364
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",27663,155,0.93 [0.74-1.18],0.5603556579660861
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24152,133,0.89 [0.62-1.29],0.5368929994345
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ALMS1,Alstrom syndrome protein 1,23740,131,0.84 [0.57-1.25],0.400555834095359
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ALPI,Intestinal-type alkaline phosphatase,23508,131,1.08 [0.94-1.23],0.3018969298329473
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ALPP,"Alkaline phosphatase, placental type",27629,155,1.02 [0.90-1.15],0.7752212906415452
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AMBN,Ameloblastin,27198,150,1.05 [0.65-1.70],0.8507026151828946
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AMBP,Protein AMBP,27947,155,2.39 [1.19-4.83],0.0146828842176891
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24190,135,1.13 [0.59-2.17],0.7107824660581656
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AMFR,E3 ubiquitin-protein ligase AMFR,27073,151,0.92 [0.74-1.15],0.4699316133036645
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AMIGO1,Amphoterin-induced protein 1,23514,134,0.93 [0.67-1.29],0.6613867837946731
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AMIGO2,Amphoterin-induced protein 2,27629,155,0.71 [0.38-1.31],0.2727973791820429
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AMN,Protein amnionless,27198,150,1.10 [0.82-1.48],0.530834509238408
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AMOT,Angiomotin,23679,128,0.70 [0.46-1.05],0.0807179322241985
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AMOTL2,Angiomotin-like protein 2,23973,130,0.97 [0.68-1.38],0.8616147537238255
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AMPD3,AMP deaminase 3,24136,133,1.05 [0.84-1.31],0.6944606915865741
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,22650,120,1.09 [0.76-1.56],0.6418162206697645
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AMY2A,Pancreatic alpha-amylase,26658,145,1.21 [0.87-1.67],0.2515920268823468
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AMY2B,Alpha-amylase 2B,25858,141,1.30 [0.94-1.79],0.111083768185986
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANG,Angiogenin,27661,154,1.27 [0.86-1.87],0.2270511005553208
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANGPT1,Angiopoietin-1,27654,153,1.14 [0.96-1.35],0.1381855127326558
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANGPT2,Angiopoietin-2,27985,155,0.88 [0.62-1.25],0.4690125252415096
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANGPTL1,Angiopoietin-related protein 1,27376,149,1.36 [0.84-2.21],0.2102775431072701
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANGPTL2,Angiopoietin-related protein 2,27803,155,1.05 [0.74-1.51],0.7723206212839453
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANGPTL3,Angiopoietin-related protein 3,27751,154,0.90 [0.61-1.34],0.616016448330331
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANGPTL4,Angiopoietin-related protein 4,27841,154,0.87 [0.64-1.18],0.3621010343093727
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANGPTL7,Angiopoietin-related protein 7,27985,155,1.65 [1.18-2.32],0.0035805288056734
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANK2,Ankyrin-2,23424,129,0.87 [0.66-1.13],0.2834713086137644
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,23508,131,1.12 [0.90-1.38],0.3066525101997088
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANKRA2,Ankyrin repeat family A protein 2,23315,128,0.86 [0.62-1.18],0.3518922249950899
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANKRD54,Ankyrin repeat domain-containing protein 54,27102,151,1.26 [1.02-1.55],0.0294373146734927
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,23568,133,1.00 [0.68-1.47],0.9888741891940056
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANPEP,Aminopeptidase N,27796,154,0.81 [0.49-1.36],0.4344619416298803
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANXA1,Annexin A1,23534,127,1.01 [0.70-1.46],0.9680079081052444
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANXA10,Annexin A10,27073,151,0.85 [0.70-1.03],0.1004852023176035
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANXA11,Annexin A11,27667,155,1.07 [0.86-1.33],0.5404013942171438
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANXA2,Annexin A2,23205,130,1.02 [0.81-1.28],0.8860639611651571
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANXA3,Annexin A3,27944,155,1.11 [0.91-1.36],0.2900539024136219
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANXA4,Annexin A4,27613,153,1.14 [0.94-1.38],0.1860379781118607
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ANXA5,Annexin A5,26991,151,0.88 [0.54-1.42],0.6030639388651529
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AOC1,Amiloride-sensitive amine oxidase [copper-containing],27198,150,0.87 [0.66-1.16],0.35399791687228
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AOC3,Membrane primary amine oxidase,27845,154,0.74 [0.47-1.16],0.1896706775925979
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AP1G2,AP-1 complex subunit gamma-like 2,24054,130,1.11 [0.91-1.36],0.312582815642899
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AP2B1,AP-2 complex subunit beta,23514,134,0.96 [0.68-1.36],0.8395857392892108
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AP3B1,AP-3 complex subunit beta-1,24066,134,1.06 [0.85-1.32],0.5914372760248429
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AP3S2,AP-3 complex subunit sigma-2,24136,133,1.00 [0.70-1.42],0.9838421049394606
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,27629,155,1.22 [0.93-1.61],0.1557987345486399
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APCS,Serum amyloid P-component,24021,133,1.38 [0.87-2.18],0.1685619119342002
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,27888,155,1.18 [0.94-1.48],0.1499826250674087
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APLP1,Amyloid-like protein 1,27752,155,0.91 [0.69-1.20],0.4943435743759103
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APOA1,Apolipoprotein A-I,24239,135,0.97 [0.53-1.76],0.9128395307282108
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APOA2,Apolipoprotein A-II,24205,134,1.08 [0.77-1.53],0.6483361872558018
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APOA4,Apolipoprotein A-IV,24239,135,1.44 [1.01-2.05],0.0446800910501828
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APOB,Apolipoprotein B-100,24205,134,1.13 [0.54-2.37],0.744136164541106
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APOBR,Apolipoprotein B receptor,23568,133,0.82 [0.56-1.20],0.3085158517158939
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APOC1,Apolipoprotein C-I,24187,134,1.02 [0.66-1.60],0.9146087777285068
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APOD,Apolipoprotein D,23119,128,1.16 [0.83-1.62],0.3881727678458625
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APOE,Apolipoprotein E,24239,135,1.01 [0.81-1.26],0.926984178254372
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APOF,Apolipoprotein F,24205,134,1.17 [0.63-2.18],0.617745834677982
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APOH,Beta-2-glycoprotein 1,27756,156,1.00 [0.67-1.49],0.9867112199999548
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APOL1,Apolipoprotein L1,24205,134,0.86 [0.66-1.12],0.2766746443594905
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APOM,Apolipoprotein M,27797,154,0.88 [0.51-1.50],0.6403659084455587
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APP,Amyloid-beta precursor protein,27715,155,1.12 [0.91-1.37],0.3018999621535844
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APPL2,DCC-interacting protein 13-beta,23679,128,1.15 [0.98-1.34],0.0802318727470029
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",APRT,Adenine phosphoribosyltransferase,27520,153,1.02 [0.76-1.37],0.898364056818948
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARAF,Serine/threonine-protein kinase A-Raf,23740,131,1.05 [0.83-1.34],0.6657926255855667
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AREG,Amphiregulin,27629,155,1.13 [0.88-1.46],0.3379475179401274
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARF6,ADP-ribosylation factor 6,24066,134,1.09 [0.93-1.27],0.2977428262144656
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARFIP1,Arfaptin-1,24152,133,1.25 [1.00-1.58],0.0545762786949399
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARG1,Arginase-1,27605,154,1.04 [0.80-1.35],0.7821379919126292
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARG2,"Arginase-2, mitochondrial",24054,130,0.89 [0.60-1.32],0.5529531429071054
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARHGAP1,Rho GTPase-activating protein 1,27102,151,1.06 [0.78-1.45],0.7091879154132814
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARHGAP25,Rho GTPase-activating protein 25,27102,151,1.06 [0.84-1.34],0.6136297350994551
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARHGAP30,Rho GTPase-activating protein 30,23740,131,1.09 [0.72-1.64],0.6882581497486987
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARHGAP45,Rho GTPase-activating protein 45,23679,128,1.12 [0.91-1.38],0.2919690790482944
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARHGAP5,Rho GTPase-activating protein 5,23315,128,0.85 [0.66-1.09],0.1924662335231867
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARHGEF1,Rho guanine nucleotide exchange factor 1,24136,133,1.14 [0.95-1.38],0.1497984128688156
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARHGEF10,Rho guanine nucleotide exchange factor 10,24152,133,1.17 [0.98-1.39],0.0781128746527671
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARHGEF12,Rho guanine nucleotide exchange factor 12,27705,155,1.12 [0.98-1.29],0.1020834531384776
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARHGEF5,Rho guanine nucleotide exchange factor 5,23410,130,0.96 [0.76-1.21],0.7260755465591311
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARID3A,AT-rich interactive domain-containing protein 3A,23410,130,0.52 [0.32-0.82],0.0055907647846499
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARID4B,AT-rich interactive domain-containing protein 4B,27073,151,0.93 [0.65-1.32],0.671920702432079
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARL13B,ADP-ribosylation factor-like protein 13B,23424,129,1.33 [1.08-1.64],0.0077616272832779
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,23424,129,1.33 [0.89-1.99],0.1638907748916306
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARMCX2,Armadillo repeat-containing X-linked protein 2,23410,130,0.88 [0.66-1.18],0.3891118416190869
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARNT,Aryl hydrocarbon receptor nuclear translocator,27198,150,1.03 [0.70-1.52],0.8743834243808145
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,23424,129,0.96 [0.69-1.32],0.7820117414075604
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARSA,Arylsulfatase A,27756,156,1.28 [0.95-1.72],0.1108162105617563
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARSB,Arylsulfatase B,27629,155,1.07 [0.83-1.38],0.5889357185080122
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ART3,Ecto-ADP-ribosyltransferase 3,27845,154,1.23 [0.79-1.89],0.3567567943181583
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ART5,Ecto-ADP-ribosyltransferase 5,23410,130,0.57 [0.38-0.84],0.005029354140922
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ARTN,Artemin,27198,150,0.79 [0.54-1.15],0.2145389871713264
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ASAH1,Acid ceramidase,23961,132,1.06 [0.75-1.50],0.7483130985110128
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ASAH2,Neutral ceramidase,27559,153,1.20 [0.90-1.60],0.2085868380167279
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ASGR1,Asialoglycoprotein receptor 1,27559,153,1.42 [0.89-2.27],0.146286276646014
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ASGR2,Asialoglycoprotein receptor 2,24205,134,1.72 [0.93-3.16],0.0841876472585624
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ASPN,Asporin,24191,134,0.53 [0.27-1.02],0.0562321682087604
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ASPSCR1,Tether containing UBX domain for GLUT4,24152,133,1.20 [0.94-1.52],0.1432788033994772
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ASRGL1,Isoaspartyl peptidase/L-asparaginase,23568,133,1.14 [0.97-1.35],0.1048512733353653
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ASS1,Argininosuccinate synthase,23424,129,0.83 [0.67-1.03],0.0897971423723256
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATF2,Cyclic AMP-dependent transcription factor ATF-2,27073,151,0.94 [0.75-1.18],0.5986726649347447
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATF4,Cyclic AMP-dependent transcription factor ATF-4,23315,128,0.93 [0.56-1.55],0.7884766183705045
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATG16L1,Autophagy-related protein 16-1,24066,134,1.13 [0.93-1.37],0.2285321007942191
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATG4A,Cysteine protease ATG4A,27102,151,1.23 [0.98-1.55],0.0705221493733129
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATOX1,Copper transport protein ATOX1,27849,154,1.15 [0.94-1.40],0.177389048400425
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,23424,129,0.90 [0.62-1.31],0.5848902816457227
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,23424,129,1.33 [0.85-2.09],0.2160873963970968
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,23424,129,0.98 [0.64-1.50],0.932661100191836
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATP1B4,Protein ATP1B4,23315,128,1.03 [0.69-1.52],0.8925298057176823
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATP2B4,Plasma membrane calcium-transporting ATPase 4,23424,129,1.18 [0.94-1.47],0.147224826413079
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATP5F1D,"ATP synthase subunit delta, mitochondrial",23424,129,1.20 [0.94-1.53],0.1454130272196738
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATP5IF1,"ATPase inhibitor, mitochondrial",27889,155,1.13 [0.99-1.29],0.0641315133723469
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATP5PO,"ATP synthase subunit O, mitochondrial",27073,151,0.76 [0.52-1.10],0.1414585420523
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATP6AP2,Renin receptor,27102,151,1.09 [0.79-1.50],0.6069572165374675
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATP6V1D,V-type proton ATPase subunit D,27629,155,1.30 [0.81-2.10],0.2824187661741392
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATP6V1F,V-type proton ATPase subunit F,27021,151,1.23 [1.00-1.51],0.0449899617874242
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATP6V1G1,V-type proton ATPase subunit G 1,23568,133,1.18 [0.95-1.48],0.1329448829167548
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATP6V1G2,V-type proton ATPase subunit G 2,23424,129,0.90 [0.75-1.07],0.2377850549686114
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATRAID,All-trans retinoic acid-induced differentiation factor,24066,134,1.43 [0.97-2.10],0.0701577514549969
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATRN,"Attractin, Isoform 2",24239,135,0.50 [0.19-1.36],0.1741399432602521
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATXN10,Ataxin-10,27073,151,1.16 [0.94-1.42],0.1616432533093604
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATXN2,Ataxin-2,23410,130,1.01 [0.87-1.16],0.9425225399218432
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATXN2L,Ataxin-2-like protein,24152,133,1.00 [0.72-1.40],0.996704102287736
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ATXN3,Ataxin-3,24136,133,1.20 [0.93-1.56],0.1572880017387862
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AXIN1,Axin-1,27705,155,1.16 [1.00-1.35],0.0540908668029234
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AXL,Tyrosine-protein kinase receptor UFO,27845,154,1.12 [0.67-1.89],0.6625736510217024
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AZI2,5-azacytidine-induced protein 2,24152,133,1.08 [0.80-1.44],0.6225325974566889
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",AZU1,Azurocidin,26866,148,1.05 [0.88-1.25],0.6194561586974356
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",B2M,Beta-2-microglobulin,24239,135,1.31 [0.90-1.92],0.1556326241944577
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,23424,129,0.61 [0.26-1.46],0.2656178038983643
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",23568,133,1.05 [0.67-1.65],0.8294863335967237
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",B4GALT1,"Beta-1,4-galactosyltransferase 1",27889,155,1.16 [0.69-1.95],0.5627169085131385
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",B4GAT1,"Beta-1,4-glucuronyltransferase 1",27756,156,0.86 [0.48-1.54],0.6084257624411115
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BABAM1,BRISC and BRCA1-A complex member 1,23508,131,1.33 [0.80-2.19],0.2685564110408901
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BACH1,Transcription regulator protein BACH1,27705,155,1.11 [0.91-1.35],0.2908105493301316
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BAG3,BAG family molecular chaperone regulator 3,27517,152,1.10 [0.76-1.60],0.6057446901974721
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BAG4,BAG family molecular chaperone regulator 4,23508,131,1.34 [0.99-1.80],0.0562019983808576
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BAG6,Large proline-rich protein BAG6,27243,152,1.64 [1.13-2.38],0.0097513635105564
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,27102,151,1.04 [0.82-1.31],0.7512083896150241
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BAMBI,BMP and activin membrane-bound inhibitor homolog,27102,151,1.29 [0.81-2.04],0.279760017907491
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BANK1,B-cell scaffold protein with ankyrin repeats,27705,155,1.15 [1.00-1.32],0.0485039286932527
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BAP18,Chromatin complexes subunit BAP18,24136,133,1.02 [0.81-1.29],0.8609055495440039
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BATF,Basic leucine zipper transcriptional factor ATF-like,23514,134,0.94 [0.77-1.16],0.5722308409679342
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BAX,Apoptosis regulator BAX,27031,151,1.05 [0.89-1.23],0.5683753261841362
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BCAM,Basal cell adhesion molecule,27756,156,0.46 [0.25-0.85],0.0135730039862796
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BCAN,Brevican core protein,27559,153,0.97 [0.63-1.49],0.8827385611459152
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24191,134,1.35 [0.82-2.21],0.2403168288068282
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",23410,130,0.85 [0.61-1.21],0.3699333425245368
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BCHE,Cholinesterase,23758,129,1.12 [0.61-2.06],0.7042888146910247
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BCL2,Apoptosis regulator Bcl-2,24066,134,1.00 [0.73-1.38],0.9883612955522566
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BCL2L1,Bcl-2-like protein 1,24136,133,1.11 [0.94-1.31],0.2015932948219405
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",27705,155,1.29 [0.92-1.79],0.1361468844707967
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BCL2L15,Bcl-2-like protein 15,23508,131,1.21 [0.95-1.56],0.1270123347640399
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BCL7A,B-cell CLL/lymphoma 7 protein family member A,23315,128,1.02 [0.79-1.33],0.879360193099251
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BCL7B,B-cell CLL/lymphoma 7 protein family member B,24054,130,0.97 [0.66-1.41],0.8598940634601129
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BCR,Breakpoint cluster region protein,27705,155,1.15 [0.98-1.34],0.0877551242661322
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BDNF,Brain-derived neurotrophic factor,24190,135,1.08 [0.89-1.32],0.436776692026158
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BECN1,Beclin-1,23568,133,1.13 [0.87-1.47],0.3602539140398381
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BEX3,Protein BEX3,23315,128,1.16 [0.85-1.59],0.3452230423893283
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BGLAP,Osteocalcin,24190,135,0.77 [0.64-0.91],0.0028467930393969
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BGN,Biglycan,27055,151,0.90 [0.80-1.02],0.1042162458038264
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BHLHE40,Class E basic helix-loop-helix protein 40,23410,130,0.83 [0.64-1.08],0.1585582655937469
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,23424,129,1.19 [0.63-2.24],0.5921396934726215
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BID,BH3-interacting domain death agonist,27705,155,1.04 [0.85-1.28],0.7011972787644736
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BIN2,Bridging integrator 2,27756,156,1.17 [1.00-1.36],0.0476516180592529
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BIRC2,Baculoviral IAP repeat-containing protein 2,27102,151,1.10 [0.88-1.38],0.3944887695049164
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BLMH,Bleomycin hydrolase,28090,154,1.11 [0.72-1.72],0.6347324634402707
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BLNK,B-cell linker protein,23508,131,1.19 [0.79-1.78],0.4102172161490045
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,23410,130,0.98 [0.77-1.24],0.8571237378511549
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24136,133,1.14 [0.76-1.70],0.5306911379338012
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BLVRB,Flavin reductase,27756,156,1.08 [0.88-1.32],0.4798550971696336
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BMP10,Bone morphogenetic protein 10,23679,128,0.64 [0.36-1.15],0.1360190098631497
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BMP4,Bone morphogenetic protein 4,27517,152,1.03 [0.75-1.41],0.8466192126713893
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BMP6,Bone morphogenetic protein 6,27199,152,1.18 [0.84-1.67],0.3448829973680184
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BMPER,BMP-binding endothelial regulator protein,23679,128,0.64 [0.29-1.38],0.2517133539819061
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24191,134,1.23 [0.78-1.93],0.3792376985616024
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,23508,131,1.31 [0.93-1.83],0.1247002639106968
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BOC,Brother of CDO,27243,152,0.64 [0.35-1.17],0.1512906060007203
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BOLA1,BolA-like protein 1,23410,130,1.07 [0.80-1.43],0.663217241937858
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BOLA2_BOLA2B,BolA-like protein 2,23568,133,1.11 [0.83-1.49],0.4881820662601275
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BPIFA2,BPI fold-containing family A member 2,22700,122,0.94 [0.80-1.11],0.4560579917209388
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BPIFB1,BPI fold-containing family B member 1,27681,154,1.08 [0.86-1.34],0.5228280781094234
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BPIFB2,BPI fold-containing family B member 2,24143,134,0.91 [0.70-1.18],0.4651465162322165
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BRAP,BRCA1-associated protein,23857,134,1.13 [0.97-1.32],0.1259490557570278
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BRD1,Bromodomain-containing protein 1,23740,131,0.98 [0.57-1.70],0.944820303535904
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BRD2,Bromodomain-containing protein 2,23410,130,1.21 [0.78-1.89],0.3965089189221105
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BRD3,Bromodomain-containing protein 3,23424,129,1.07 [0.77-1.48],0.6949860430178989
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BRDT,Bromodomain testis-specific protein,23424,129,0.86 [0.54-1.37],0.525048003642945
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BRK1,Protein BRICK1,27073,151,1.16 [0.84-1.60],0.3737027006771333
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BRME1,Break repair meiotic recombinase recruitment factor 1,23410,130,0.87 [0.56-1.34],0.5271981872873177
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BRSK2,Serine/threonine-protein kinase BRSK2,24152,133,1.02 [0.67-1.55],0.9118045118982938
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BSG,Basigin,27994,156,1.56 [0.74-3.26],0.2418369377553404
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BSND,Barttin,23315,128,1.15 [0.73-1.82],0.5403025760834033
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,27991,156,0.82 [0.64-1.07],0.1459549826606865
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BST2,Bone marrow stromal antigen 2,27991,156,1.14 [0.89-1.45],0.3100988357530821
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BTC,Probetacellulin,27102,151,1.15 [0.96-1.37],0.1205688131123742
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BTD,Biotinidase,24239,135,0.65 [0.30-1.39],0.2634959782850065
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BTLA,B- and T-lymphocyte attenuator,23315,128,0.95 [0.77-1.17],0.6486788790141879
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BTN1A1,Butyrophilin subfamily 1 member A1,24008,129,0.91 [0.61-1.38],0.6665950325968886
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BTN2A1,Butyrophilin subfamily 2 member A1,27889,155,0.86 [0.49-1.52],0.6008606069953137
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BTN3A2,Butyrophilin subfamily 3 member A2,27705,155,1.46 [1.03-2.08],0.0358403600046108
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",BTNL10,Butyrophilin-like protein 10,23315,128,0.91 [0.58-1.43],0.6729047568086233
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C19orf12,Protein C19orf12,27073,151,0.96 [0.75-1.22],0.7382841630795105
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C1GALT1C1,C1GALT1-specific chaperone 1,23424,129,0.88 [0.51-1.51],0.6418808864321544
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C1QA,Complement C1q subcomponent subunit A,27897,155,1.62 [0.89-2.94],0.1144455837627333
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24152,133,1.19 [0.98-1.43],0.0719906531428436
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C1QL2,Complement C1q-like protein 2,23508,131,0.74 [0.49-1.11],0.14113351242664
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,27845,154,1.19 [0.85-1.66],0.3001960150555777
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,23679,128,0.61 [0.42-0.90],0.0128571797981409
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24152,133,0.99 [0.60-1.63],0.9770419336829866
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,23630,128,0.74 [0.54-1.02],0.0694151754725376
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C1R,Complement C1r subcomponent,24239,135,1.29 [0.62-2.71],0.4983018054099318
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C1RL,Complement C1r subcomponent-like protein,24201,134,0.88 [0.38-2.03],0.7621190686490084
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C1S,Complement C1s subcomponent,24239,135,1.20 [0.55-2.61],0.6482618287269096
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C2,Complement C2,27797,154,1.26 [0.66-2.39],0.4783478507515188
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C2CD2L,Phospholipid transfer protein C2CD2L,27021,151,0.87 [0.62-1.22],0.4294779804899206
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C2orf69,UPF0565 protein C2orf69,23514,134,0.90 [0.67-1.22],0.5072268538925397
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C3,Complement C3,22987,124,0.86 [0.57-1.29],0.4692755971390933
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C4BPB,C4b-binding protein beta chain,27849,154,1.09 [0.78-1.54],0.6097302590718958
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C5,Complement C5,24239,135,1.16 [0.40-3.35],0.7859466919399134
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C7,Complement component C7,23657,129,1.35 [0.78-2.32],0.2864410643174697
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C7orf50,Uncharacterized protein C7orf50,24136,133,0.62 [0.25-1.51],0.2890367308118146
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C8B,Complement component C8 beta chain,24239,135,0.61 [0.36-1.03],0.0652853413651703
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C9,Complement component C9,24205,134,1.00 [0.71-1.40],0.9876840624068975
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",C9orf40,Uncharacterized protein C9orf40,24066,134,1.08 [0.89-1.31],0.4384919755480778
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CA1,Carbonic anhydrase 1,27109,150,1.07 [0.86-1.34],0.5432122857611315
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CA11,Carbonic anhydrase-related protein 11,27102,151,1.06 [0.70-1.61],0.7770775624185994
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CA12,Carbonic anhydrase 12,27629,155,0.98 [0.64-1.52],0.9373643811963922
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CA13,Carbonic anhydrase 13,27457,153,1.12 [0.97-1.29],0.1095136352399546
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CA14,Carbonic anhydrase 14,27985,155,1.39 [0.92-2.09],0.1170378584503188
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CA2,Carbonic anhydrase 2,27666,154,1.13 [0.93-1.37],0.2083204715628548
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CA3,Carbonic anhydrase 3,28040,154,1.09 [0.87-1.36],0.4501305452290988
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CA4,Carbonic anhydrase 4,28090,154,1.28 [0.71-2.33],0.4114439029137066
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CA5A,"Carbonic anhydrase 5A, mitochondrial",27243,152,0.99 [0.84-1.16],0.8772355010928733
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CA6,Carbonic anhydrase 6,27668,156,0.97 [0.77-1.21],0.7653590846477496
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CA7,Carbonic anhydrase 7,23740,131,1.05 [0.66-1.67],0.8267444912361605
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CA8,Carbonic anhydrase-related protein,23508,131,0.84 [0.42-1.67],0.6112708576668625
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CA9,Carbonic anhydrase 9,27985,155,1.09 [0.79-1.51],0.5900932394953355
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CABP2,Calcium-binding protein 2,23514,134,0.97 [0.75-1.26],0.8404312483310713
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,23410,130,0.81 [0.47-1.42],0.4669342704291466
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,23424,129,1.10 [0.85-1.42],0.4716676478220611
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,23410,130,1.13 [0.87-1.47],0.3637023839820712
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24152,133,1.19 [0.98-1.45],0.0769203924391876
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CACYBP,Calcyclin-binding protein,23631,128,1.14 [0.96-1.35],0.1312742628042554
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CADPS,Calcium-dependent secretion activator 1,23514,134,1.05 [0.74-1.49],0.7809306045093084
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CALB1,Calbindin,27629,155,1.25 [0.88-1.78],0.2086861574071339
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CALB2,Calretinin,27073,151,1.18 [0.75-1.84],0.4766566741171115
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CALCA,Calcitonin,27507,153,1.15 [0.91-1.47],0.2474559384514966
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CALCB,Calcitonin gene-related peptide 2,24136,133,0.96 [0.62-1.48],0.8510924520205059
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,27894,155,1.19 [1.03-1.36],0.0152253265517393
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,23568,133,1.18 [0.96-1.46],0.1154101309148969
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CALY,Neuron-specific vesicular protein calcyon,23424,129,1.15 [0.78-1.72],0.4804753463645645
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,27102,151,1.30 [0.97-1.75],0.0834283405691762
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,23514,134,1.04 [0.77-1.40],0.8044046266745686
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24152,133,1.09 [0.94-1.27],0.2428972814599677
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CANT1,Soluble calcium-activated nucleotidase 1,27676,155,1.02 [0.51-2.06],0.9454177860242744
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CAPG,Macrophage-capping protein,27537,153,1.09 [0.86-1.38],0.4751190161205685
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CAPN3,Calpain-3,24054,130,1.09 [0.71-1.68],0.6970295548001375
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CAPS,Calcyphosin,24136,133,1.11 [0.95-1.29],0.1885988805566235
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CARHSP1,Calcium-regulated heat-stable protein 1,27073,151,1.18 [0.91-1.53],0.2228678536717186
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CASC3,Protein CASC3,23514,134,1.21 [0.82-1.77],0.3326516166533723
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CASP1,Caspase-1,27073,151,0.91 [0.73-1.13],0.3972843634009668
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CASP10,Caspase-10,27073,151,1.25 [1.03-1.53],0.0240579911767152
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CASP2,Caspase-2,27705,155,1.08 [0.88-1.33],0.4412291238873497
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CASP3,Caspase-3,28090,154,1.16 [0.99-1.37],0.0669018087805657
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CASP4,Caspase-4,23740,131,0.97 [0.87-1.07],0.5081597594105621
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CASP7,Caspase-7,24136,133,1.20 [0.99-1.46],0.0699217250667048
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CASP8,Caspase-8,27898,155,1.04 [0.84-1.30],0.7097124734329707
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CASP9,Caspase-9,23508,131,1.08 [0.83-1.40],0.5892231599401956
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CASQ2,Calsequestrin-2,23424,129,1.21 [0.91-1.60],0.1820556142103424
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CAT,Catalase,23836,132,1.21 [0.91-1.61],0.178745062823744
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CBLIF,Cobalamin binding intrinsic factor,27707,155,0.96 [0.78-1.17],0.6726968709349712
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CBLN1,Cerebellin-1,23410,130,0.91 [0.75-1.10],0.3336788573829442
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CBLN4,Cerebellin-4,27985,155,0.69 [0.44-1.08],0.1007983264711792
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CBS,Cystathionine beta-synthase,23568,133,0.98 [0.70-1.37],0.913967463548656
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CBX2,Chromobox protein homolog 2,23424,129,0.96 [0.62-1.47],0.8397969472504394
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,27559,153,1.21 [1.01-1.46],0.0401495563237802
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCAR2,Cell cycle and apoptosis regulator protein 2,24136,133,0.80 [0.56-1.15],0.2265342317083547
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCDC134,Coiled-coil domain-containing protein 134,24054,130,1.19 [0.86-1.63],0.2891583899043494
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCDC28A,Coiled-coil domain-containing protein 28A,23514,134,0.63 [0.36-1.11],0.1117645897216877
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCDC50,Coiled-coil domain-containing protein 50,24152,133,1.14 [0.94-1.37],0.1833504196533477
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCDC80,Coiled-coil domain-containing protein 80,27752,155,0.83 [0.54-1.26],0.3770427493003379
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,23568,133,1.09 [0.83-1.42],0.5413921992386905
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL11,Eotaxin,28040,156,1.47 [1.03-2.10],0.0332131938577482
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL13,C-C motif chemokine 13,27990,155,1.10 [0.90-1.35],0.3407797260765909
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL14,C-C motif chemokine 14,27661,154,0.96 [0.67-1.39],0.8408297784190834
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL15,C-C motif chemokine 15,28090,154,1.19 [0.88-1.62],0.2552034564807156
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL16,C-C motif chemokine 16,28090,154,1.00 [0.77-1.31],0.9758630584789012
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL17,C-C motif chemokine 17,27713,154,1.06 [0.91-1.24],0.4315378945951277
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL18,C-C motif chemokine 18,27350,152,1.13 [0.94-1.35],0.1931965637913097
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL19,C-C motif chemokine 19,27991,156,1.02 [0.92-1.14],0.6834971255894249
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL2,C-C motif chemokine 2,27517,152,1.12 [0.86-1.46],0.4087568154641467
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL20,C-C motif chemokine 20,28040,156,0.95 [0.80-1.13],0.5579735614811876
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL21,C-C motif chemokine 21,27889,155,1.34 [1.01-1.78],0.0451829561035934
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL22,C-C motif chemokine 22,27493,152,0.97 [0.74-1.29],0.8532884172452753
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL23,C-C motif chemokine 23,27889,155,1.31 [0.93-1.83],0.1169332843385053
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL24,C-C motif chemokine 24,27841,154,0.87 [0.73-1.03],0.1093248854522997
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL25,C-C motif chemokine 25,28040,156,1.10 [0.84-1.46],0.4852326286920186
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL26,C-C motif chemokine 26,27705,155,0.97 [0.83-1.14],0.7338837701255634
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL27,C-C motif chemokine 27,27752,155,1.05 [0.83-1.34],0.659264079001275
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL28,C-C motif chemokine 28,27617,154,1.13 [0.90-1.42],0.2742013800600034
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL3,C-C motif chemokine 3,27705,155,0.98 [0.77-1.24],0.863283474929247
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL4,C-C motif chemokine 4,27799,155,0.98 [0.79-1.22],0.8587333250429873
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL5,C-C motif chemokine 5,27845,154,1.06 [0.93-1.22],0.3792962180350754
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL7,C-C motif chemokine 7,27705,155,1.04 [0.83-1.31],0.713408286621731
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCL8,C-C motif chemokine 8,27947,155,1.15 [0.91-1.45],0.2463232742897185
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCN1,CCN family member 1,27581,155,0.94 [0.79-1.13],0.5248277141375243
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCN2,CCN family member 2,27751,153,1.07 [0.84-1.36],0.5955682615842631
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCN3,CCN family member 3,28050,152,0.93 [0.60-1.43],0.7386717119338027
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCN4,CCN family member 4,27985,155,1.05 [0.75-1.47],0.7815803293755935
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCN5,CCN family member 5,27756,156,0.84 [0.59-1.21],0.3584631674835378
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCND2,G1/S-specific cyclin-D2,23740,131,0.96 [0.61-1.50],0.8424002642276758
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCNE1,G1/S-specific cyclin-E1,23508,131,0.98 [0.82-1.18],0.8675043109703782
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCS,Copper chaperone for superoxide dismutase,27559,153,1.12 [0.84-1.49],0.4584391772834207
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CCT5,T-complex protein 1 subunit epsilon,27102,151,1.24 [0.93-1.64],0.1415266638812145
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD101,Immunoglobulin superfamily member 2,24066,134,0.75 [0.52-1.09],0.1354803941903455
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD109,CD109 antigen,27756,156,0.80 [0.53-1.21],0.2921718824925903
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD14,Monocyte differentiation antigen CD14,27151,153,1.23 [0.88-1.73],0.2233279556307484
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD160,CD160 antigen,28040,156,0.93 [0.68-1.27],0.6464754646877207
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD163,Scavenger receptor cysteine-rich type 1 protein M130,27845,154,1.14 [0.82-1.59],0.4276953883325143
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD164,Sialomucin core protein 24,27756,156,0.79 [0.43-1.43],0.4293988446518165
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD164L2,CD164 sialomucin-like 2 protein,23514,134,0.72 [0.45-1.16],0.1790728062135755
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD177,CD177 antigen,27713,156,1.06 [0.94-1.19],0.3463668719114393
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD1C,T-cell surface glycoprotein CD1c,27849,154,0.50 [0.29-0.85],0.010136236090557
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD2,T-cell surface antigen CD2,23424,129,1.06 [0.69-1.62],0.7887175239262332
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD200,OX-2 membrane glycoprotein,27705,155,0.90 [0.52-1.56],0.70257817070675
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD200R1,Cell surface glycoprotein CD200 receptor 1,27617,154,1.01 [0.67-1.53],0.9490643348906752
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD207,C-type lectin domain family 4 member K,27166,154,0.99 [0.68-1.44],0.9501374573539684
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD209,CD209 antigen,27818,153,0.69 [0.47-1.01],0.0538878194465792
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD22,B-cell receptor CD22,28040,156,0.96 [0.67-1.36],0.8071558827394567
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD226,CD226 antigen,23508,131,1.27 [0.85-1.89],0.2363362690444622
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD244,Natural killer cell receptor 2B4,28040,156,0.92 [0.54-1.57],0.7653528796985607
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD248,Endosialin,24190,135,0.93 [0.62-1.40],0.7213602907148247
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD27,CD27 antigen,27849,154,0.97 [0.67-1.40],0.8689689100917986
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD274,Programmed cell death 1 ligand 1,27559,153,1.32 [0.91-1.92],0.1400079987816456
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD276,CD276 antigen,27754,153,0.59 [0.41-0.86],0.0059700017599476
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD28,T-cell-specific surface glycoprotein CD28,27102,151,0.98 [0.65-1.48],0.929335062469251
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD2AP,CD2-associated protein,27752,155,1.29 [1.04-1.60],0.0208101111858584
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD300A,CMRF35-like molecule 8,23679,128,1.56 [0.88-2.76],0.1290919694010194
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD300C,CMRF35-like molecule 6,27991,156,1.27 [0.84-1.91],0.2543460854902251
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD300E,CMRF35-like molecule 2,27882,155,0.94 [0.65-1.36],0.743688838974523
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD300LF,CMRF35-like molecule 1,27985,155,1.04 [0.83-1.32],0.7125624002725122
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD300LG,CMRF35-like molecule 9,27756,156,0.77 [0.53-1.13],0.1824615440666984
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD302,CD302 antigen,27629,155,1.43 [0.90-2.26],0.1260363875578863
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD33,Myeloid cell surface antigen CD33,27849,154,0.94 [0.79-1.12],0.5098509304251724
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD34,Hematopoietic progenitor cell antigen CD34,27899,156,1.19 [0.66-2.14],0.5551961321007176
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD36,Platelet glycoprotein 4,23508,131,1.23 [0.86-1.76],0.2504123434053725
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,27629,155,1.68 [1.08-2.63],0.0226031619042656
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD3D,T-cell surface glycoprotein CD3 delta chain,23410,130,0.95 [0.59-1.55],0.8489616498655843
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD3E,T-cell surface glycoprotein CD3 epsilon chain,23740,131,1.07 [0.68-1.66],0.7762532876963089
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD3G,T-cell surface glycoprotein CD3 gamma chain,23508,131,0.88 [0.71-1.10],0.2596193563729695
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD4,T-cell surface glycoprotein CD4,27659,154,1.38 [0.94-2.03],0.1030692624172372
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD40,Tumor necrosis factor receptor superfamily member 5,27751,154,1.36 [1.04-1.77],0.0225247584238808
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD40LG,CD40 ligand,28040,156,1.09 [0.91-1.31],0.3424448070963387
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD46,Membrane cofactor protein,27565,154,1.52 [0.98-2.36],0.0605235961021441
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD48,CD48 antigen,27841,154,1.18 [0.72-1.92],0.5171548877253842
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD5,T-cell surface glycoprotein CD5,27947,155,1.16 [0.76-1.78],0.493744303492471
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD55,Complement decay-accelerating factor,26767,150,1.08 [0.62-1.88],0.7905112604110149
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD58,Lymphocyte function-associated antigen 3,27714,152,0.66 [0.30-1.46],0.3007454336205297
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD59,CD59 glycoprotein,26726,150,1.77 [0.99-3.17],0.055827866648596
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD5L,CD5 antigen-like,24096,133,0.78 [0.54-1.11],0.168684256733636
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD6,T-cell differentiation antigen CD6,27994,156,1.01 [0.77-1.31],0.9549571753666264
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD63,CD63 antigen,27517,152,1.16 [0.88-1.53],0.2820551018188114
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD69,Early activation antigen CD69,27620,155,1.23 [1.04-1.45],0.015119454471879
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD7,T-cell antigen CD7,23458,131,0.86 [0.57-1.29],0.4685284548123789
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD70,CD70 antigen,27705,155,0.90 [0.64-1.26],0.5280356486317456
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD72,B-cell differentiation antigen CD72,23679,128,0.62 [0.41-0.95],0.0283742361384693
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD74,HLA class II histocompatibility antigen gamma chain,27991,156,0.97 [0.64-1.46],0.8694200770535663
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD79B,B-cell antigen receptor complex-associated protein beta chain,28040,156,1.07 [0.77-1.48],0.6957830367431834
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD80,T-lymphocyte activation antigen CD80,24191,134,0.72 [0.44-1.19],0.2018986298427516
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD82,CD82 antigen,23740,131,1.38 [1.04-1.83],0.0265298376219021
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD83,CD83 antigen,27705,155,1.24 [0.82-1.88],0.3063247979363126
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD84,SLAM family member 5,27705,155,1.40 [0.89-2.21],0.1500954683192973
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD86,T-lymphocyte activation antigen CD86,24066,134,0.54 [0.35-0.82],0.003790857063915
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD8A,T-cell surface glycoprotein CD8 alpha chain,27991,156,1.24 [0.93-1.65],0.1411997884569723
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD93,Complement component C1q receptor,26684,146,0.71 [0.44-1.16],0.1696919095645862
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD99,CD99 antigen,27756,156,1.10 [0.53-2.29],0.8018500077020463
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CD99L2,CD99 antigen-like protein 2,27756,156,1.25 [0.69-2.24],0.4585156117756637
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDA,Cytidine deaminase,24142,133,1.12 [0.80-1.56],0.4998948081844273
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDAN1,Codanin-1,24136,133,0.66 [0.30-1.44],0.2959379695343637
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDC123,Cell division cycle protein 123 homolog,23315,128,1.06 [0.83-1.35],0.6360529940838788
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDC25A,M-phase inducer phosphatase 1,23315,128,0.94 [0.62-1.43],0.7781086269238503
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDC26,Anaphase-promoting complex subunit CDC26,24025,134,1.08 [0.86-1.36],0.4980289106535127
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDC27,Cell division cycle protein 27 homolog,27102,151,1.12 [0.89-1.41],0.3170151117966953
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDC37,Hsp90 co-chaperone Cdc37,27849,154,1.16 [0.98-1.38],0.0755783549175734
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDC42BPB,Serine/threonine-protein kinase MRCK beta,24066,134,1.08 [0.92-1.27],0.3308831463938073
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDCP1,CUB domain-containing protein 1,27559,153,0.95 [0.70-1.28],0.723815263330252
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDH1,Cadherin-1,26814,151,0.76 [0.51-1.14],0.1823567386554789
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDH15,Cadherin-15,27939,156,1.02 [0.73-1.42],0.8925079305801634
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDH17,Cadherin-17,27752,155,0.94 [0.76-1.17],0.6027231163251343
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDH2,Cadherin-2,27752,155,0.93 [0.62-1.39],0.7260630115844218
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDH22,Cadherin-22,23740,131,1.03 [0.58-1.80],0.9292315744727618
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDH23,Cadherin-23,24136,133,0.85 [0.45-1.60],0.605702926355135
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDH3,Cadherin-3,27991,156,0.77 [0.51-1.16],0.2163683796584791
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDH4,Cadherin-4,23410,130,0.97 [0.68-1.38],0.8533886136228953
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDH5,Cadherin-5,28090,154,0.60 [0.37-0.97],0.0378677591489803
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDH6,Cadherin-6,27752,155,1.16 [0.80-1.68],0.4288540296845476
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDHR1,Cadherin-related family member 1,27073,151,1.05 [0.76-1.46],0.7626116060045267
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDHR2,Cadherin-related family member 2,27629,155,1.00 [0.83-1.20],0.9621036531114332
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDHR5,Cadherin-related family member 5,27752,155,1.25 [0.86-1.81],0.2451763471604395
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDK1,Cyclin-dependent kinase 1,23315,128,1.16 [0.74-1.82],0.5104708122674121
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24152,133,0.84 [0.62-1.12],0.2293839224952047
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDKL5,Cyclin-dependent kinase-like 5,23410,130,1.40 [1.11-1.77],0.0040285044911753
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDKN1A,Cyclin-dependent kinase inhibitor 1,27629,155,1.11 [0.97-1.27],0.1313906774083091
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,27629,155,1.15 [0.99-1.35],0.0755289834984202
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDNF,Cerebral dopamine neurotrophic factor,27629,155,1.36 [0.89-2.07],0.1551920604166747
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,27803,154,0.70 [0.42-1.18],0.177140622361993
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CDSN,Corneodesmosin,27948,156,1.19 [0.86-1.65],0.2870065969809344
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,27804,154,0.82 [0.47-1.43],0.4845478793432265
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24066,134,1.06 [0.87-1.30],0.5434880818676244
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,23740,131,1.05 [0.83-1.31],0.6907324962451078
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24066,134,1.02 [0.67-1.54],0.939383834036984
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,23740,131,1.18 [0.84-1.67],0.3438872322586668
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,27705,155,1.06 [0.90-1.24],0.512914549635302
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,27102,151,1.03 [0.77-1.39],0.826112738158154
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,26745,150,1.04 [0.83-1.29],0.7537896294911482
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24190,135,1.34 [0.92-1.93],0.1234644863489773
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,27243,152,1.30 [1.00-1.70],0.0505451932470554
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEBPA,CCAAT/enhancer-binding protein alpha,23508,131,1.08 [0.73-1.59],0.7076272381720714
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEBPB,CCAAT/enhancer-binding protein beta,27243,152,1.00 [0.69-1.46],0.9973406170253598
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CELA2A,Chymotrypsin-like elastase family member 2A,24190,135,1.23 [0.92-1.63],0.1584533434179199
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CELA3A,Chymotrypsin-like elastase family member 3A,28043,154,1.00 [0.77-1.29],0.9873373771271357
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,23679,128,0.98 [0.54-1.77],0.9407990610255804
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEMIP2,Cell surface hyaluronidase,23508,131,1.17 [0.77-1.78],0.4588662671593166
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEND1,Cell cycle exit and neuronal differentiation protein 1,23410,130,1.14 [0.89-1.46],0.302720850683012
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CENPF,Centromere protein F,23740,131,1.14 [0.86-1.52],0.3659684321865664
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CENPJ,Centromere protein J,23740,131,1.03 [0.82-1.28],0.8168841699091673
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEP112,Centrosomal protein of 112 kDa,23424,129,1.07 [0.76-1.50],0.7056468079956257
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEP152,Centrosomal protein of 152 kDa,23315,128,1.01 [0.68-1.49],0.960393270996928
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEP164,Centrosomal protein of 164 kDa,27198,150,0.91 [0.71-1.17],0.4811811107978601
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEP170,Centrosomal protein of 170 kDa,23568,133,1.09 [0.88-1.34],0.4223606703830481
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEP20,Centrosomal protein 20,27102,151,1.26 [1.05-1.52],0.0133358752040017
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEP290,Centrosomal protein of 290 kDa,23740,131,0.93 [0.66-1.29],0.6523241698169626
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEP350,Centrosome-associated protein 350,23315,128,1.08 [0.69-1.68],0.7297123086980464
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEP43,Centrosomal protein 43,27023,152,1.14 [0.93-1.40],0.2183900439283017
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CEP85,Centrosomal protein of 85 kDa,27102,151,1.30 [1.05-1.60],0.0170899853910973
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CERT,Ceramide transfer protein,27073,151,1.16 [0.92-1.47],0.2029221990313998
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CES1,Liver carboxylesterase 1,27813,154,0.94 [0.78-1.14],0.5517630211767867
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CES2,Cocaine esterase,27629,155,0.85 [0.64-1.11],0.2334911189668445
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CES3,Carboxylesterase 3,27629,155,0.90 [0.72-1.13],0.3655760910575296
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CETN2,Centrin-2,27073,151,1.05 [0.85-1.30],0.6567748177109443
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CETN3,Centrin-3,24066,134,1.11 [0.90-1.37],0.3278664648227628
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CFB,Complement factor B,23777,130,0.83 [0.51-1.36],0.461861390512269
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CFC1,Cryptic protein,27102,151,1.26 [0.96-1.64],0.0938676171144371
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CFD,Complement factor D,24239,135,1.19 [0.50-2.84],0.695788621936861
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CFH,Complement factor H,22798,126,1.24 [0.60-2.57],0.5607951944782
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CFHR2,Complement factor H-related protein 2,24053,135,1.15 [0.85-1.55],0.3758743209091246
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CFHR4,Complement factor H-related protein 4,24196,135,0.96 [0.77-1.20],0.7489628170147611
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CFHR5,Complement factor H-related protein 5,23879,131,1.11 [0.74-1.66],0.6174369800426632
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CFI,Complement factor I,24239,135,1.15 [0.51-2.58],0.7302910815907606
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CFP,Properdin,24239,135,1.12 [0.57-2.21],0.7449402914368816
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CGA,Glycoprotein hormones alpha chain,27756,156,1.09 [0.95-1.25],0.2127338964874223
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24205,134,1.05 [0.81-1.36],0.7143158912908196
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CGN,Cingulin,23514,134,0.92 [0.60-1.40],0.6952556325387842
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CGREF1,Cell growth regulator with EF hand domain protein 1,27752,155,1.42 [1.02-1.97],0.0367784540652491
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,27102,151,1.16 [0.93-1.45],0.1954229687668289
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CHAD,Chondroadherin,23679,128,0.67 [0.49-0.92],0.0138441741033061
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24136,133,1.66 [1.16-2.38],0.0060960998955058
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CHCHD6,MICOS complex subunit MIC25,24054,130,1.30 [0.79-2.14],0.2969237977641298
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CHEK2,Serine/threonine-protein kinase Chk2,27243,152,1.27 [0.86-1.88],0.2307096585305312
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CHGA,Chromogranin-A,24190,135,1.13 [0.95-1.36],0.1701750272880202
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CHGB,Secretogranin-1,27887,156,1.15 [0.81-1.65],0.4317655242396759
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CHI3L1,Chitinase-3-like protein 1,27116,148,0.98 [0.80-1.20],0.8102717942548014
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CHIT1,Chitotriosidase-1,27861,154,1.01 [0.92-1.12],0.8275584802136938
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CHL1,Neural cell adhesion molecule L1-like protein,27802,154,0.79 [0.50-1.24],0.3025720515070642
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CHM,Rab proteins geranylgeranyltransferase component A 1,23514,134,1.26 [0.98-1.62],0.0761636236487188
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CHMP1A,Charged multivesicular body protein 1a,27559,153,1.10 [0.91-1.32],0.3194374779656551
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CHMP6,Charged multivesicular body protein 6,24191,134,1.36 [1.01-1.81],0.0404894836589021
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CHP1,Calcineurin B homologous protein 1,23410,130,1.00 [0.79-1.25],0.9866703201103322
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CHRDL1,Chordin-like protein 1,27841,154,1.01 [0.64-1.62],0.9550303280903084
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CHRDL2,Chordin-like protein 2,27752,155,0.87 [0.69-1.10],0.2468214089171899
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CHRM1,Muscarinic acetylcholine receptor M1,23514,134,0.60 [0.35-1.01],0.0565753507129392
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CIAPIN1,Anamorsin,27849,154,1.20 [0.96-1.49],0.1050223265269004
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CILP,Cartilage intermediate layer protein 1,24190,135,0.94 [0.69-1.27],0.6798015175503771
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CINP,Cyclin-dependent kinase 2-interacting protein,23740,131,1.21 [0.89-1.65],0.2202780027291545
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CIRBP,Cold-inducible RNA-binding protein,24066,134,1.14 [0.96-1.36],0.1278327516329295
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CIT,Citron Rho-interacting kinase,23514,134,1.03 [0.72-1.47],0.8882982321378401
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CKAP4,Cytoskeleton-associated protein 4,27905,156,1.19 [0.70-2.03],0.5215659143165063
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CKB,Creatine kinase B-type,24190,135,0.82 [0.62-1.07],0.1454106858107982
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",27662,152,1.03 [0.83-1.27],0.8153538321055411
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLASP1,CLIP-associating protein 1,23315,128,1.06 [0.85-1.33],0.588563608123682
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLC,Galectin-10,27711,155,0.84 [0.67-1.05],0.1245103863143156
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLEC10A,C-type lectin domain family 10 member A,27559,153,0.92 [0.62-1.37],0.6965579346778401
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLEC11A,C-type lectin domain family 11 member A,27704,156,1.01 [0.75-1.37],0.9256565408618226
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLEC12A,C-type lectin domain family 12 member A,23508,131,1.44 [0.68-3.07],0.3421121649710128
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLEC14A,C-type lectin domain family 14 member A,27756,156,0.99 [0.63-1.56],0.9546857836045052
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLEC1A,C-type lectin domain family 1 member A,27243,152,1.32 [0.85-2.04],0.2151027208533813
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLEC1B,C-type lectin domain family 1 member B,27991,156,1.20 [1.04-1.39],0.013002412563928
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLEC2L,C-type lectin domain family 2 member L,23514,134,1.01 [0.73-1.40],0.9410625218942034
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLEC3B,Tetranectin,23653,129,0.71 [0.32-1.59],0.4094906253436954
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLEC4A,C-type lectin domain family 4 member A,27705,155,0.64 [0.44-0.93],0.0202420908325106
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLEC4C,C-type lectin domain family 4 member C,27705,155,0.70 [0.52-0.95],0.0241701125474497
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLEC4D,C-type lectin domain family 4 member D,27705,155,1.06 [0.84-1.32],0.6406176281903542
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLEC4G,C-type lectin domain family 4 member G,27705,155,1.35 [0.88-2.05],0.1675932068100577
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLEC4M,C-type lectin domain family 4 member M,24143,135,0.76 [0.54-1.07],0.12057491113602
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLEC5A,C-type lectin domain family 5 member A,27663,155,0.75 [0.45-1.25],0.2662852594626566
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLEC6A,C-type lectin domain family 6 member A,27102,151,1.14 [0.84-1.55],0.3852595096209293
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLEC7A,C-type lectin domain family 7 member A,28040,156,1.19 [0.90-1.57],0.2138120473632337
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLGN,Calmegin,23514,134,1.12 [0.78-1.61],0.5535260725926041
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLIC5,Chloride intracellular channel protein 5,23514,134,0.89 [0.52-1.50],0.6537001986404518
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLINT1,Clathrin interactor 1,23315,128,0.94 [0.64-1.38],0.7542329773130182
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLIP2,CAP-Gly domain-containing linker protein 2,27705,155,1.09 [0.96-1.24],0.1945402572891437
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLMP,CXADR-like membrane protein,27985,155,1.55 [0.78-3.08],0.2085295715597229
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLNS1A,Methylosome subunit pICln,23514,134,1.15 [0.72-1.83],0.5601564040543391
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",27507,153,1.09 [0.94-1.27],0.2335128294333481
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLPS,Colipase,27715,155,1.13 [0.92-1.40],0.2344429981588849
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLSPN,Claspin,27021,151,0.83 [0.52-1.32],0.4312043897325865
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLSTN1,Calsyntenin-1,27073,151,1.01 [0.77-1.33],0.9325538218727047
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLSTN2,Calsyntenin-2,28040,156,1.02 [0.71-1.46],0.9055106464349372
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLSTN3,Calsyntenin-3,24136,133,0.82 [0.48-1.42],0.4846992015214744
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLTA,Clathrin light chain A,27243,152,0.98 [0.73-1.33],0.9144831444615438
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLU,Clusterin,24239,135,0.96 [0.57-1.63],0.8777017551799493
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CLUL1,Clusterin-like protein 1,27711,155,0.75 [0.55-1.02],0.0659645176353104
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CMC1,COX assembly mitochondrial protein homolog,24191,134,1.16 [0.97-1.39],0.1082996827562381
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CMIP,C-Maf-inducing protein,24054,130,1.18 [0.97-1.44],0.1050419784864443
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CNDP1,Beta-Ala-His dipeptidase,27845,154,1.03 [0.76-1.41],0.8360041971519815
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CNGB3,Cyclic nucleotide-gated cation channel beta-3,23410,130,0.89 [0.63-1.24],0.4803284890325527
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",23522,133,1.22 [0.99-1.49],0.0609796384279034
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CNPY2,Protein canopy homolog 2,27243,152,1.37 [1.17-1.61],0.0001402308526137
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CNPY4,Protein canopy homolog 4,27629,155,1.12 [0.93-1.36],0.227158990538873
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CNST,Consortin,27752,155,1.23 [1.07-1.40],0.0026868209061639
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CNTF,Ciliary neurotrophic factor,23410,130,1.23 [0.76-1.98],0.3943206271696929
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CNTN1,Contactin-1,28090,154,0.73 [0.44-1.23],0.2412829893993755
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CNTN2,Contactin-2,27985,155,1.01 [0.73-1.38],0.9655176936891384
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CNTN3,Contactin-3,27756,156,1.24 [0.83-1.85],0.2884416934286656
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CNTN4,Contactin-4,27756,156,0.82 [0.46-1.47],0.5034917728229305
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CNTN5,Contactin-5,27815,155,0.70 [0.47-1.04],0.0779680595309852
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CNTNAP2,Contactin-associated protein-like 2,27705,155,0.86 [0.60-1.24],0.4247938517987052
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CNTNAP4,Contactin-associated protein-like 4,23514,134,1.00 [0.85-1.17],0.9592913077896814
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COCH,Cochlin,24191,134,1.09 [0.77-1.54],0.6142752514489574
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COL15A1,Collagen alpha-1(XV) chain,24190,135,0.67 [0.35-1.26],0.2113703322592578
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COL18A1,Collagen alpha-1(XVIII) chain,27865,154,1.54 [0.84-2.82],0.1669092228794797
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COL1A1,Collagen alpha-1(I) chain,28090,154,0.64 [0.37-1.11],0.1128419212612235
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COL24A1,Collagen alpha-1(XXIV) chain,24066,134,0.92 [0.69-1.22],0.5484758925883954
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COL28A1,Collagen alpha-1(XXVIII) chain,23514,134,1.01 [0.80-1.27],0.9266039276580094
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COL2A1,Collagen alpha-1(II) chain,23568,133,0.97 [0.79-1.19],0.747553915618532
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COL3A1,Collagen alpha-1(III) chain,24190,135,1.18 [0.59-2.36],0.6482986664051102
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COL4A1,Collagen alpha-1(IV) chain,27752,155,0.79 [0.55-1.14],0.2025874273717891
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COL4A4,Collagen alpha-4(IV) chain,23700,131,0.93 [0.69-1.27],0.660049836165661
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COL5A1,Collagen alpha-1(V) chain,23679,128,0.49 [0.31-0.78],0.0029454536968922
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COL6A3,Collagen alpha-3(VI) chain,28090,154,1.16 [0.76-1.77],0.4829521992832736
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COL9A1,Collagen alpha-1(IX) chain,27705,155,1.00 [0.73-1.38],0.9834430430891252
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COL9A2,Collagen alpha-2(IX) chain,23740,131,1.19 [0.88-1.62],0.2595958781420909
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COLEC12,Collectin-12,27754,153,0.88 [0.50-1.57],0.6742195756456357
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COMMD1,COMM domain-containing protein 1,23568,133,1.18 [0.91-1.53],0.2223447437932902
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COMMD9,COMM domain-containing protein 9,24054,130,1.29 [0.90-1.86],0.1632286855958654
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COMP,Cartilage oligomeric matrix protein,27439,150,0.69 [0.45-1.05],0.0839707122649025
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COMT,Catechol O-methyltransferase,26955,150,1.16 [0.98-1.37],0.0925069246394881
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COPB2,Coatomer subunit beta',23424,129,1.25 [0.86-1.81],0.2355371951524361
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COPE,Coatomer subunit epsilon,27073,151,1.08 [0.81-1.43],0.6199496087857435
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",23568,133,1.25 [0.90-1.74],0.1834236080623439
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CORO1A,Coronin-1A,27166,152,1.12 [0.97-1.30],0.1356999453214979
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CORO6,Coronin-6,23410,130,0.73 [0.44-1.20],0.2129658280694129
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",27629,155,1.08 [0.89-1.32],0.4262842286432962
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",COX6B1,Cytochrome c oxidase subunit 6B1,24191,134,1.21 [0.73-1.99],0.4569522641895246
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CPA1,Carboxypeptidase A1,28090,154,1.09 [0.85-1.40],0.4921925634994727
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CPA2,Carboxypeptidase A2,27890,156,0.94 [0.75-1.17],0.5818411445951027
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CPA4,Carboxypeptidase A4,23195,127,0.81 [0.55-1.18],0.2733857418810236
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CPB1,Carboxypeptidase B,28090,154,1.11 [0.86-1.42],0.4187451367445917
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CPB2,Carboxypeptidase B2,24187,134,1.55 [0.75-3.21],0.2398391881813095
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CPE,Carboxypeptidase E,27780,155,1.00 [0.69-1.44],0.9953002231532871
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CPLX2,Complexin-2,23315,128,0.98 [0.57-1.68],0.9307901641429976
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CPM,Carboxypeptidase M,27858,156,1.32 [0.89-1.96],0.1699685141507901
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",23508,131,1.40 [0.81-2.43],0.2309531551469571
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CPPED1,Serine/threonine-protein phosphatase CPPED1,27991,156,1.03 [0.83-1.26],0.8159908689512487
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CPQ,Carboxypeptidase Q,24142,134,0.91 [0.60-1.37],0.6417095140341142
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CPTP,Ceramide-1-phosphate transfer protein,23424,129,0.96 [0.63-1.45],0.8409552976268347
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CPVL,Probable serine carboxypeptidase CPVL,27948,154,1.08 [0.76-1.54],0.6575562697507401
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CPXM1,Probable carboxypeptidase X1,27849,154,1.08 [0.88-1.33],0.4748392897010951
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CPXM2,Inactive carboxypeptidase-like protein X2,24191,134,0.66 [0.33-1.31],0.2313939384519755
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CR1,Complement receptor type 1,24111,133,0.91 [0.57-1.45],0.6896288145967975
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CR2,Complement receptor type 2,27845,154,0.97 [0.71-1.31],0.826190368427968
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,27102,151,1.13 [0.96-1.32],0.1395248890961145
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRADD,Death domain-containing protein CRADD,27507,153,1.17 [0.97-1.41],0.0977144645926718
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CREB3,Cyclic AMP-responsive element-binding protein 3,23315,128,1.16 [0.90-1.51],0.2592482629580468
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CREBZF,CREB/ATF bZIP transcription factor,23315,128,1.13 [0.62-2.08],0.6827812434922217
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CREG1,Protein CREG1,27399,152,1.26 [0.87-1.84],0.2227324201122053
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRELD1,Protein disulfide isomerase CRELD1,23679,128,0.98 [0.62-1.53],0.9192265130023014
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRELD2,Protein disulfide isomerase CRELD2,27841,154,1.15 [0.88-1.50],0.3164037958155306
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRH,Corticoliberin,27055,151,0.97 [0.82-1.15],0.72076531654711
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRHBP,Corticotropin-releasing factor-binding protein,27754,153,1.49 [0.90-2.46],0.117948034946387
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRHR1,Corticotropin-releasing factor receptor 1,27243,152,1.12 [0.92-1.38],0.2660953415539866
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRIM1,Cysteine-rich motor neuron 1 protein,27889,155,1.08 [0.54-2.13],0.8337049587394617
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRIP2,Cysteine-rich protein 2,27559,153,0.82 [0.55-1.23],0.3488625696162061
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRISP2,Cysteine-rich secretory protein 2,27985,155,0.97 [0.77-1.22],0.7629899055236419
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRISP3,Cysteine-rich secretory protein 3,23980,133,0.78 [0.43-1.44],0.4289915023048793
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRKL,Crk-like protein,27801,153,1.13 [0.99-1.30],0.0725407101564978
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRLF1,Cytokine receptor-like factor 1,27889,155,0.88 [0.52-1.47],0.6148859056606697
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRNN,Cornulin,26947,152,1.32 [1.06-1.64],0.0127222752484565
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRTAC1,Cartilage acidic protein 1,28090,154,0.86 [0.54-1.37],0.529345371720392
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRTAM,Cytotoxic and regulatory T-cell molecule,27559,153,0.97 [0.73-1.30],0.8600892865003446
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRTAP,Cartilage-associated protein,23514,134,1.05 [0.75-1.45],0.7895091645588171
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRX,Cone-rod homeobox protein,27243,152,0.83 [0.70-0.98],0.0305561826346099
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRYBB1,Beta-crystallin B1,24191,134,1.13 [0.89-1.45],0.3213848973142468
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRYBB2,Beta-crystallin B2,24136,133,1.03 [0.78-1.35],0.8437873687078483
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRYGD,Gamma-crystallin D,24136,133,1.05 [0.88-1.24],0.6080533507146104
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRYM,Ketimine reductase mu-crystallin,23410,130,1.12 [0.92-1.36],0.2764536278220992
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CRYZL1,Quinone oxidoreductase-like protein 1,23568,133,1.17 [0.98-1.40],0.0848219231412805
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CSDE1,Cold shock domain-containing protein E1,23424,129,1.14 [1.01-1.29],0.0377678860862151
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CSF1,Macrophage colony-stimulating factor 1,27889,155,1.03 [0.61-1.73],0.9185668577630066
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CSF1R,Macrophage colony-stimulating factor 1 receptor,24205,134,0.69 [0.45-1.05],0.0820970112554425
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CSF2,Granulocyte-macrophage colony-stimulating factor,23424,129,1.17 [0.76-1.81],0.4774846315991663
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,27559,153,1.07 [0.86-1.35],0.5382125373098716
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CSF2RB,Cytokine receptor common subunit beta,23508,131,1.22 [0.83-1.78],0.3052435070059042
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CSF3,Granulocyte colony-stimulating factor,27198,150,1.11 [0.83-1.48],0.4875282323321197
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CSF3R,Granulocyte colony-stimulating factor receptor,23508,131,1.03 [0.62-1.71],0.9106610353247976
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CSH1,Chorionic somatomammotropin hormone 1,24205,134,1.17 [0.93-1.48],0.1777846889856362
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CSNK1D,Casein kinase I isoform delta,23508,131,1.03 [0.79-1.33],0.8378956977120612
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CSNK2A1,Casein kinase II subunit alpha,24152,133,1.00 [0.70-1.45],0.978986629798798
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CSPG4,Chondroitin sulfate proteoglycan 4,24190,135,0.73 [0.45-1.20],0.2135836454669002
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CSPG5,Chondroitin sulfate proteoglycan 5,23410,130,1.13 [0.82-1.55],0.4683102683397245
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CSRP3,Cysteine and glycine-rich protein 3,23424,129,0.98 [0.82-1.18],0.8282638845183087
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CST1,Cystatin-SN,20974,107,1.06 [0.87-1.28],0.5551947391430925
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CST3,Cystatin-C,27804,154,1.99 [1.25-3.18],0.0038273340316245
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CST5,Cystatin-D,27281,150,1.25 [0.97-1.62],0.0864596959072653
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CST6,Cystatin-M,27013,148,1.16 [0.85-1.58],0.3503475247540702
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CST7,Cystatin-F,27799,155,1.05 [0.90-1.21],0.5493916687591278
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CSTB,Cystatin-B,27367,149,1.26 [0.90-1.74],0.1743257946016986
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTAG1A_CTAG1B,Cancer/testis antigen 1,23693,131,0.98 [0.70-1.37],0.8903354808407299
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTBS,Di-N-acetylchitobiase,23844,133,1.43 [0.77-2.66],0.2558633549814764
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTF1,Cardiotrophin-1,27243,152,1.08 [0.91-1.27],0.3675247011641855
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTHRC1,Collagen triple helix repeat-containing protein 1,24190,135,0.70 [0.38-1.27],0.2373455637694874
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTLA4,Cytotoxic T-lymphocyte protein 4,24190,135,0.55 [0.32-0.96],0.0366821740463427
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTNNA1,Catenin alpha-1,23410,130,0.86 [0.51-1.43],0.5558562903976058
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTRB1,Chymotrypsinogen B,27756,156,1.17 [0.90-1.53],0.2362967623252576
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTRC,Chymotrypsin-C,27757,154,0.98 [0.78-1.24],0.8871042745945696
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTRL,Chymotrypsin-like protease CTRL-1,24136,133,1.09 [0.85-1.41],0.4927568416836487
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTSB,Cathepsin B,27781,154,1.16 [0.89-1.50],0.2678087734344728
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTSC,Dipeptidyl peptidase 1,27718,153,0.95 [0.68-1.33],0.7528463673102304
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTSD,Cathepsin D,25911,143,1.09 [0.75-1.60],0.6397966300848261
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTSE,Cathepsin E,23679,128,0.99 [0.72-1.37],0.9612729325583168
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTSF,Cathepsin F,27849,154,0.93 [0.66-1.32],0.6899957593169588
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTSH,Pro-cathepsin H,27163,150,1.12 [0.92-1.37],0.246657886961444
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTSL,Cathepsin L1,27752,155,0.89 [0.49-1.62],0.708054965437342
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTSO,Cathepsin O,28040,156,1.58 [1.01-2.46],0.0450244980090764
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTSS,Cathepsin S,21773,115,1.23 [0.59-2.56],0.5780117139591937
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTSV,Cathepsin L2,27905,154,1.01 [0.74-1.40],0.929159423623741
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CTSZ,Cathepsin Z,27751,153,1.25 [0.79-1.98],0.330673752772761
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CUZD1,CUB and zona pellucida-like domain-containing protein 1,23514,134,0.92 [0.57-1.49],0.7309993317555459
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CWC15,Spliceosome-associated protein CWC15 homolog,23928,132,1.08 [0.85-1.39],0.5181956751621575
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CX3CL1,Fractalkine,27559,153,1.12 [0.74-1.70],0.588515606573296
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CXADR,Coxsackievirus and adenovirus receptor,27705,155,1.27 [0.98-1.64],0.0662798365238697
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CXCL1,Growth-regulated alpha protein,27710,154,1.04 [0.90-1.20],0.5708216037865688
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CXCL10,C-X-C motif chemokine 10,27889,155,0.99 [0.81-1.22],0.9496214755354444
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CXCL11,C-X-C motif chemokine 11,27991,156,1.00 [0.84-1.19],0.9825581162356752
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CXCL12,Stromal cell-derived factor 1,27198,150,0.82 [0.57-1.17],0.2753463414384514
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CXCL13,C-X-C motif chemokine 13,27991,156,1.26 [1.06-1.50],0.0074612331264537
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CXCL14,C-X-C motif chemokine 14,27198,150,0.87 [0.67-1.13],0.2898030173525653
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CXCL16,C-X-C motif chemokine 16,28043,154,2.07 [1.16-3.69],0.0141081388917974
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CXCL17,C-X-C motif chemokine 17,28040,156,1.51 [1.15-1.98],0.0032029177246727
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CXCL3,C-X-C motif chemokine 3,27751,154,1.09 [0.94-1.27],0.2559890060036004
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CXCL5,C-X-C motif chemokine 5,27664,155,1.09 [0.97-1.23],0.1614689438376405
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CXCL6,C-X-C motif chemokine 6,28040,156,1.10 [0.92-1.32],0.2897156476110344
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CXCL8,Interleukin-8,27523,154,0.99 [0.80-1.22],0.896804321424377
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CXCL9,C-X-C motif chemokine 9,27889,155,0.92 [0.74-1.15],0.4779498284104044
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CYB5A,Cytochrome b5,23315,128,1.09 [0.88-1.33],0.4344585400293165
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CYB5R2,NADH-cytochrome b5 reductase 2,23778,134,1.06 [0.80-1.42],0.6818111864162832
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",23424,129,1.05 [0.88-1.26],0.574626593091719
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CYTH3,Cytohesin-3,23315,128,0.85 [0.66-1.10],0.2143202422385832
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",CYTL1,Cytokine-like protein 1,24190,135,1.30 [0.64-2.65],0.474210707144866
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DAAM1,Disheveled-associated activator of morphogenesis 1,23679,128,1.11 [0.91-1.37],0.2996233258355549
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DAB2,Disabled homolog 2,27985,155,1.10 [0.96-1.25],0.1620477344241664
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DAG1,Dystroglycan,27889,155,1.24 [0.93-1.65],0.1488339545296759
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DAND5,DAN domain family member 5,23508,131,1.07 [0.80-1.43],0.6607943577664427
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DAPK2,Death-associated protein kinase 2,23508,131,0.99 [0.73-1.34],0.9589427035448176
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,27705,155,1.08 [0.95-1.22],0.2376202098013278
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DARS1,"Aspartate--tRNA ligase, cytoplasmic",27507,153,1.10 [0.91-1.34],0.3346196934831041
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DBH,Dopamine beta-hydroxylase,24156,133,1.14 [0.96-1.35],0.1476403032239533
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DBI,Acyl-CoA-binding protein,27624,155,1.15 [0.96-1.36],0.1285172555441028
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DBN1,Drebrin,23508,131,1.11 [0.81-1.52],0.5040122136583954
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DBNL,Drebrin-like protein,27889,155,1.13 [0.97-1.32],0.1135678224620173
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",27849,154,1.07 [0.71-1.61],0.7381706357443794
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DCC,Netrin receptor DCC,23514,134,0.72 [0.32-1.64],0.4392052836412176
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DCDC2C,Doublecortin domain-containing protein 2C,23315,128,1.01 [0.78-1.32],0.9251992952765924
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DCLRE1C,Protein artemis,23315,128,1.25 [0.78-2.00],0.3480708890142209
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DCN,Decorin,27243,152,0.77 [0.40-1.47],0.4276969740051417
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DCTD,Deoxycytidylate deaminase,23679,128,1.21 [1.01-1.46],0.0405249398058146
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DCTN1,Dynactin subunit 1,27985,155,1.13 [0.91-1.41],0.2509972809351263
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DCTN2,Dynactin subunit 2,27629,155,1.03 [0.89-1.20],0.6646593325078005
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DCTN6,Dynactin subunit 6,27073,151,1.01 [0.83-1.24],0.8880163030144123
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DCTPP1,dCTP pyrophosphatase 1,27752,155,0.91 [0.58-1.42],0.6672316690507126
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DCUN1D1,DCN1-like protein 1,23410,130,0.94 [0.74-1.19],0.6010209428829687
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DCUN1D2,DCN1-like protein 2,23315,128,1.07 [0.88-1.30],0.4971346566567216
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DCXR,L-xylulose reductase,27849,154,0.90 [0.68-1.19],0.4577302131435535
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DDA1,DET1- and DDB1-associated protein 1,23424,129,1.13 [0.77-1.66],0.5324223210681234
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",27629,155,0.92 [0.66-1.26],0.5917695922291992
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DDC,Aromatic-L-amino-acid decarboxylase,27707,155,0.92 [0.69-1.23],0.5610451533951716
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DDHD2,Phospholipase DDHD2,24152,133,1.21 [0.94-1.55],0.1318693898094435
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DDI2,Protein DDI1 homolog 2,23679,128,1.06 [0.86-1.31],0.5909210085853477
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DDR1,Epithelial discoidin domain-containing receptor 1,27991,156,0.81 [0.44-1.51],0.5159973701804283
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DDT,D-dopachrome decarboxylase,24190,135,1.01 [0.68-1.50],0.9595782210220034
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DDX1,ATP-dependent RNA helicase DDX1,24066,134,0.76 [0.53-1.09],0.1408183776039051
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DDX25,ATP-dependent RNA helicase DDX25,23514,134,0.69 [0.41-1.14],0.1424326039602096
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DDX39A,ATP-dependent RNA helicase DDX39A,23508,131,0.76 [0.34-1.68],0.4990978362823463
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DDX4,Probable ATP-dependent RNA helicase DDX4,23508,131,1.15 [0.87-1.50],0.3270684906142
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DDX53,Probable ATP-dependent RNA helicase DDX53,23514,134,0.90 [0.56-1.44],0.6498438188477573
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DDX58,Antiviral innate immune response receptor RIG-I,27102,151,1.17 [0.95-1.46],0.1410532794428389
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",27705,155,1.13 [0.98-1.31],0.0938728628465842
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DEFA1_DEFA1B,Neutrophil defensin 1,27175,152,1.28 [1.01-1.64],0.0419523050948923
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DEFB103A_DEFB103B,Beta-defensin 103,23327,130,1.02 [0.68-1.52],0.9290432387170544
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DEFB104A_DEFB104B,Beta-defensin 104,23410,130,0.92 [0.68-1.25],0.5983248263058287
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DEFB116,Beta-defensin 116,23410,130,1.17 [0.97-1.40],0.0917322399549978
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DEFB118,Beta-defensin 118,23410,130,1.06 [0.81-1.39],0.6552327002717122
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DEFB4A_DEFB4B,Beta-defensin 4A,27375,155,1.03 [0.93-1.13],0.5852052888333978
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DENND2B,DENN domain-containing protein 2B,23424,129,1.25 [0.98-1.60],0.0779802013244969
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DENR,Density-regulated protein,23508,131,1.49 [1.19-1.87],0.000494292647922
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DFFA,DNA fragmentation factor subunit alpha,28040,156,1.20 [0.98-1.46],0.0783834204953992
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DGCR6,Protein DGCR6,23410,130,0.54 [0.33-0.89],0.0153693200961058
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DGKA,Diacylglycerol kinase alpha,23508,131,1.13 [0.83-1.53],0.4414736594655196
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DGKZ,Diacylglycerol kinase zeta,27198,150,0.86 [0.56-1.31],0.4856216123059708
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DHODH,Dihydroorotate dehydrogenase,23424,129,0.87 [0.59-1.28],0.4783172454964367
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DHPS,Deoxyhypusine synthase,24054,130,0.66 [0.41-1.06],0.0821971538555141
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24136,133,1.11 [0.80-1.53],0.5314843152064643
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DIABLO,"Diablo homolog, mitochondrial",27663,155,1.17 [1.03-1.34],0.0148474717034455
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DIPK1C,Divergent protein kinase domain 1C,23514,134,0.97 [0.65-1.43],0.8715067892847168
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DIPK2B,Divergent protein kinase domain 2B,23679,128,0.47 [0.25-0.90],0.0234979293995643
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DKK1,Dickkopf-related protein 1,27991,156,1.13 [0.90-1.43],0.3039407286397383
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DKK3,Dickkopf-related protein 3,28090,154,1.02 [0.63-1.66],0.9352287616778234
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DKK4,Dickkopf-related protein 4,27518,153,1.08 [0.79-1.45],0.6385722117917403
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DKKL1,Dickkopf-like protein 1,27629,155,0.99 [0.84-1.17],0.9194904088997916
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DLG4,Disks large homolog 4,24136,133,1.13 [0.90-1.41],0.3026610767676881
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DLGAP5,Disks large-associated protein 5,24152,133,1.19 [0.95-1.49],0.1241237933878537
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DLK1,Protein delta homolog 1,28090,154,0.98 [0.75-1.28],0.9003959147347589
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DLL1,Delta-like protein 1,27849,154,1.19 [0.73-1.95],0.4829064835594103
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DLL4,Delta-like protein 4,23568,133,0.90 [0.70-1.16],0.418216141615496
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DMD,Dystrophin,23568,133,1.26 [0.97-1.64],0.0850125831821187
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DMP1,Dentin matrix acidic phosphoprotein 1,23568,133,0.88 [0.69-1.13],0.3283326311697263
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNAJA1,DnaJ homolog subfamily A member 1,23315,128,0.98 [0.68-1.42],0.9336739962176076
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNAJA2,DnaJ homolog subfamily A member 2,27951,156,1.12 [0.94-1.33],0.2077855366497849
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNAJA4,DnaJ homolog subfamily A member 4,24136,133,1.18 [0.95-1.46],0.1401623817067819
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNAJB1,DnaJ homolog subfamily B member 1,27629,155,1.17 [0.99-1.37],0.0593579364225527
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNAJB14,DnaJ homolog subfamily B member 14,24066,134,1.12 [0.88-1.42],0.3678252591126302
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNAJB2,DnaJ homolog subfamily B member 2,23679,128,1.07 [0.78-1.45],0.6837892150725768
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNAJB6,DnaJ homolog subfamily B member 6,23452,127,1.10 [0.90-1.35],0.3491600269527634
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNAJB8,DnaJ homolog subfamily B member 8,27243,152,0.87 [0.67-1.15],0.3281616362753782
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNAJC21,DnaJ homolog subfamily C member 21,24136,133,1.35 [0.91-2.00],0.1358238773581696
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNAJC6,Putative tyrosine-protein phosphatase auxilin,23568,133,1.21 [1.00-1.47],0.0497836865221656
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNAJC9,DnaJ homolog subfamily C member 9,24066,134,1.15 [0.93-1.41],0.2052865369274886
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNER,Delta and Notch-like epidermal growth factor-related receptor,27709,154,0.99 [0.55-1.76],0.9651918096541862
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNLZ,DNL-type zinc finger protein,23410,130,0.99 [0.82-1.18],0.8809349803338515
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNM1,Dynamin-1,24066,134,1.10 [0.95-1.28],0.2007232483185672
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNM3,Dynamin-3,24152,133,1.18 [0.89-1.56],0.2520541778480172
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNMBP,Dynamin-binding protein,27559,153,1.24 [1.00-1.53],0.046021255107424
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNPEP,Aspartyl aminopeptidase,24136,133,1.11 [0.84-1.47],0.4602754701274277
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,27849,154,1.31 [1.01-1.71],0.041422951417081
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DOC2B,Double C2-like domain-containing protein beta,23514,134,0.86 [0.52-1.43],0.5648506046578554
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DOCK9,Dedicator of cytokinesis protein 9,23410,130,0.92 [0.79-1.08],0.3326680892380463
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DOK1,Docking protein 1,24136,133,1.15 [1.01-1.31],0.0325295305805071
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DOK2,Docking protein 2,27752,155,1.12 [1.00-1.26],0.0581982204149555
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DPEP1,Dipeptidase 1,27507,153,1.17 [0.88-1.57],0.2786143510286004
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DPEP2,Dipeptidase 2,27629,155,0.88 [0.54-1.45],0.623032784321028
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DPP10,Inactive dipeptidyl peptidase 10,27705,155,1.02 [0.67-1.54],0.9373606490548364
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DPP4,Dipeptidyl peptidase 4,27221,151,0.54 [0.33-0.88],0.012806054983194
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DPP6,Dipeptidyl aminopeptidase-like protein 6,27629,155,0.79 [0.51-1.21],0.2797136895991157
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DPP7,Dipeptidyl peptidase 2,27519,152,1.07 [0.84-1.37],0.5634440606252336
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DPT,Dermatopontin,28090,154,1.18 [0.69-2.01],0.5452447701993556
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DPY30,Protein dpy-30 homolog,27888,155,1.10 [0.87-1.37],0.4274215731710142
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DRAXIN,Draxin,27559,153,0.78 [0.56-1.10],0.1543106015649438
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DRG2,Developmentally-regulated GTP-binding protein 2,27629,155,1.15 [0.90-1.48],0.2597815374509482
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DSC2,Desmocollin-2,27465,154,1.00 [0.65-1.54],0.9987740079104374
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DSCAM,Down syndrome cell adhesion molecule,24152,133,1.36 [0.86-2.15],0.186237082232115
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DSG2,Desmoglein-2,27756,156,0.81 [0.48-1.38],0.4406033182957657
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DSG3,Desmoglein-3,27895,155,1.12 [0.73-1.71],0.6034533150112131
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DSG4,Desmoglein-4,27542,155,1.03 [0.78-1.37],0.8174315550010167
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DTD1,D-aminoacyl-tRNA deacylase 1,23679,128,1.17 [0.96-1.41],0.1171640405076903
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DTNB,Dystrobrevin beta,24013,130,1.32 [0.92-1.89],0.1272064469333658
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DTX2,Probable E3 ubiquitin-protein ligase DTX2,23514,134,1.02 [0.80-1.29],0.8884456954797813
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DTX3,Probable E3 ubiquitin-protein ligase DTX3,27629,155,0.96 [0.53-1.74],0.8831449458681052
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DTYMK,Thymidylate kinase,24191,134,1.24 [0.99-1.57],0.0645950597744911
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DUOX2,Dual oxidase 2,27243,152,0.91 [0.73-1.12],0.354809739471276
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DUSP13,Dual specificity protein phosphatase 13 isoform A,24054,130,1.02 [0.68-1.54],0.9146292132232564
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DUSP29,Dual specificity phosphatase 29,23514,134,1.06 [0.84-1.34],0.6228931038187131
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DUSP3,Dual specificity protein phosphatase 3,27073,151,1.11 [0.95-1.28],0.1805676659315254
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24066,134,1.17 [0.99-1.37],0.0586320649543798
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DXO,Decapping and exoribonuclease protein,24136,133,1.17 [0.82-1.66],0.383286041309647
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24054,130,1.14 [0.84-1.55],0.3874021183142355
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DYNLT1,Dynein light chain Tctex-type 1,23514,134,1.06 [0.87-1.29],0.553146906608312
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",DYNLT3,Dynein light chain Tctex-type 3,24054,130,1.13 [0.78-1.64],0.5285304490088629
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,27559,153,1.10 [0.95-1.28],0.2043820700901863
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EBI3_IL27,Interleukin-27,27936,155,1.05 [0.68-1.63],0.8166495882909699
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ECE1,Endothelin-converting enzyme 1,27073,151,0.66 [0.44-0.99],0.0465569556432523
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24191,134,0.96 [0.76-1.21],0.7235687493822224
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ECHS1,"Enoyl-CoA hydratase, mitochondrial",23568,133,1.08 [0.91-1.28],0.3749560670389318
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ECI2,Enoyl-CoA delta isomerase 2,23424,129,1.22 [0.96-1.55],0.1064530648641644
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ECM1,Extracellular matrix protein 1,23545,130,0.91 [0.58-1.43],0.6808351251530342
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ECSCR,Endothelial cell-specific chemotaxis regulator,23410,130,0.95 [0.67-1.34],0.7764690940598256
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EDA2R,Tumor necrosis factor receptor superfamily member 27,27985,155,1.50 [1.02-2.21],0.0405164730216521
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EDAR,Tumor necrosis factor receptor superfamily member EDAR,27705,155,1.19 [1.03-1.39],0.0216683059851493
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EDDM3B,Epididymal secretory protein E3-beta,24054,130,1.09 [0.74-1.60],0.6713017475021008
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,23424,129,1.22 [0.81-1.84],0.332027022127256
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EDF1,Endothelial differentiation-related factor 1,24152,133,1.14 [0.93-1.40],0.2121799700569642
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,27243,152,0.94 [0.63-1.40],0.7468943937719772
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EDN1,Endothelin-1,23568,133,1.60 [0.94-2.73],0.0849031424099141
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EDNRB,Endothelin receptor type B,23508,131,0.89 [0.60-1.32],0.5579458568643088
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EEF1D,Elongation factor 1-delta,24191,134,1.10 [0.92-1.31],0.2932525338357667
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EFCAB14,EF-hand calcium-binding domain-containing protein 14,24066,134,1.17 [0.66-2.08],0.5811427659612666
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EFCAB2,Dynein regulatory complex protein 8,23740,131,1.06 [0.66-1.69],0.807482799707709
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,27798,154,1.04 [0.65-1.67],0.8762089947381994
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EFHD1,EF-hand domain-containing protein D1,24152,133,0.89 [0.55-1.46],0.647023833287039
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EFNA1,Ephrin-A1,27714,155,1.63 [0.98-2.71],0.0579352814444735
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EFNA4,Ephrin-A4,27517,152,1.42 [0.87-2.29],0.1577493417454016
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EFNB2,Ephrin-B2,23514,134,1.12 [0.88-1.43],0.3388672055682564
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EGF,Pro-epidermal growth factor,27710,153,1.16 [1.01-1.34],0.0383071630959192
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EGFL7,Epidermal growth factor-like protein 7,27102,151,1.06 [0.74-1.50],0.7554159002283136
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EGFLAM,Pikachurin,24066,134,1.11 [0.66-1.86],0.6851281940420915
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EGFR,Epidermal growth factor receptor,28090,154,1.29 [0.54-3.10],0.561451814484454
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EGLN1,Egl nine homolog 1,27705,155,1.09 [0.86-1.38],0.4831891126554767
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EHBP1,EH domain-binding protein 1,24191,134,1.09 [0.87-1.35],0.4526095247373914
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EHD3,EH domain-containing protein 3,23568,133,1.17 [1.01-1.36],0.0342705912996449
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24136,133,1.03 [0.77-1.39],0.830719485443016
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",23978,134,1.17 [1.01-1.36],0.0311368282414331
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,23424,129,1.17 [0.93-1.48],0.1844864651254317
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,23568,133,1.17 [0.81-1.69],0.4133652651354703
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EIF4B,Eukaryotic translation initiation factor 4B,27559,153,1.25 [0.98-1.61],0.0729544024846269
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EIF4E,Eukaryotic translation initiation factor 4E,23508,131,1.13 [0.94-1.36],0.1998222035825658
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,27752,155,1.23 [1.01-1.51],0.0435903477267483
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,28040,156,1.17 [1.02-1.35],0.0279001790116516
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24152,133,1.04 [0.81-1.33],0.7713495254516257
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EIF5,Eukaryotic translation initiation factor 5,23424,129,1.25 [0.90-1.73],0.1886288148371739
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EIF5A,Eukaryotic translation initiation factor 5A-1,27198,150,0.90 [0.55-1.48],0.6798506972275583
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ELAC1,Zinc phosphodiesterase ELAC protein 1,24152,133,1.14 [0.94-1.38],0.1912479621150127
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ELAVL4,ELAV-like protein 4,23410,130,0.91 [0.75-1.12],0.3876974532477328
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ELN,Elastin,24191,134,1.29 [0.81-2.06],0.2807119960587527
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ELOA,Elongin-A,27629,155,1.02 [0.79-1.32],0.8945936977743787
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ELOB,Elongin-B,23424,129,1.25 [0.89-1.76],0.2009447158141819
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENAH,Protein enabled homolog,27198,150,1.00 [0.74-1.35],0.9851046123740856
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENDOU,Poly(U)-specific endoribonuclease,22339,123,0.98 [0.70-1.39],0.9250987340068824
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENG,Endoglin,28090,154,0.58 [0.25-1.33],0.1971884167688847
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENO1,Alpha-enolase,27706,156,1.15 [0.96-1.38],0.1298343452875318
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENO2,Gamma-enolase,27991,156,1.19 [0.96-1.46],0.1127684304656968
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENO3,Beta-enolase,23568,133,1.00 [0.75-1.35],0.9769481265941938
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENOPH1,Enolase-phosphatase E1,24054,130,1.13 [0.89-1.43],0.3321484034861482
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,23424,129,1.04 [0.57-1.89],0.8973154099705377
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENPEP,Glutamyl aminopeptidase,23424,129,0.91 [0.60-1.36],0.634249247736643
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,28090,154,0.96 [0.59-1.55],0.8585826046692702
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,27889,155,1.06 [0.75-1.50],0.7567878464034513
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,23568,133,0.78 [0.50-1.23],0.2925190509265998
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,26884,150,1.11 [0.94-1.30],0.2244344067409259
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENSA,Alpha-endosulfine,24054,130,1.02 [0.74-1.40],0.918782854642696
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,27102,151,0.95 [0.68-1.33],0.7716609647566071
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,27243,152,1.11 [0.56-2.20],0.7690854158547824
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,27243,152,1.32 [0.75-2.32],0.3280501936223963
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ENTR1,Endosome-associated-trafficking regulator 1,23568,133,0.98 [0.73-1.31],0.8890223800733367
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EP300,Histone acetyltransferase p300,23508,131,1.25 [0.75-2.08],0.3988056885114346
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EPB41L5,Band 4.1-like protein 5,23514,134,1.00 [0.78-1.29],0.987530697594474
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EPCAM,Epithelial cell adhesion molecule,27759,154,1.00 [0.86-1.15],0.96673380238172
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EPGN,Epigen,24054,130,1.02 [0.74-1.41],0.9013880090762132
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EPHA1,Ephrin type-A receptor 1,27849,154,1.46 [0.96-2.22],0.0741908690681958
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EPHA10,Ephrin type-A receptor 10,27073,151,0.99 [0.79-1.25],0.9604013832364758
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EPHA2,Ephrin type-A receptor 2,26770,146,1.16 [0.72-1.89],0.5418144290614559
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EPHA4,Ephrin type-A receptor 4,23679,128,0.55 [0.30-1.01],0.053442281348911
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EPHB4,Ephrin type-B receptor 4,28090,154,0.89 [0.49-1.62],0.7150074280733596
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EPHB6,Ephrin type-B receptor 6,27507,153,1.05 [0.65-1.68],0.8514910738402847
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EPHX2,Bifunctional epoxide hydrolase 2,27243,152,0.86 [0.67-1.11],0.2486831842537371
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EPN1,Epsin-1,23740,131,1.06 [0.74-1.50],0.7552626647961231
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EPO,Erythropoietin,27705,155,0.82 [0.67-0.99],0.0434194653996154
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EPPK1,Epiplakin,23568,133,0.90 [0.72-1.13],0.3822241299394111
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,27937,155,1.08 [0.68-1.73],0.7401706864020012
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ERBB2,Receptor tyrosine-protein kinase erbB-2,27849,154,0.73 [0.42-1.27],0.2624120159332541
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ERBB3,Receptor tyrosine-protein kinase erbB-3,27673,153,1.09 [0.52-2.29],0.8248176695428018
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ERBB4,Receptor tyrosine-protein kinase erbB-4,27849,154,0.88 [0.49-1.57],0.6670250063907288
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ERBIN,Erbin,27629,155,1.13 [0.98-1.30],0.0833220101177352
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ERC2,ERC protein 2,23514,134,1.09 [0.90-1.33],0.3794579288260397
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ERCC1,DNA excision repair protein ERCC-1,23315,128,1.35 [0.91-2.00],0.1367889867906595
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EREG,Proepiregulin,27507,153,1.05 [0.88-1.25],0.5865716721250372
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ERI1,3'-5' exoribonuclease 1,23740,131,1.27 [0.80-2.02],0.3030270957208307
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ERMAP,Erythroid membrane-associated protein,23508,131,1.28 [0.90-1.83],0.1660825911001631
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24054,130,1.08 [0.71-1.66],0.7087692287615692
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ERP29,Endoplasmic reticulum resident protein 29,23679,128,1.12 [0.97-1.29],0.1331984730981469
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ERP44,Endoplasmic reticulum resident protein 44,27581,155,1.26 [0.73-2.17],0.4079087158751102
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,23424,129,1.12 [0.85-1.49],0.4081284585647665
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ESAM,Endothelial cell-selective adhesion molecule,28090,154,1.10 [0.70-1.73],0.6686439085051923
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ESM1,Endothelial cell-specific molecule 1,27754,153,0.66 [0.43-1.00],0.0500006405873891
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ESPL1,Separin,23315,128,0.71 [0.49-1.04],0.0788308429219135
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ESR1,Estrogen receptor,23508,131,1.08 [0.84-1.40],0.5461768436855992
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ESYT2,Extended synaptotagmin-2,24136,133,1.07 [0.88-1.31],0.5074772085513024
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EVI2B,Protein EVI2B,23315,128,1.04 [0.69-1.57],0.8534458530126274
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EVI5,Ecotropic viral integration site 5 protein homolog,23508,131,1.12 [0.93-1.35],0.2419838210540051
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EVPL,Envoplakin,23740,131,0.91 [0.54-1.53],0.7169042163402509
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EXOSC10,Exosome component 10,23424,129,0.94 [0.70-1.26],0.6679832976491661
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EXTL1,Exostosin-like 1,23424,129,0.80 [0.54-1.18],0.2581577451785612
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",EZR,Ezrin,27991,156,1.34 [0.76-2.37],0.3126423026948127
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",F10,Coagulation factor X,24205,134,2.02 [1.29-3.17],0.0022556841059941
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",F11,Coagulation factor XI,23883,131,1.33 [0.85-2.08],0.2085809749512508
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",F11R,Junctional adhesion molecule A,27756,156,1.39 [1.10-1.76],0.0066499704719519
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",F12,Coagulation factor XII,24239,135,1.03 [0.70-1.52],0.8818839335515147
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",F13B,Coagulation factor XIII B chain,24096,133,0.89 [0.46-1.70],0.7134791142883674
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",F2,Prothrombin,24239,135,1.84 [0.60-5.60],0.2846445372849978
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",F2R,Proteinase-activated receptor 1,27841,154,1.20 [0.94-1.53],0.1362477127331978
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",F3,Tissue factor,27821,155,1.26 [0.77-2.07],0.3610746737230469
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",F7,Coagulation factor VII,27802,154,1.53 [0.95-2.44],0.077908702348792
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",F9,Coagulation factor IX,27797,154,1.20 [0.55-2.60],0.6473132979426168
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FABP1,"Fatty acid-binding protein, liver",27754,153,1.05 [0.91-1.22],0.4989598305097662
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FABP2,"Fatty acid-binding protein, intestinal",27752,155,1.07 [0.89-1.28],0.4933528313247987
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FABP3,"Fatty acid-binding protein, heart",24191,134,1.22 [0.88-1.70],0.239262311872055
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FABP4,"Fatty acid-binding protein, adipocyte",28090,154,1.11 [0.83-1.47],0.4912576234186552
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FABP5,Fatty acid-binding protein 5,27902,155,1.17 [0.96-1.42],0.1177521380492059
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FABP6,Gastrotropin,27198,152,1.01 [0.77-1.31],0.963798478713287
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FABP9,Fatty acid-binding protein 9,27705,155,1.00 [0.77-1.29],0.9862774442467276
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FADD,FAS-associated death domain protein,27752,155,1.13 [0.95-1.36],0.1764563542646368
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FAM13A,Protein FAM13A,24066,134,1.19 [0.94-1.50],0.1472975614372563
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FAM171A2,Protein FAM171A2,24152,133,0.90 [0.80-1.01],0.0644760754000336
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FAM171B,Protein FAM171B,24054,130,0.68 [0.34-1.34],0.2671457209520718
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FAM172A,Cotranscriptional regulator FAM172A,23568,133,1.17 [0.90-1.52],0.2438525440106582
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FAM20A,Pseudokinase FAM20A,24191,134,1.18 [0.67-2.10],0.5674644330245888
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FAM3B,Protein FAM3B,27629,155,1.15 [0.78-1.71],0.4814474413790904
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FAM3C,Protein FAM3C,27707,155,1.41 [0.87-2.27],0.1622589263471622
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FAM3D,Protein FAM3D,24066,134,1.05 [0.86-1.28],0.6559398764023965
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FAP,Prolyl endopeptidase FAP,28090,154,0.47 [0.28-0.77],0.0032426539977389
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FARSA,Phenylalanine--tRNA ligase alpha subunit,23514,134,1.11 [0.89-1.40],0.3524098165810472
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FAS,Tumor necrosis factor receptor superfamily member 6,28000,154,1.14 [0.76-1.71],0.5308724386311895
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FASLG,Tumor necrosis factor ligand superfamily member 6,28040,156,0.71 [0.49-1.03],0.0722242606134462
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FBLN2,Fibulin-2,24190,135,0.74 [0.44-1.26],0.2720798703054573
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FBN2,Fibrillin-2,23514,134,0.90 [0.69-1.18],0.441793553634152
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FBP1,"Fructose-1,6-bisphosphatase 1",27752,155,1.00 [0.83-1.22],0.9687036434240368
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24191,134,0.98 [0.78-1.24],0.8814886264858791
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FCAR,Immunoglobulin alpha Fc receptor,27705,155,1.33 [0.98-1.79],0.0637798576896866
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24152,133,0.74 [0.37-1.47],0.3878092135121924
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FCER2,Low affinity immunoglobulin epsilon Fc receptor,27756,156,0.94 [0.70-1.27],0.6912233534351334
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,27621,154,0.92 [0.74-1.14],0.4436873618403275
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,27102,151,0.99 [0.77-1.27],0.9550390005702376
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,27756,154,1.03 [0.77-1.37],0.8543179679034147
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FCN1,Ficolin-1,24156,133,1.18 [0.87-1.61],0.2938699886844229
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FCN2,Ficolin-2,27622,152,1.34 [0.93-1.93],0.1182347746032796
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FCRL1,Fc receptor-like protein 1,27752,155,0.84 [0.60-1.16],0.2778059671436637
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FCRL2,Fc receptor-like protein 2,27907,154,0.90 [0.67-1.23],0.5166994298667937
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FCRL3,Fc receptor-like protein 3,27198,150,0.91 [0.69-1.19],0.4945200009924643
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FCRL5,Fc receptor-like protein 5,27756,156,0.93 [0.72-1.20],0.5773200319088113
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FCRL6,Fc receptor-like protein 6,27705,155,0.90 [0.73-1.11],0.3193868956465724
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FCRLB,Fc receptor-like B,27102,151,1.07 [0.84-1.35],0.5850009654596411
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FDX1,"Adrenodoxin, mitochondrial",23424,129,0.91 [0.68-1.21],0.52404796021708
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FDX2,"Ferredoxin-2, mitochondrial",23424,129,1.15 [0.89-1.48],0.2979981114492208
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FEN1,Flap endonuclease 1,27102,151,1.02 [0.83-1.27],0.8232519446174941
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FES,Tyrosine-protein kinase Fes/Fps,27102,151,0.80 [0.58-1.10],0.1705263520770946
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FETUB,Fetuin-B,27797,154,1.13 [0.75-1.71],0.5469806266083672
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGA,Fibrinogen alpha chain,23649,128,0.71 [0.41-1.25],0.2381649034184002
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24152,133,1.11 [0.90-1.36],0.3220024688797982
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGF12,Fibroblast growth factor 12,23508,131,0.88 [0.58-1.33],0.5493864374944908
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGF16,Fibroblast growth factor 16,23508,131,1.02 [0.72-1.43],0.927330906525204
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGF19,Fibroblast growth factor 19,27889,155,0.95 [0.79-1.14],0.5725370582733015
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGF2,Fibroblast growth factor 2,27705,155,0.94 [0.75-1.16],0.5455376289352392
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGF20,Fibroblast growth factor 20,23508,131,1.01 [0.69-1.46],0.965861909127841
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGF21,Fibroblast growth factor 21,27936,155,1.00 [0.89-1.12],0.9495539727882848
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGF23,Fibroblast growth factor 23,27941,155,0.97 [0.78-1.19],0.7520736068192724
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGF3,Fibroblast growth factor 3,23508,131,1.23 [0.77-1.98],0.3815460916621351
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGF5,Fibroblast growth factor 5,27198,150,1.44 [0.95-2.18],0.0876612903118451
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGF6,Fibroblast growth factor 6,23508,131,0.87 [0.56-1.36],0.5518776666806332
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGF7,Fibroblast growth factor 7,23315,128,0.86 [0.67-1.10],0.2231713735002911
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGF9,Fibroblast growth factor 9,23273,128,1.19 [0.79-1.79],0.4111368631821834
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGFBP1,Fibroblast growth factor-binding protein 1,27849,154,0.86 [0.55-1.35],0.513121444134743
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGFBP2,Fibroblast growth factor-binding protein 2,24190,135,0.94 [0.68-1.30],0.7023371326767258
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGFBP3,Fibroblast growth factor-binding protein 3,24136,133,0.95 [0.61-1.49],0.8370434595176917
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGFR2,Fibroblast growth factor receptor 2,27849,154,1.33 [0.69-2.58],0.3941227793529148
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGFR4,Fibroblast growth factor receptor 4,23679,128,1.00 [0.73-1.37],0.994088858984431
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGL1,Fibrinogen-like protein 1,24205,134,0.96 [0.74-1.24],0.7369706171811263
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FGR,Tyrosine-protein kinase Fgr,27073,151,1.07 [0.85-1.35],0.583018012626441
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FH,"Fumarate hydratase, mitochondrial",23410,130,0.97 [0.79-1.19],0.7649553826263489
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FHIP2A,FHF complex subunit HOOK interacting protein 2A,23424,129,0.88 [0.60-1.28],0.5002571467050998
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FHIT,Bis(5'-adenosyl)-triphosphatase,27073,151,1.13 [0.93-1.37],0.2073956378153184
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FIS1,Mitochondrial fission 1 protein,27759,154,1.18 [0.99-1.40],0.0702955049956844
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24152,133,1.12 [0.95-1.32],0.1858073924786776
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,27817,155,1.06 [0.93-1.20],0.4111961972048904
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,27559,153,1.14 [0.83-1.56],0.4297603648168153
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,27559,153,1.17 [1.01-1.37],0.0393093738262988
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,27021,151,1.14 [0.86-1.51],0.3565406065352626
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FKBPL,FK506-binding protein-like,24066,134,1.09 [0.82-1.43],0.5623247843015063
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FLI1,Friend leukemia integration 1 transcription factor,27102,151,1.08 [0.95-1.23],0.2562527693994593
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,27559,153,0.66 [0.40-1.10],0.1125769688551738
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FLT1,Vascular endothelial growth factor receptor 1,27585,155,0.85 [0.46-1.57],0.5991442155581892
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FLT3,Receptor-type tyrosine-protein kinase FLT3,27102,151,0.87 [0.53-1.43],0.5858535104197151
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FLT3LG,Fms-related tyrosine kinase 3 ligand,28040,156,0.91 [0.60-1.40],0.6704522022131891
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FLT4,Vascular endothelial growth factor receptor 3,27849,154,1.52 [0.99-2.33],0.0561816058152785
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FMNL1,Formin-like protein 1,27073,151,1.02 [0.82-1.27],0.8256752697448032
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FMR1,Synaptic functional regulator FMR1,27102,151,1.31 [0.88-1.97],0.1855704589993954
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FN1,Fibronectin,24239,135,0.65 [0.35-1.22],0.1797043231610117
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FNDC1,Fibronectin type III domain-containing protein 1,24136,133,0.93 [0.65-1.33],0.6804312898134173
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24054,130,1.10 [0.70-1.71],0.681575358174134
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FOLH1,Glutamate carboxypeptidase 2,23508,131,0.98 [0.84-1.15],0.8123929257995327
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FOLR1,Folate receptor alpha,27712,154,1.36 [0.83-2.23],0.2246995211059879
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FOLR2,Folate receptor beta,27991,156,0.70 [0.43-1.14],0.1534234778485606
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FOLR3,Folate receptor gamma,27760,153,1.01 [0.94-1.09],0.7690809927618748
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FOS,Proto-oncogene c-Fos,23273,128,0.93 [0.58-1.50],0.769550042354693
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FOSB,Protein fosB,27073,151,0.90 [0.61-1.33],0.5888311529888494
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FOXJ3,Forkhead box protein J3,23508,131,1.23 [0.88-1.70],0.2204854596514345
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FOXO1,Forkhead box protein O1,27705,155,1.10 [0.93-1.30],0.2508096926859707
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FOXO3,Forkhead box protein O3,27102,151,1.09 [0.95-1.25],0.235742822851644
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FRMD4B,FERM domain-containing protein 4B,23424,129,1.10 [0.88-1.39],0.4022824102133248
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FRMD7,FERM domain-containing protein 7,23514,134,0.81 [0.49-1.35],0.4192024738552528
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FRZB,Secreted frizzled-related protein 3,27464,152,0.83 [0.51-1.36],0.4643899025105128
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FSHB,Follitropin subunit beta,23568,133,1.19 [0.94-1.51],0.1406894955218471
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FST,Follistatin,27841,154,1.00 [0.77-1.31],0.9740789435053272
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FSTL1,Follistatin-related protein 1,23568,133,0.56 [0.27-1.17],0.1252890133338894
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FSTL3,Follistatin-related protein 3,27707,153,1.25 [0.79-1.97],0.3511480751800407
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FTCD,Formimidoyltransferase-cyclodeaminase,24095,133,0.92 [0.75-1.13],0.4506919683166186
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FUCA1,Tissue alpha-L-fucosidase,27928,152,1.03 [0.86-1.23],0.7671692242752189
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FUOM,Fucose mutarotase,23679,128,0.78 [0.59-1.02],0.0722100422790901
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FURIN,Furin,27849,154,1.18 [0.78-1.79],0.4322034714809107
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FUS,RNA-binding protein FUS,27059,151,1.34 [0.96-1.87],0.0875598182949306
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",23690,131,1.07 [0.83-1.37],0.6069966164049689
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,27991,156,0.97 [0.71-1.33],0.8639793129815798
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FUT8,"Alpha-(1,6)-fucosyltransferase",27559,153,1.13 [0.89-1.43],0.3301125819422918
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FXN,"Frataxin, mitochondrial",27985,155,1.13 [0.93-1.36],0.2212642359565632
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FXYD5,FXYD domain-containing ion transport regulator 5,27198,150,1.03 [0.83-1.28],0.7677591058803797
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FYB1,FYN-binding protein 1,27715,155,1.20 [1.03-1.40],0.0231801662621022
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FZD10,Frizzled-10,23514,134,1.13 [0.89-1.43],0.331870895128749
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",FZD8,Frizzled-8,23410,130,1.38 [1.03-1.84],0.0287900845793383
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GABARAP,Gamma-aminobutyric acid receptor-associated protein,24054,130,1.31 [1.00-1.71],0.0499861508217187
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,23740,131,1.00 [0.77-1.29],0.9954445416724552
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,23410,130,0.74 [0.54-1.02],0.0690601090592609
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GAD1,Glutamate decarboxylase 1,23315,128,0.75 [0.39-1.45],0.3948053755167277
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GAD2,Glutamate decarboxylase 2,23508,131,1.09 [0.79-1.51],0.5853386815944815
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,23740,131,1.11 [0.84-1.47],0.4439091801268383
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,23568,133,1.19 [0.88-1.61],0.2475393026606656
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GAGE2A,G antigen 2A,23315,128,1.14 [0.90-1.45],0.270242295307595
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GAL,Galanin peptides,27889,155,0.87 [0.70-1.09],0.2315685325807072
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,27629,155,0.83 [0.50-1.38],0.4769248596801911
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,27985,155,1.09 [0.62-1.90],0.7678339906457413
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,27198,150,1.09 [0.77-1.53],0.6358662593790658
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24191,134,0.65 [0.35-1.20],0.1723466802037933
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GALNT7,N-acetylgalactosaminyltransferase 7,27629,155,0.90 [0.45-1.77],0.7526056105158226
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GAMT,Guanidinoacetate N-methyltransferase,23424,129,1.20 [0.82-1.76],0.3391429560820763
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23161,127,2.09 [1.16-3.76],0.0141110615432841
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GART,Trifunctional purine biosynthetic protein adenosine-3,24152,133,1.00 [0.54-1.88],0.9914904568846772
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GAS2,Growth arrest-specific protein 2,23740,131,0.57 [0.37-0.87],0.0093441134127216
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GAS6,Growth arrest-specific protein 6,27901,154,0.67 [0.39-1.16],0.15653810622852
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GASK1A,Golgi-associated kinase 1A,23424,129,1.42 [0.96-2.08],0.0781061959565111
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GAST,Gastrin,24136,133,1.06 [0.93-1.20],0.4089023148976207
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,23315,128,0.88 [0.46-1.68],0.7041298118202319
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",23568,133,0.99 [0.80-1.23],0.9420185299620464
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GBA,Lysosomal acid glucosylceramidase,23514,134,1.02 [0.76-1.37],0.884844523481293
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GBP1,Guanylate-binding protein 1,24095,133,1.01 [0.78-1.29],0.9638802555806834
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GBP2,Guanylate-binding protein 2,27198,150,0.92 [0.72-1.17],0.5042074048721836
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GBP4,Guanylate-binding protein 4,27073,151,1.03 [0.77-1.38],0.8393702040445941
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GBP6,Guanylate-binding protein 6,23424,129,0.80 [0.52-1.22],0.3026578860362616
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GC,Vitamin D-binding protein,24239,135,1.35 [0.73-2.50],0.3410194049932215
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GCC1,GRIP and coiled-coil domain-containing protein 1,24136,133,1.11 [0.95-1.30],0.1713797462335997
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GCG,Pro-glucagon,27102,151,1.03 [0.92-1.16],0.5661345449359727
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23111,126,1.02 [0.74-1.41],0.8829683095866144
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GCLM,Glutamate--cysteine ligase regulatory subunit,23424,129,1.26 [0.93-1.70],0.1368934377025006
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",27629,155,0.87 [0.58-1.32],0.5212091784276907
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GDF15,Growth/differentiation factor 15,28090,154,1.12 [0.83-1.49],0.4592988132057335
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GDF2,Growth/differentiation factor 2,27752,155,0.79 [0.53-1.18],0.2536273384869771
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GDNF,Glial cell line-derived neurotrophic factor,27073,151,1.10 [0.76-1.59],0.6273261286917327
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GET3,ATPase GET3,24191,134,0.98 [0.74-1.30],0.8891760698245139
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GFAP,Glial fibrillary acidic protein,27059,151,1.28 [0.93-1.75],0.1296182720361513
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GFER,FAD-linked sulfhydryl oxidase ALR,27102,151,1.24 [1.00-1.55],0.0498430264810507
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,27102,151,0.93 [0.81-1.05],0.2394022979075094
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GFRA1,GDNF family receptor alpha-1,27936,155,1.45 [0.88-2.39],0.1446334899510604
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GFRA2,GDNF family receptor alpha-2,27629,155,1.04 [0.54-2.03],0.9013807202577642
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GFRA3,GDNF family receptor alpha-3,27473,153,0.58 [0.34-0.97],0.0363278628487129
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GFRAL,GDNF family receptor alpha-like,23399,130,0.87 [0.66-1.15],0.331305663644062
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GGA1,ADP-ribosylation factor-binding protein GGA1,27073,151,0.83 [0.66-1.05],0.1189817578488108
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GGACT,Gamma-glutamylaminecyclotransferase,24191,134,1.18 [0.94-1.48],0.1579089047332793
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GGCT,Gamma-glutamylcyclotransferase,24142,133,1.18 [0.85-1.65],0.3235578862328749
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GGH,Gamma-glutamyl hydrolase,27267,150,0.98 [0.65-1.50],0.9347324769227676
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GGT1,Glutathione hydrolase 1 proenzyme,27714,155,1.12 [0.83-1.50],0.4595213818237299
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GGT5,Glutathione hydrolase 5 proenzyme,27559,153,0.97 [0.52-1.81],0.9201043631700144
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GH1,Somatotropin,27707,155,0.99 [0.92-1.07],0.8723220811206469
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GH2,Growth hormone variant,27102,151,0.93 [0.85-1.02],0.1375666516974892
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GHR,Growth hormone receptor,23679,128,0.95 [0.54-1.70],0.8715714591489347
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GHRHR,Growth hormone-releasing hormone receptor,27073,151,0.88 [0.67-1.17],0.3837646226202887
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GHRL,Appetite-regulating hormone,27752,155,1.15 [0.95-1.38],0.15160687241652
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GID8,Glucose-induced degradation protein 8 homolog,24152,133,1.06 [0.67-1.69],0.8061577049152324
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GIGYF2,GRB10-interacting GYF protein 2,24152,133,1.13 [0.92-1.40],0.2336061827815199
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GIMAP7,GTPase IMAP family member 7,23679,128,1.03 [0.63-1.71],0.8983961820915021
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GIMAP8,GTPase IMAP family member 8,23315,128,0.93 [0.66-1.31],0.6738334440780911
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GIP,Gastric inhibitory polypeptide,23568,133,1.02 [0.72-1.45],0.9088890876472652
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GIPC2,PDZ domain-containing protein GIPC2,24136,133,1.01 [0.57-1.78],0.9788629469518229
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GIPC3,PDZ domain-containing protein GIPC3,24066,134,1.13 [0.95-1.34],0.1658686411937626
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GIPR,Gastric inhibitory polypeptide receptor,23508,131,0.90 [0.61-1.33],0.6033779075738889
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GIT1,ARF GTPase-activating protein GIT1,23508,131,1.13 [0.94-1.34],0.1842136285086448
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GJA8,Gap junction alpha-8 protein,23315,128,1.15 [0.91-1.44],0.2384988501423307
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GKN1,Gastrokine-1,26538,150,0.94 [0.56-1.59],0.8171527656106181
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GLA,Alpha-galactosidase A,23631,128,1.14 [0.72-1.81],0.5658793243641941
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GLB1,Beta-galactosidase,27559,153,1.06 [0.75-1.50],0.7336304596723326
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GLI2,Zinc finger protein GLI2,23508,131,0.94 [0.56-1.57],0.8120265032416528
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GLO1,Lactoylglutathione lyase,27243,152,1.33 [1.05-1.67],0.017163063671809
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GLOD4,Glyoxalase domain-containing protein 4,27711,153,1.29 [0.88-1.90],0.1954627031711129
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GLP1R,Glucagon-like peptide 1 receptor,23410,130,0.75 [0.46-1.24],0.2591905658042663
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GLRX,Glutaredoxin-1,27574,154,1.17 [0.92-1.49],0.1957131797415712
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",23679,128,1.14 [0.94-1.37],0.1744827245332082
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,27073,151,1.04 [0.79-1.38],0.7750395447604486
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GLYR1,Putative oxidoreductase GLYR1,24054,130,0.71 [0.51-0.99],0.0459688159040271
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GM2A,Ganglioside GM2 activator,23602,130,1.30 [0.93-1.82],0.123214516604917
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GMFG,Glia maturation factor gamma,24191,134,1.21 [0.96-1.52],0.0997204954196387
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GMPR,GMP reductase 1,28040,156,1.13 [0.85-1.49],0.4002811625364471
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GMPR2,GMP reductase 2,23679,128,1.11 [0.86-1.43],0.4108431997415717
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GNAS,Neuroendocrine secretory protein 55,24152,133,1.08 [0.91-1.28],0.3887411992515259
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,27102,151,1.17 [0.95-1.45],0.1386645934442738
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,23514,134,1.07 [0.80-1.42],0.6497481613779099
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GNLY,Granulysin,27756,156,0.93 [0.70-1.23],0.6002052101236132
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GNPDA1,Glucosamine-6-phosphate isomerase 1,23568,133,1.16 [0.74-1.82],0.5044896595446924
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GNPDA2,Glucosamine-6-phosphate isomerase 2,23679,128,0.92 [0.58-1.46],0.7253576630251244
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GOLGA3,Golgin subfamily A member 3,24152,133,1.25 [1.02-1.52],0.0312323476126937
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GOLM2,Protein GOLM2,27991,156,1.22 [0.66-2.26],0.5352615321444065
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,27705,155,1.14 [0.99-1.32],0.068381409276223
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GORASP2,Golgi reassembly-stacking protein 2,24066,134,1.15 [0.82-1.63],0.4214683073268691
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GOT1,"Aspartate aminotransferase, cytoplasmic",24190,135,0.79 [0.52-1.18],0.2464684603493847
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GP1BA,Platelet glycoprotein Ib alpha chain,27618,151,1.18 [0.76-1.84],0.4638410687600635
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GP1BB,Platelet glycoprotein Ib beta chain,23424,129,1.13 [0.88-1.46],0.3380660833355358
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,26896,148,1.07 [0.91-1.26],0.4075626615124126
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GP5,Platelet glycoprotein V,23679,128,1.12 [0.70-1.79],0.647723370967711
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GP6,Platelet glycoprotein VI,27715,155,1.20 [1.02-1.42],0.0266246237710277
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GPA33,Cell surface A33 antigen,27629,155,1.03 [0.92-1.14],0.6306224565137579
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GPC1,Glypican-1,27985,155,1.18 [0.73-1.92],0.5058404547117331
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GPC5,Glypican-5,27559,153,1.05 [0.81-1.35],0.7333934846501908
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GPD1,Glycerol-3-phosphate dehydrogenase,24054,130,1.13 [0.82-1.55],0.4508385953101811
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GPHA2,Glycoprotein hormone alpha-2,24066,134,0.83 [0.57-1.21],0.3295860680615641
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GPI,Glucose-6-phosphate isomerase,24205,134,1.22 [0.88-1.70],0.2295194814420708
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24066,134,0.86 [0.69-1.06],0.1497265945397647
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GPKOW,G-patch domain and KOW motifs-containing protein,27073,151,0.91 [0.54-1.54],0.7265472543170157
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GPNMB,Transmembrane glycoprotein NMB,27000,151,0.93 [0.56-1.54],0.7717069741271418
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GPR101,Probable G-protein coupled receptor 101,23410,130,0.83 [0.61-1.14],0.2602945617598792
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GPR158,Probable G-protein coupled receptor 158,24152,133,1.18 [0.79-1.76],0.4228057684697409
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GPR15L,Protein GPR15L,24066,134,1.14 [0.88-1.48],0.3206283502247814
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GPR37,Prosaposin receptor GPR37,27243,152,1.20 [0.97-1.49],0.0945567282383955
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GPRC5C,G-protein coupled receptor family C group 5 member C,24054,130,1.13 [0.87-1.48],0.3631348947070734
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GRAP2,GRB2-related adapter protein 2,27752,155,1.10 [0.98-1.23],0.1051426225717581
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24191,134,1.19 [0.93-1.53],0.170646443257792
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GRIK2,"Glutamate receptor ionotropic, kainate 2",24152,133,0.96 [0.64-1.45],0.8572381856154485
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",23410,130,1.25 [1.01-1.55],0.0407669410096139
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GRK5,G protein-coupled receptor kinase 5,27243,152,1.08 [0.83-1.41],0.5578647753666681
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GRN,Progranulin,27630,155,0.85 [0.47-1.52],0.576229924687073
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GRP,Gastrin-releasing peptide,23568,133,1.23 [0.91-1.67],0.1780132278184995
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GRPEL1,"GrpE protein homolog 1, mitochondrial",27629,155,1.08 [0.86-1.36],0.5056914284239895
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GRSF1,G-rich sequence factor 1,23192,128,1.09 [0.89-1.34],0.4165760675226414
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GSAP,Gamma-secretase-activating protein,27102,151,0.89 [0.73-1.07],0.2091959710999219
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GSN,Gelsolin,24122,134,1.02 [0.42-2.48],0.9628612356565338
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GSR,"Glutathione reductase, mitochondrial",24062,133,1.49 [0.73-3.07],0.276131920649677
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GSTA1,Glutathione S-transferase A1,27711,155,0.92 [0.77-1.10],0.3672169770531911
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GSTA3,Glutathione S-transferase A3,27102,151,0.92 [0.75-1.12],0.3910176209105626
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GSTM4,Glutathione S-transferase Mu 4,23424,129,1.11 [0.90-1.36],0.3429841101231916
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GSTP1,Glutathione S-transferase P,26904,150,1.07 [0.87-1.32],0.498483792046171
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GSTT2B,Glutathione S-transferase theta-2B,24136,133,1.08 [1.00-1.15],0.0443842500267555
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,23740,131,0.83 [0.63-1.10],0.2018273877325453
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GTPBP2,GTP-binding protein 2,23514,134,1.15 [0.94-1.42],0.1782999571243881
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GUCA2A,Guanylin,27628,154,1.43 [0.94-2.19],0.0977434941973115
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GUCY2C,Heat-stable enterotoxin receptor,23740,131,1.10 [0.93-1.31],0.2711663998584497
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GUK1,Guanylate kinase,23424,129,1.05 [0.72-1.54],0.7985080328171892
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GUSB,Beta-glucuronidase,27878,152,1.13 [0.89-1.43],0.328999313833019
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GYS1,"Glycogen [starch] synthase, muscle",27243,152,1.14 [0.98-1.33],0.0896903824008658
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GZMA,Granzyme A,28040,156,1.04 [0.70-1.57],0.8324389254962308
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GZMB,Granzyme B,27705,155,1.03 [0.83-1.28],0.770655357335649
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",GZMH,Granzyme H,27243,152,1.15 [0.98-1.37],0.095586901928703
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",H2AP,Huntingtin-interacting protein M,23315,128,0.81 [0.53-1.22],0.3039263073207663
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",23424,129,0.81 [0.59-1.12],0.2050670121911416
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",27898,155,1.07 [0.89-1.29],0.4633783690876429
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HAO1,Hydroxyacid oxidase 1,27985,155,1.00 [0.90-1.11],0.9875543188230408
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HARS1,"Histidine--tRNA ligase, cytoplasmic",27756,156,1.14 [0.95-1.37],0.1523229926112277
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HAVCR1,Hepatitis A virus cellular receptor 1,27947,155,1.22 [0.97-1.53],0.0817671454919159
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HAVCR2,Hepatitis A virus cellular receptor 2,27756,156,1.21 [0.80-1.83],0.3659281811077043
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HBEGF,Proheparin-binding EGF-like growth factor,27898,155,1.14 [0.94-1.38],0.192110737998567
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HBQ1,Hemoglobin subunit theta-1,27985,155,1.13 [0.90-1.42],0.2839719385416552
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HBZ,Hemoglobin subunit zeta,24191,134,1.03 [0.88-1.21],0.6834667198565749
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HCG22,Protein PBMUCL2,23424,129,0.97 [0.70-1.33],0.8390101842302309
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HCLS1,Hematopoietic lineage cell-specific protein,28040,156,1.29 [1.00-1.67],0.046832529867096
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HDAC8,Histone deacetylase 8,23508,131,0.95 [0.72-1.26],0.7458264135318802
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HDAC9,Histone deacetylase 9,23410,130,0.98 [0.74-1.28],0.8677922116317495
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HDDC2,5'-deoxynucleotidase HDDC2,24066,134,0.89 [0.61-1.30],0.5419801300629165
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HDGF,Hepatoma-derived growth factor,27950,155,1.08 [0.93-1.25],0.3172497191105945
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HDGFL2,Hepatoma-derived growth factor-related protein 2,24136,133,1.13 [0.88-1.45],0.3377423079470846
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HEBP1,Heme-binding protein 1,27243,152,1.09 [0.85-1.38],0.5035685149022359
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HEG1,Protein HEG homolog 1,23679,128,0.67 [0.35-1.28],0.2297943783496088
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HEPACAM2,HEPACAM family member 2,24136,133,0.82 [0.55-1.22],0.3217806878511657
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HEPH,Hephaestin,24191,134,0.52 [0.28-0.94],0.0308964216181611
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HEXIM1,Protein HEXIM1,27705,155,1.24 [1.04-1.47],0.0141483779450875
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HGF,Hepatocyte growth factor,28040,156,1.21 [0.81-1.80],0.3537960494084265
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HGFAC,Hepatocyte growth factor activator,23966,130,0.68 [0.42-1.11],0.1251447010386512
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,27102,151,1.12 [0.93-1.34],0.2267505450243279
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HHEX,Hematopoietically-expressed homeobox protein HHEX,24136,133,1.20 [0.97-1.49],0.0978836983012538
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HIF1A,Hypoxia-inducible factor 1-alpha,23508,131,1.22 [1.01-1.46],0.0363016846858363
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HIP1,Huntingtin-interacting protein 1,23424,129,1.19 [0.77-1.83],0.4299312143429984
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HIP1R,Huntingtin-interacting protein 1-related protein,24093,131,0.89 [0.59-1.33],0.5653414427830755
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HJV,Hemojuvelin,24152,133,1.16 [0.83-1.62],0.3832212287460226
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HK2,Hexokinase-2,27243,152,1.14 [0.69-1.87],0.6126347638996117
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",24152,133,0.79 [0.48-1.30],0.3561056793337247
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",27625,155,1.13 [0.76-1.67],0.5442114252965254
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",27705,155,1.22 [0.75-1.98],0.4233888128926849
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HMBS,Porphobilinogen deaminase,27985,155,1.21 [0.89-1.65],0.2149980834452125
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HMCN2,Hemicentin-2,23636,128,0.77 [0.58-1.03],0.079251864479419
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",23568,133,1.05 [0.76-1.46],0.7479104217515039
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",23424,129,1.03 [0.71-1.49],0.8660384243294164
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HMMR,Hyaluronan mediated motility receptor,23275,128,1.00 [0.70-1.44],0.9859498447373288
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HMOX1,Heme oxygenase 1,27435,153,1.14 [0.84-1.54],0.4096149672237187
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HMOX2,Heme oxygenase 2,27073,151,1.08 [0.80-1.46],0.621694794321221
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HNF1A,Hepatocyte nuclear factor 1-alpha,23514,134,0.92 [0.72-1.18],0.5278564929307022
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HNMT,Histamine N-methyltransferase,27423,152,0.82 [0.60-1.12],0.2144070377207025
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,27161,152,1.17 [0.98-1.40],0.0812843361593732
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24152,133,1.14 [0.83-1.56],0.4101136158012349
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HPCAL1,Hippocalcin-like protein 1,28040,156,1.18 [0.97-1.43],0.1072271044332097
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HPGDS,Hematopoietic prostaglandin D synthase,27102,151,0.63 [0.42-0.94],0.0228905630100596
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HPSE,Heparanase,23856,132,1.09 [0.91-1.30],0.3580434194933847
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HRAS,GTPase Hras,23694,131,0.98 [0.82-1.16],0.7823050871565544
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,23568,133,1.27 [0.86-1.88],0.2250130324797186
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HRG,Histidine-rich glycoprotein,24096,133,0.78 [0.47-1.31],0.3524007937556986
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HS1BP3,HCLS1-binding protein 3,23568,133,1.22 [1.01-1.46],0.0357615259907884
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,27629,155,1.03 [0.71-1.48],0.8913958577207715
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,27985,155,1.45 [1.00-2.10],0.0516142559725948
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,23508,131,1.56 [0.92-2.62],0.0970135663577761
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HSBP1,Heat shock factor-binding protein 1,23568,133,1.09 [0.92-1.30],0.3249944188115926
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,27705,155,0.92 [0.64-1.33],0.668046089892691
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24136,133,0.98 [0.75-1.28],0.8640450473338975
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HSD17B3,Testosterone 17-beta-dehydrogenase 3,23424,129,1.26 [0.94-1.69],0.1285922334525764
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,23568,133,1.11 [0.79-1.57],0.5351546903853587
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HSP90B1,Endoplasmin,26937,151,0.94 [0.75-1.18],0.5929260680473324
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HSPA1A,Heat shock 70 kDa protein 1A,27849,154,1.11 [0.92-1.34],0.2811027299605371
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HSPA2,Heat shock-related 70 kDa protein 2,24054,130,0.87 [0.52-1.46],0.5912374428723014
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HSPB1,Heat shock protein beta-1,27300,153,1.22 [0.98-1.53],0.077475620734868
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HSPB6,Heat shock protein beta-6,27985,155,1.18 [0.81-1.72],0.3918599689992748
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,27525,153,1.20 [0.68-2.13],0.5218309295494594
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HTR1A,5-hydroxytryptamine receptor 1A,23410,130,0.85 [0.66-1.09],0.1896529915956586
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HTR1B,5-hydroxytryptamine receptor 1B,23410,130,1.03 [0.70-1.52],0.8645462171171776
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HTRA2,"Serine protease HTRA2, mitochondrial",27849,154,1.20 [0.96-1.50],0.1183922907114146
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HYAL1,Hyaluronidase-1,27568,152,1.12 [0.61-2.06],0.709814469030852
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",HYOU1,Hypoxia up-regulated protein 1,28090,154,1.64 [0.85-3.14],0.1398537381784614
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ICA1,Islet cell autoantigen 1,27198,150,1.18 [0.98-1.41],0.0746744667099287
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ICAM1,Intercellular adhesion molecule 1,27622,153,0.95 [0.58-1.57],0.8559855768822449
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ICAM2,Intercellular adhesion molecule 2,28090,154,1.10 [0.70-1.74],0.6794317471073894
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ICAM3,Intercellular adhesion molecule 3,28090,154,1.03 [0.59-1.82],0.9121660094470448
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ICAM4,Intercellular adhesion molecule 4,27705,155,1.08 [0.83-1.41],0.5742805467526617
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ICAM5,Intercellular adhesion molecule 5,27752,155,1.02 [0.75-1.40],0.8840819155735989
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ICOSLG,ICOS ligand,27629,155,1.02 [0.49-2.15],0.9480950874178472
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ID4,DNA-binding protein inhibitor ID-4,23740,131,1.24 [0.92-1.66],0.1514801357810386
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IDI2,Isopentenyl-diphosphate delta-isomerase 2,27073,151,0.84 [0.61-1.18],0.3188271309291703
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IDO1,"Indoleamine 2,3-dioxygenase 1",23568,133,0.77 [0.59-1.00],0.0529066954733146
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IDS,Iduronate 2-sulfatase,28040,156,2.79 [0.52-15.06],0.2320378621374117
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IDUA,Alpha-L-iduronidase,27985,155,1.16 [0.85-1.59],0.3382911651141631
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,23474,130,0.82 [0.53-1.26],0.3624079756692704
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,23740,131,1.15 [0.86-1.54],0.353160459752476
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,23740,131,1.39 [0.93-2.05],0.1042710729923343
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IFNAR1,Interferon alpha/beta receptor 1,24066,134,0.44 [0.23-0.83],0.0114467678187034
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IFNG,Interferon gamma,27198,150,0.92 [0.82-1.03],0.1600697432052366
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IFNGR1,Interferon gamma receptor 1,27889,155,1.16 [0.57-2.36],0.6860871824372761
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IFNGR2,Interferon gamma receptor 2,27559,153,0.89 [0.67-1.17],0.3967963450684648
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IFNL1,Interferon lambda-1,27073,151,0.79 [0.57-1.09],0.1555807115344301
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IFNL2,Interferon lambda-2,23410,130,1.02 [0.79-1.31],0.8921521146839432
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IFNLR1,Interferon lambda receptor 1,27705,155,0.79 [0.53-1.18],0.2517036896406633
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IFNW1,Interferon omega-1,23424,129,1.06 [0.69-1.63],0.7984292430969122
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IFT20,Intraflagellar transport protein 20 homolog,23514,134,0.90 [0.61-1.32],0.5790200178991085
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGBP1,Immunoglobulin-binding protein 1,24152,133,1.03 [0.79-1.34],0.8439687973991742
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,23410,130,0.88 [0.60-1.28],0.4891114966365923
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24190,135,0.28 [0.16-0.50],1.3961159441852894e-05
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGF1R,Insulin-like growth factor 1 receptor,27629,155,0.81 [0.41-1.60],0.5425593044462924
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,23424,129,1.08 [0.77-1.52],0.6549593640566738
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGF2R,Cation-independent mannose-6-phosphate receptor,27756,156,1.13 [0.61-2.07],0.6994892528244511
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGFBP1,Insulin-like growth factor-binding protein 1,28040,154,0.97 [0.86-1.10],0.6739732619004322
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGFBP2,Insulin-like growth factor-binding protein 2,28043,154,0.88 [0.71-1.10],0.2665484039040098
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGFBP3,Insulin-like growth factor-binding protein 3,27845,154,2.21 [1.27-3.85],0.004893275149155
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGFBP4,Insulin-like growth factor-binding protein 4,27382,155,1.27 [0.91-1.77],0.1532670343303198
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGFBP6,Insulin-like growth factor-binding protein 6,27619,154,1.66 [1.05-2.62],0.0301378348518421
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGFBP7,Insulin-like growth factor-binding protein 7,28090,154,1.24 [0.79-1.96],0.3566255411154653
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGFBPL1,Insulin-like growth factor-binding protein-like 1,27752,155,0.88 [0.57-1.35],0.5576607228592418
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGFL4,Insulin growth factor-like family member 4,23508,131,0.96 [0.76-1.20],0.701804852509579
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGHMBP2,DNA-binding protein SMUBP-2,23424,129,1.00 [0.74-1.34],0.9794013373284984
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGLC2,Immunoglobulin lambda constant 2,24188,135,1.05 [0.54-2.04],0.8961652154918313
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGLON5,IgLON family member 5,23315,128,0.86 [0.69-1.08],0.2066416805016526
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGSF21,Immunoglobulin superfamily member 21,23568,133,1.09 [0.73-1.62],0.6831951472402376
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGSF3,Immunoglobulin superfamily member 3,27629,155,0.68 [0.43-1.08],0.1037295348563053
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGSF8,Immunoglobulin superfamily member 8,27752,155,1.82 [1.18-2.79],0.0064534220347885
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IGSF9,Protein turtle homolog A,24191,134,0.96 [0.78-1.18],0.6808814138871426
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IKBKG,NF-kappa-B essential modulator,27705,155,1.17 [1.00-1.37],0.0448764643191169
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IKZF2,Zinc finger protein Helios,27102,151,0.96 [0.82-1.13],0.6247668364460044
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL10,Interleukin-10,27198,150,0.99 [0.84-1.18],0.9524480301826695
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL10RA,Interleukin-10 receptor subunit alpha,27198,150,0.90 [0.69-1.17],0.4189787424490113
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL10RB,Interleukin-10 receptor subunit beta,27889,155,1.05 [0.64-1.73],0.8390773725664578
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL11,Interleukin-11,27198,150,0.88 [0.69-1.13],0.3275442039527524
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL12A_IL12B,Interleukin-12,27629,155,1.06 [0.88-1.27],0.5646914605153249
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL12B,Interleukin-12 subunit beta,28040,156,1.05 [0.81-1.36],0.7140920675799558
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL12RB1,Interleukin-12 receptor subunit beta-1,27198,150,1.07 [0.73-1.58],0.7228737411233063
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL12RB2,Interleukin-12 receptor subunit beta-2,23508,131,0.73 [0.47-1.12],0.1520750484199186
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL13,Interleukin-13,27198,150,1.04 [0.80-1.37],0.7563316757300204
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL13RA1,Interleukin-13 receptor subunit alpha-1,27413,152,1.10 [0.56-2.17],0.7894420703870118
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL13RA2,Interleukin-13 receptor subunit alpha-2,23410,130,0.74 [0.41-1.32],0.3093335297485389
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL15,Interleukin-15,27705,155,2.13 [1.48-3.08],5.440060023952158e-05
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL15RA,Interleukin-15 receptor subunit alpha,27198,150,1.14 [0.75-1.73],0.5271858616546247
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL16,Pro-interleukin-16,28040,156,1.09 [0.79-1.51],0.6042372903662704
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL17A,Interleukin-17A,27168,150,1.47 [1.13-1.90],0.0036705941890504
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL17C,Interleukin-17C,27198,150,1.03 [0.83-1.27],0.7844793659885846
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL17D,Interleukin-17D,27198,150,0.66 [0.40-1.10],0.1100652086303464
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL17F,Interleukin-17F,27198,150,1.03 [0.87-1.23],0.7197477928172433
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL17RA,Interleukin-17 receptor A,27756,156,1.34 [0.97-1.85],0.0742853425562058
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL17RB,Interleukin-17 receptor B,27354,150,1.08 [0.82-1.41],0.5946237349682801
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL18,Interleukin-18,27665,152,1.13 [0.84-1.51],0.4137042162412633
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL18BP,Interleukin-18-binding protein,27845,154,0.94 [0.58-1.52],0.8020763350423045
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL18R1,Interleukin-18 receptor 1,28040,156,1.03 [0.68-1.58],0.8781793190563789
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL18RAP,Interleukin-18 receptor accessory protein,27385,151,0.99 [0.91-1.08],0.8253110884695664
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL19,Interleukin-19,27061,151,0.88 [0.70-1.10],0.2632469305136693
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL1A,Interleukin-1 alpha,27198,150,0.92 [0.69-1.23],0.5783861273624734
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL1B,Interleukin-1 beta,27066,149,1.15 [0.90-1.46],0.2601008328459094
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL1R1,Interleukin-1 receptor type 1,27714,155,1.46 [0.78-2.75],0.2410998799625687
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL1R2,Interleukin-1 receptor type 2,27711,153,1.20 [0.57-2.50],0.6317105008223868
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL1RAP,Interleukin-1 receptor accessory protein,27756,156,1.10 [0.80-1.53],0.5503918395524301
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL1RL1,Interleukin-1 receptor-like 1,28000,154,0.94 [0.69-1.28],0.7080282124450564
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL1RL2,Interleukin-1 receptor-like 2,27198,150,1.01 [0.71-1.43],0.9510177952380444
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL1RN,Interleukin-1 receptor antagonist protein,27711,154,0.98 [0.76-1.27],0.8789138340328387
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL2,Interleukin-2,27198,150,0.93 [0.58-1.47],0.7437413240845063
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL20,Interleukin-20,27198,150,1.02 [0.77-1.35],0.8807945838897224
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL20RA,Interleukin-20 receptor subunit alpha,27198,150,0.97 [0.70-1.36],0.8724715602321508
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL20RB,Interleukin-20 receptor subunit beta,23508,131,1.07 [0.73-1.57],0.7391140666470998
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL21R,Interleukin-21 receptor,23508,131,0.84 [0.59-1.19],0.3358146532151951
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL22,Interleukin-22,24054,130,0.90 [0.68-1.17],0.4269408115427954
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL22RA1,Interleukin-22 receptor subunit alpha-1,27198,150,1.07 [0.78-1.46],0.6804976849711715
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL24,Interleukin-24,27198,150,1.02 [0.76-1.38],0.8766463917067673
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL25,Interleukin-25,23237,128,1.16 [0.72-1.88],0.5411911740205374
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL2RA,Interleukin-2 receptor subunit alpha,27536,149,0.78 [0.54-1.14],0.205839628790081
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL2RB,Interleukin-2 receptor subunit beta,27198,150,0.72 [0.46-1.11],0.1338640719452361
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL2RG,Cytokine receptor common subunit gamma,24054,130,1.08 [0.73-1.61],0.6883957243605852
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL3,Interleukin-3,23315,128,0.95 [0.72-1.24],0.7040251768032506
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL31,Interleukin-31,23508,131,1.03 [0.78-1.36],0.8371356217963324
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL31RA,Interleukin-31 receptor subunit alpha,23411,131,1.07 [0.71-1.62],0.7483562109259303
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL32,Interleukin-32,27705,155,0.94 [0.67-1.32],0.711602978354859
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL33,Interleukin-33,27198,150,0.70 [0.48-1.02],0.0607369683976911
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL34,Interleukin-34,27031,151,1.11 [0.74-1.67],0.6116066073169697
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL36A,Interleukin-36 alpha,23508,131,0.89 [0.65-1.22],0.4777612944195815
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL36G,Interleukin-36 gamma,23408,129,0.71 [0.52-0.95],0.0237256303375423
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL3RA,Interleukin-3 receptor subunit alpha,27198,150,0.70 [0.44-1.13],0.1425813520029708
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL4,Interleukin-4,27198,150,1.03 [0.87-1.21],0.7580895161610004
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL4R,Interleukin-4 receptor subunit alpha,27705,155,1.03 [0.69-1.54],0.871235916192301
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL5,Interleukin-5,27198,150,1.08 [0.99-1.18],0.0763474856536192
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL5RA,Interleukin-5 receptor subunit alpha,27705,155,1.04 [0.81-1.35],0.7443707336709839
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL6,Interleukin-6,27629,155,0.89 [0.72-1.10],0.2781838514566409
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL6R,Interleukin-6 receptor subunit alpha,27571,151,0.97 [0.63-1.48],0.8799958418537269
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL6ST,Interleukin-6 receptor subunit beta,27752,155,0.88 [0.39-1.99],0.7645771215627772
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL7,Interleukin-7,27705,155,1.13 [0.91-1.40],0.2571716248207245
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL7R,Interleukin-7 receptor subunit alpha,27756,156,0.86 [0.66-1.11],0.2478329863101711
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IL9,Interleukin-9,23740,131,1.29 [1.04-1.59],0.0188118228238245
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,27035,151,1.11 [0.87-1.41],0.3875330138342659
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IMMT,MICOS complex subunit MIC60,24054,130,0.91 [0.62-1.34],0.6402524342990872
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IMPA1,Inositol monophosphatase 1,27559,153,1.07 [0.85-1.35],0.5494555829529133
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IMPACT,Protein IMPACT,24136,133,1.21 [0.91-1.62],0.1884392876640752
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IMPG1,Interphotoreceptor matrix proteoglycan 1,23410,130,1.04 [0.61-1.77],0.8877217254583697
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ING1,Inhibitor of growth protein 1,27021,151,1.19 [0.90-1.57],0.2188274483634293
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",INHBB,Inhibin beta B chain,23679,128,0.93 [0.67-1.30],0.6888349088094599
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",INHBC,Inhibin beta C chain,27756,156,1.00 [0.72-1.39],0.990575131895071
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",INPP1,Inositol polyphosphate 1-phosphatase,27629,155,0.96 [0.74-1.25],0.7673654523608249
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",23568,133,1.31 [0.99-1.74],0.0557547358024134
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24152,133,1.15 [0.82-1.63],0.4205265421753974
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",27629,155,1.19 [1.03-1.38],0.0184022941084961
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",INSL3,Insulin-like 3,24136,133,0.93 [0.71-1.21],0.5842310182118006
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",INSL4,Early placenta insulin-like peptide,24054,130,1.00 [0.76-1.33],0.9945828149572375
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",INSL5,Insulin-like peptide INSL5,24066,134,0.90 [0.75-1.08],0.2702431940526046
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",INSR,Insulin receptor,23508,131,0.47 [0.17-1.30],0.1465387421648403
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IPCEF1,Interactor protein for cytohesin exchange factors 1,27517,152,1.10 [0.93-1.29],0.2605414917290786
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IQGAP2,Ras GTPase-activating-like protein IQGAP2,27629,155,1.13 [0.88-1.44],0.3496686557186883
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",27243,152,1.17 [1.01-1.35],0.0404352547727048
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IRAK1,Interleukin-1 receptor-associated kinase 1,27198,150,1.22 [0.99-1.49],0.0583162489682977
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IRAK4,Interleukin-1 receptor-associated kinase 4,27705,155,1.12 [0.97-1.29],0.115464699690836
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,26690,150,0.93 [0.63-1.38],0.732658929873886
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ISM1,Isthmin-1,27705,155,1.06 [0.74-1.51],0.7436258099276292
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ISM2,Isthmin-2,24190,135,0.98 [0.68-1.41],0.9143907016919522
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IST1,IST1 homolog,23898,134,1.10 [0.93-1.30],0.2518577434603963
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITGA11,Integrin alpha-11,27705,155,0.83 [0.55-1.25],0.3612169239656365
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITGA2,Integrin alpha-2,23679,128,0.57 [0.35-0.95],0.0296112961236328
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITGA5,Integrin alpha-5,27756,156,0.72 [0.40-1.28],0.2577074145600745
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITGA6,Integrin alpha-6,27705,155,0.98 [0.75-1.27],0.8703701637660075
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITGAL,Integrin alpha-L,23508,131,0.84 [0.59-1.21],0.3489461656241818
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITGAM,Integrin alpha-M,27756,156,0.90 [0.57-1.40],0.6371877533389405
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITGAV,Integrin alpha-V,27985,155,0.95 [0.41-2.23],0.91043149632668
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITGAX,Integrin alpha-X,23740,131,1.25 [0.96-1.62],0.1002118943911787
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITGB1,Integrin beta-1,27707,154,0.74 [0.38-1.44],0.3724435049181449
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITGB1BP1,Integrin beta-1-binding protein 1,27102,151,1.12 [0.80-1.58],0.5102603583878021
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITGB1BP2,Integrin beta-1-binding protein 2,27243,152,1.08 [0.94-1.23],0.2669638062179642
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITGB2,Integrin beta-2,27576,152,0.86 [0.52-1.42],0.5438438625819655
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITGB5,Integrin beta-5,27849,154,1.04 [0.72-1.52],0.8265039631464639
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITGB6,Integrin beta-6,27198,150,0.98 [0.60-1.60],0.9471084835883632
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITGB7,Integrin beta-7,27985,155,0.88 [0.64-1.20],0.4220936539070723
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITGBL1,Integrin beta-like protein 1,24190,135,0.72 [0.44-1.18],0.1893368454518371
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24239,135,1.20 [0.51-2.79],0.6739386336316083
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,27845,154,0.66 [0.46-0.94],0.0210023942407689
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24239,135,1.07 [0.59-1.95],0.8144181461462522
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24054,130,1.14 [0.82-1.59],0.4335276285025871
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITM2A,Integral membrane protein 2A,27705,155,0.93 [0.73-1.18],0.5391190950531579
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITPA,Inosine triphosphate pyrophosphatase,23424,129,1.22 [0.96-1.55],0.1080808231661483
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",23568,133,1.05 [0.83-1.31],0.6987936001749226
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",23410,130,0.67 [0.44-1.02],0.0595198782019018
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",27073,151,1.11 [0.84-1.46],0.449732300489132
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",IZUMO1,Izumo sperm-egg fusion protein 1,23315,128,1.08 [0.78-1.48],0.6507687461221313
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",JAM2,Junctional adhesion molecule B,27991,156,0.83 [0.47-1.46],0.5094800259850001
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",JAM3,Junctional adhesion molecule C,23679,128,1.26 [0.92-1.72],0.1441728691001432
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",JCHAIN,Immunoglobulin J chain,27198,150,0.88 [0.69-1.11],0.2786890240905165
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,23315,128,1.36 [1.07-1.74],0.0119183716256175
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",JPT2,Jupiter microtubule associated homolog 2,24066,134,1.14 [0.94-1.38],0.1784341913796384
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",JUN,Transcription factor AP-1,27198,150,1.00 [0.76-1.31],0.977038770264036
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,27629,155,1.09 [0.79-1.49],0.6075142582169046
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KAZN,Kazrin,24066,134,1.12 [0.95-1.32],0.1696501526478877
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KCNC4,Potassium voltage-gated channel subfamily C member 4,23410,130,0.86 [0.61-1.19],0.3591388381336217
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KCNH2,Potassium voltage-gated channel subfamily H member 2,23514,134,0.75 [0.57-0.99],0.0460226505920078
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KCNIP4,Kv channel-interacting protein 4,27073,151,1.03 [0.79-1.35],0.839871266809603
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KCTD5,BTB/POZ domain-containing protein KCTD5,23687,128,1.02 [0.69-1.49],0.93574472348373
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KDM3A,Lysine-specific demethylase 3A,23508,131,0.95 [0.78-1.15],0.5822912506128339
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KDR,Vascular endothelial growth factor receptor 2,27849,154,1.39 [0.80-2.42],0.2400980839584141
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KEL,Kell blood group glycoprotein,27073,151,0.97 [0.65-1.46],0.8872522353332746
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KHDC3L,KH domain-containing protein 3,23315,128,0.89 [0.67-1.18],0.4102313754187332
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KHK,Ketohexokinase,23568,133,1.02 [0.79-1.32],0.8519949927533992
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KIAA0319,Dyslexia-associated protein KIAA0319,24136,133,0.92 [0.54-1.56],0.7584715664229548
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KIAA1549,UPF0606 protein KIAA1549,23740,131,1.12 [0.89-1.41],0.3195792297099401
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KIAA1549L,UPF0606 protein KIAA1549L,23740,131,0.99 [0.55-1.77],0.967856086495055
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KIAA2013,Uncharacterized protein KIAA2013,24054,130,1.17 [0.92-1.49],0.1927129037747736
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KIF1C,Kinesin-like protein KIF1C,23424,129,0.98 [0.62-1.55],0.9417107316782976
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KIF20B,Kinesin-like protein KIF20B,23410,130,0.98 [0.79-1.22],0.8603945170592208
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KIF22,Kinesin-like protein KIF22,23424,129,1.10 [0.96-1.27],0.185331342658207
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KIFBP,KIF-binding protein,27629,155,1.16 [0.97-1.38],0.1064377346503841
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24054,130,1.09 [0.89-1.32],0.4133452152480081
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,27102,151,1.08 [0.89-1.30],0.4570220298309229
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24066,134,1.00 [0.90-1.10],0.9322113355358136
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,27102,151,0.99 [0.88-1.12],0.893571552735506
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,23315,128,1.11 [0.94-1.31],0.2273797468171353
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KIRREL1,Kin of IRRE-like protein 1,23410,130,0.89 [0.65-1.22],0.4689699086748878
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KIRREL2,Kin of IRRE-like protein 2,27073,151,0.84 [0.58-1.21],0.336808654631953
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KIT,Mast/stem cell growth factor receptor Kit,27797,154,0.41 [0.26-0.65],0.0001782008324588
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KITLG,Kit ligand,27752,155,1.09 [0.74-1.61],0.6694374924236743
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLB,Beta-klotho,27073,151,1.04 [0.86-1.26],0.683479947676425
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLF4,Krueppel-like factor 4,23410,130,0.81 [0.52-1.26],0.3592451831584612
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLHL41,Kelch-like protein 41,24152,133,1.01 [0.73-1.41],0.9313078999863016
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLK1,Kallikrein-1,27474,153,1.02 [0.91-1.14],0.784421466443725
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLK10,Kallikrein-10,27756,154,0.96 [0.67-1.37],0.8086284917659436
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLK11,Kallikrein-11,27584,153,1.08 [0.66-1.74],0.7682724191769135
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLK12,Kallikrein-12,27102,151,0.98 [0.89-1.08],0.6611698511023962
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLK13,Kallikrein-13,27147,155,1.39 [1.01-1.91],0.0463688715873529
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLK14,Kallikrein-14,27985,155,0.86 [0.63-1.16],0.3231272040526055
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLK15,Kallikrein-15,24015,130,1.07 [0.77-1.49],0.6832005752618495
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLK3,Prostate-specific antigen,24190,135,0.95 [0.71-1.27],0.7129833421277085
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLK4,Kallikrein-4,27985,155,0.72 [0.57-0.92],0.0083469677097354
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLK6,Kallikrein-6,27809,154,1.24 [0.77-1.99],0.3738149300307003
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLK7,Kallikrein-7,23046,127,0.97 [0.62-1.51],0.8865545766370198
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLK8,Kallikrein-8,26830,151,1.01 [0.67-1.52],0.9778430527314989
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLKB1,Plasma kallikrein,23748,128,1.47 [0.76-2.86],0.2566940537251144
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLRB1,Killer cell lectin-like receptor subfamily B member 1,28040,156,0.74 [0.50-1.09],0.1320457656861809
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,23410,130,1.12 [0.87-1.43],0.3760412493049173
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLRD1,Natural killer cells antigen CD94,28040,156,0.87 [0.64-1.18],0.3648410943267648
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLRF1,Killer cell lectin-like receptor subfamily F member 1,23508,131,0.91 [0.60-1.37],0.6373263449215918
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KLRK1,NKG2-D type II integral membrane protein,24136,133,0.99 [0.68-1.42],0.9444095483203038
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KRT14,"Keratin, type I cytoskeletal 14",26195,149,1.24 [0.78-1.99],0.3622538439075244
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KRT17,"Keratin, type I cytoskeletal 17",23424,129,0.94 [0.60-1.46],0.785346188486707
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KRT18,"Keratin, type I cytoskeletal 18",27629,155,0.86 [0.71-1.05],0.1374632676290402
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KRT19,"Keratin, type I cytoskeletal 19",27663,155,0.94 [0.76-1.17],0.5817273289557812
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KRT5,"Keratin, type II cytoskeletal 5",27073,151,0.70 [0.51-0.96],0.0260044606753959
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KRT6C,"Keratin, type II cytoskeletal 6C",23424,129,1.10 [0.75-1.61],0.6267583875536199
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KRT8,"Keratin, type II cytoskeletal 8",23410,130,0.92 [0.67-1.26],0.6010950488126845
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KYAT1,Kynurenine--oxoglutarate transaminase 1,27705,155,1.15 [0.90-1.47],0.2585974020743026
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",KYNU,Kynureninase,28040,156,1.06 [0.78-1.45],0.695824436638899
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",L1CAM,Neural cell adhesion molecule L1,27849,154,0.87 [0.53-1.42],0.5732711372098445
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24191,134,1.10 [0.91-1.31],0.321681848177326
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LACRT,Extracellular glycoprotein lacritin,24009,130,0.92 [0.66-1.29],0.636623762516443
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LACTB2,Endoribonuclease LACTB2,27752,155,1.20 [0.98-1.48],0.0822844356852345
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LAG3,Lymphocyte activation gene 3 protein,27629,155,1.08 [0.77-1.52],0.6383759755360882
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,27754,153,1.42 [1.04-1.95],0.0265260550546257
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,27559,153,1.18 [1.02-1.37],0.0234221714547156
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LAMA1,Laminin subunit alpha-1,23424,129,1.10 [0.83-1.45],0.515479544274517
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LAMA4,Laminin subunit alpha-4,27889,155,0.93 [0.61-1.43],0.7424844166656387
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LAMB1,Laminin subunit beta-1,23568,133,1.64 [0.94-2.87],0.0829669292390615
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LAMP1,Lysosome-associated membrane glycoprotein 1,23510,131,1.39 [0.93-2.07],0.1086900361237119
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LAMP2,Lysosome-associated membrane glycoprotein 2,26910,150,1.40 [0.63-3.11],0.4063180188268576
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LAMP3,Lysosome-associated membrane glycoprotein 3,27994,156,1.30 [1.01-1.68],0.0421594470348488
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LAMTOR5,Ragulator complex protein LAMTOR5,24054,130,0.87 [0.57-1.33],0.5242710141263449
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LAP3,Cytosol aminopeptidase,27198,150,1.04 [0.78-1.39],0.7794318666050954
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LARP1,La-related protein 1,24054,130,1.00 [0.77-1.28],0.9704718072938822
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LAT,Linker for activation of T-cells family member 1,28040,156,1.23 [1.02-1.49],0.0346330226847258
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LAT2,Linker for activation of T-cells family member 2,27629,155,1.07 [0.95-1.20],0.2438718859737048
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LATS1,Serine/threonine-protein kinase LATS1,23508,131,1.12 [0.92-1.36],0.2730607298934935
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LAYN,Layilin,27507,153,1.08 [0.70-1.66],0.7320139437855031
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LBP,Lipopolysaccharide-binding protein,27845,154,0.92 [0.72-1.17],0.5011251751912074
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LBR,Delta(14)-sterol reductase LBR,27991,156,1.17 [0.97-1.40],0.0940452465195481
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LCAT,Phosphatidylcholine-sterol acyltransferase,24205,134,1.72 [0.81-3.68],0.1583263199228932
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LCN15,Lipocalin-15,24152,133,1.21 [0.99-1.50],0.0669788810181603
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LCN2,Neutrophil gelatinase-associated lipocalin,26904,150,1.35 [0.94-1.94],0.1073537831045895
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LCP1,Plastin-2,24190,135,1.08 [0.77-1.51],0.6687824806539392
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LDLR,Low-density lipoprotein receptor,27819,154,1.01 [0.77-1.32],0.9453068348003406
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LDLRAP1,Low density lipoprotein receptor adapter protein 1,24152,133,1.18 [1.00-1.41],0.0554371165264211
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LECT2,Leukocyte cell-derived chemotaxin-2,24191,134,1.02 [0.79-1.32],0.8712775994953929
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LEFTY2,Left-right determination factor 2,27936,155,0.89 [0.69-1.15],0.3801868368878213
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LEG1,Protein LEG1 homolog,22849,118,0.86 [0.66-1.12],0.2614063265774042
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LELP1,Late cornified envelope-like proline-rich protein 1,23410,130,0.98 [0.78-1.23],0.8293258541688816
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LEO1,RNA polymerase-associated protein LEO1,24152,133,1.32 [0.86-2.01],0.1989982879302319
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LEP,Leptin,27752,155,1.18 [0.94-1.48],0.1492948332993671
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LEPR,Leptin receptor,27752,155,1.10 [0.70-1.72],0.6921835072234408
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LETM1,Mitochondrial proton/calcium exchanger protein,24152,133,1.19 [0.88-1.60],0.2559516254155241
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LGALS1,Galectin-1,27752,155,1.21 [0.80-1.82],0.3742250973482904
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LGALS3,Galectin-3,27812,154,0.92 [0.57-1.49],0.7273653637805719
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LGALS3BP,Galectin-3-binding protein,24239,135,1.01 [0.58-1.74],0.979109899100332
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LGALS4,Galectin-4,27754,153,1.15 [0.88-1.50],0.3054342390636548
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LGALS7_LGALS7B,Galectin-7,27668,153,0.91 [0.64-1.31],0.6226569368609174
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LGALS8,Galectin-8,27991,156,1.12 [0.89-1.40],0.335791590024151
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LGALS9,Galectin-9,27751,154,1.25 [0.81-1.92],0.3066939073089695
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LGMN,Legumain,27889,155,1.30 [0.89-1.91],0.1760850384161992
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LHB,Lutropin subunit beta,27102,151,1.00 [0.85-1.17],0.9836966994989466
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,27801,154,1.27 [1.01-1.59],0.0369691501691108
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LIF,Leukemia inhibitory factor,27073,151,0.87 [0.64-1.17],0.3423562457890953
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LIFR,Leukemia inhibitory factor receptor,27705,155,0.93 [0.53-1.64],0.7965156421134572
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,27756,156,0.79 [0.55-1.14],0.2101905555045965
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24190,135,1.06 [0.92-1.21],0.4175945330200108
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,23424,129,1.00 [0.73-1.39],0.9765137564990006
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,27707,155,1.33 [0.85-2.07],0.2129870083190682
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24191,134,1.05 [0.84-1.32],0.6754517721109199
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,28090,154,1.05 [0.63-1.75],0.8584668880584329
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,27953,154,0.94 [0.63-1.41],0.7739655315622846
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,27198,150,1.47 [1.06-2.03],0.0201292612513287
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,28090,154,1.05 [0.85-1.28],0.6624108902624811
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LIPF,Gastric triacylglycerol lipase,23568,133,0.89 [0.67-1.18],0.4160409050478622
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LMNB1,Lamin-B1,24019,134,1.17 [0.92-1.49],0.2023413648167628
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LMNB2,Lamin-B2,24136,133,1.07 [0.60-1.91],0.8252307621780341
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LMOD1,Leiomodin-1,24152,133,1.15 [0.76-1.75],0.5102420469306206
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LMOD2,Leiomodin-2,23410,130,0.92 [0.70-1.20],0.5202420778376095
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LONP1,"Lon protease homolog, mitochondrial",23568,133,1.15 [0.95-1.39],0.1397496524217289
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LPA,Apolipoprotein(a),23639,128,1.00 [0.91-1.10],0.9770233252405142
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LPCAT2,Lysophosphatidylcholine acyltransferase 2,27629,155,0.85 [0.58-1.27],0.4310525397915008
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LPL,Lipoprotein lipase,27752,155,0.93 [0.69-1.26],0.6265622063875487
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LPO,Lactoperoxidase,26890,146,0.83 [0.65-1.07],0.1532850165298227
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LPP,Lipoma-preferred partner,23424,129,1.32 [1.03-1.68],0.0268762870036576
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,23424,129,1.13 [0.89-1.43],0.3294833966674332
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,23514,134,0.72 [0.48-1.08],0.1156031235072468
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRG1,Leucine-rich alpha-2-glycoprotein,24239,135,1.09 [0.58-2.06],0.7962373631384648
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,27898,155,1.08 [0.72-1.62],0.7140971364511541
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,23417,129,1.02 [0.56-1.83],0.9531683915904708
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRP1,Prolow-density lipoprotein receptor-related protein 1,27629,155,0.68 [0.39-1.19],0.1759837713369483
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRP11,Low-density lipoprotein receptor-related protein 11,27752,155,1.19 [0.79-1.79],0.395060970451917
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRP2,Low-density lipoprotein receptor-related protein 2,23514,134,1.04 [0.67-1.62],0.8587830788985086
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRP2BP,LRP2-binding protein,23514,134,0.88 [0.71-1.11],0.2828079513612401
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,27991,156,1.05 [0.82-1.33],0.714873336196057
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRRC25,Leucine-rich repeat-containing protein 25,27629,155,1.07 [0.75-1.53],0.7090264295680606
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRRC37A2,Leucine-rich repeat-containing protein 37A2,24066,134,1.28 [0.86-1.89],0.222989907315116
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRRC38,Leucine-rich repeat-containing protein 38,23514,134,1.14 [0.84-1.56],0.407643089416003
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRRC59,Leucine-rich repeat-containing protein 59,24191,134,1.08 [0.77-1.53],0.6520721191636611
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24054,130,1.22 [0.88-1.69],0.2388886682137075
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRRN1,Leucine-rich repeat neuronal protein 1,27198,150,0.66 [0.45-0.95],0.0265280407227805
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,23514,134,0.77 [0.49-1.19],0.238293472509962
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24152,133,1.02 [0.56-1.85],0.9389436649855154
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LSM1,U6 snRNA-associated Sm-like protein LSm1,27102,151,1.00 [0.78-1.28],0.989712344974921
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LSM8,U6 snRNA-associated Sm-like protein LSm8,23740,131,1.12 [0.96-1.32],0.1492890378863376
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LSP1,Lymphocyte-specific protein 1,27705,155,1.10 [0.78-1.55],0.5780110923399484
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LTA,Lymphotoxin-alpha,27705,155,0.94 [0.66-1.35],0.7506491150529471
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LTA4H,Leukotriene A-4 hydrolase,27985,155,0.90 [0.70-1.15],0.3886406761909265
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LTB,Lymphotoxin-beta,24054,130,0.99 [0.62-1.59],0.9688434088907124
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LTBP2,Latent-transforming growth factor beta-binding protein 2,28090,154,0.67 [0.42-1.07],0.0938418170199286
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LTBP3,Latent-transforming growth factor beta-binding protein 3,27102,151,0.96 [0.74-1.25],0.7598827219357893
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LTBR,Tumor necrosis factor receptor superfamily member 3,27624,152,1.02 [0.60-1.74],0.9378060716052068
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LTO1,Protein LTO1 homolog,27198,150,0.93 [0.65-1.33],0.6880020078153506
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LUZP2,Leucine zipper protein 2,24054,130,1.03 [0.71-1.50],0.8670803671403473
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LXN,Latexin,27433,150,1.05 [0.85-1.29],0.6788691364203824
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LY6D,Lymphocyte antigen 6D,27619,153,1.11 [0.75-1.63],0.6074030029322314
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LY75,Lymphocyte antigen 75,27705,155,0.92 [0.64-1.32],0.6613970030900903
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LY9,T-lymphocyte surface antigen Ly-9,27454,151,1.37 [0.83-2.28],0.2192148629671974
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LY96,Lymphocyte antigen 96,27559,153,1.27 [0.86-1.87],0.2280235617657097
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LYAR,Cell growth-regulating nucleolar protein,27102,151,0.97 [0.74-1.28],0.8441863438415934
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LYN,Tyrosine-protein kinase Lyn,27629,155,1.12 [0.94-1.32],0.2035017699281295
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LYPD1,Ly6/PLAUR domain-containing protein 1,27073,151,0.84 [0.64-1.10],0.216572417660197
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LYPD3,Ly6/PLAUR domain-containing protein 3,27621,154,0.92 [0.62-1.38],0.7031455089327509
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LYPD8,Ly6/PLAUR domain-containing protein 8,27102,151,0.86 [0.64-1.16],0.3125760918510233
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LYPLA2,Acyl-protein thioesterase 2,23410,130,0.93 [0.78-1.10],0.3870651851470712
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,23514,134,0.99 [0.84-1.16],0.9124199156384616
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24239,135,1.10 [0.47-2.54],0.8306634812656158
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LYZL2,Lysozyme-like protein 2,23315,128,0.74 [0.44-1.23],0.2477426177624724
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",LZTFL1,Leucine zipper transcription factor-like protein 1,23679,128,1.17 [0.93-1.48],0.1823880829762656
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",M6PR,Cation-dependent mannose-6-phosphate receptor,23568,133,1.17 [0.82-1.66],0.3825099420895905
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,27463,153,0.93 [0.69-1.26],0.6503708785216836
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAEA,E3 ubiquitin-protein transferase MAEA,27102,151,1.22 [0.87-1.70],0.2464022336550897
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAG,Myelin-associated glycoprotein,23514,134,1.02 [0.71-1.45],0.92994328644188
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAGEA3,Melanoma-associated antigen 3,23740,131,1.04 [0.85-1.27],0.7177221346544589
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAGED1,Melanoma-associated antigen D1,27102,151,1.14 [0.85-1.53],0.3729945652980191
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAMDC2,MAM domain-containing protein 2,24191,134,0.99 [0.60-1.62],0.9625179934334498
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAMDC4,Apical endosomal glycoprotein,24054,130,1.07 [0.80-1.44],0.6519659904423196
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",23568,133,0.76 [0.40-1.45],0.4090393114012858
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAN2B2,Epididymis-specific alpha-mannosidase,24191,134,0.89 [0.68-1.18],0.4254147811470076
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",23315,128,0.79 [0.56-1.10],0.1640210512814183
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MANF,Mesencephalic astrocyte-derived neurotrophic factor,27889,155,1.13 [1.00-1.28],0.0543165647413838
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MANSC1,MANSC domain-containing protein 1,27849,154,1.19 [0.71-1.98],0.5141838293038381
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MANSC4,MANSC domain-containing protein 4,23424,129,0.94 [0.71-1.24],0.6636469877841649
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,23410,130,1.04 [0.62-1.75],0.8783952650127307
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,23424,129,0.93 [0.71-1.23],0.6281092916553546
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAP2,Microtubule-associated protein 2,24136,133,1.23 [0.88-1.72],0.2359801024462094
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24066,134,1.05 [0.82-1.35],0.7006639936883814
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,27705,155,1.11 [0.97-1.28],0.1396351639283215
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,27102,151,1.16 [1.01-1.33],0.0373283794793199
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,27507,153,1.09 [0.96-1.24],0.2037350526152835
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAPK13,Mitogen-activated protein kinase 13,23315,128,1.13 [0.80-1.59],0.4978069621807407
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAPK9,Mitogen-activated protein kinase 9,27705,155,1.26 [0.92-1.74],0.1561796340074562
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAPKAPK2,MAP kinase-activated protein kinase 2,23740,131,1.08 [0.86-1.35],0.4979531481795547
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAPRE3,Microtubule-associated protein RP/EB family member 3,23315,128,1.07 [0.96-1.19],0.2080647918101601
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAPT,Microtubule-associated protein tau,27073,151,0.99 [0.75-1.31],0.9610960076848978
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MARCO,Macrophage receptor MARCO,27752,155,0.95 [0.56-1.62],0.8476535332655204
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MARS1,"Methionine--tRNA ligase, cytoplasmic",23631,128,1.18 [0.97-1.44],0.0968257641896931
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MASP1,Mannan-binding lectin serine protease 1,27507,153,1.15 [0.63-2.09],0.6399177394067299
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MATN2,Matrilin-2,27803,154,1.25 [0.78-1.99],0.3616730002804021
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MATN3,Matrilin-3,27517,152,1.61 [1.04-2.48],0.0308763409910211
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAVS,Mitochondrial antiviral-signaling protein,27102,151,1.19 [1.02-1.38],0.0227943413022998
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MAX,Protein max,27073,151,1.13 [0.99-1.30],0.0754607966966534
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MB,Myoglobin,28090,154,1.07 [0.80-1.41],0.6543429796929651
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MBL2,Mannose-binding protein C,23881,130,0.98 [0.84-1.15],0.830023552778024
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MCAM,Cell surface glycoprotein MUC18,27845,154,0.73 [0.48-1.10],0.1353300833092749
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24152,133,1.18 [0.84-1.65],0.3326626733770832
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MCEMP1,Mast cell-expressed membrane protein 1,23508,131,1.15 [0.97-1.37],0.1035987772852714
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MCFD2,Multiple coagulation factor deficiency protein 2,27635,155,1.28 [0.93-1.76],0.1318553448821755
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MCTS1,Malignant T-cell-amplified sequence 1,24066,134,0.85 [0.43-1.65],0.6224845235734717
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,27559,153,1.26 [1.03-1.55],0.0269610295856088
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MDH1,"Malate dehydrogenase, cytoplasmic",24061,133,1.24 [0.85-1.81],0.269334776267523
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MDK,Midkine,27770,154,1.08 [0.82-1.41],0.595987518660548
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MDM1,Nuclear protein MDM1,23514,134,0.81 [0.47-1.39],0.4348882253568873
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",23568,133,1.14 [0.96-1.37],0.1407302342030832
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MED18,Mediator of RNA polymerase II transcription subunit 18,27102,151,1.24 [1.03-1.50],0.0266472307986748
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MED21,Mediator of RNA polymerase II transcription subunit 21,23424,129,1.30 [1.01-1.67],0.0384133327126414
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MEGF10,Multiple epidermal growth factor-like domains protein 10,27754,153,1.04 [0.72-1.49],0.850042584390027
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MEGF11,Multiple epidermal growth factor-like domains protein 11,23424,129,0.78 [0.44-1.38],0.3900131025356051
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MEGF9,Multiple epidermal growth factor-like domains protein 9,28000,154,1.45 [0.78-2.70],0.2403408896750313
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MELTF,Melanotransferrin,24191,134,0.97 [0.55-1.70],0.9170721777171716
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MENT,Protein MENT,23679,128,0.84 [0.38-1.85],0.6669759928961221
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MEP1A,Meprin A subunit alpha,24066,134,1.03 [0.81-1.31],0.8141959315808994
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MEP1B,Meprin A subunit beta,27752,155,0.97 [0.86-1.09],0.621707478331111
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MEPE,Matrix extracellular phosphoglycoprotein,27754,153,0.92 [0.54-1.56],0.7540491773161494
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MERTK,Tyrosine-protein kinase Mer,28040,156,1.26 [0.75-2.13],0.3809367158365867
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MESD,LRP chaperone MESD,27756,156,1.09 [0.97-1.22],0.1651030435337632
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MET,Hepatocyte growth factor receptor,27825,154,0.78 [0.38-1.60],0.5033448764163683
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",METAP1,Methionine aminopeptidase 1,27073,151,0.75 [0.46-1.25],0.2729208531027988
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",27705,155,1.06 [0.89-1.26],0.4945452688305325
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",METAP2,Methionine aminopeptidase 2,27936,155,1.15 [0.90-1.46],0.2695351087047973
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MFAP3,Microfibril-associated glycoprotein 3,27243,152,1.14 [0.87-1.48],0.3415682156226937
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MFAP3L,Microfibrillar-associated protein 3-like,23514,134,0.86 [0.64-1.15],0.3072685111195171
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MFAP4,Microfibril-associated glycoprotein 4,23679,128,0.45 [0.26-0.78],0.0041546101284113
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MFAP5,Microfibrillar-associated protein 5,28090,154,1.13 [0.80-1.59],0.5012734926557716
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MFGE8,Lactadherin,27756,156,1.15 [0.82-1.60],0.4152589563652414
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MGLL,Monoglyceride lipase,27841,154,1.17 [0.99-1.39],0.0633535982208041
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MGMT,Methylated-DNA--protein-cysteine methyltransferase,27705,155,1.09 [0.97-1.22],0.1693391485931091
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MIA,Melanoma-derived growth regulatory protein,27849,154,1.04 [0.71-1.52],0.8324649983082666
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MICALL2,MICAL-like protein 2,23514,134,1.03 [0.82-1.31],0.7780529573992343
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,27705,155,1.03 [0.93-1.14],0.5934507815576795
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MIF,Macrophage migration inhibitory factor,27717,156,1.15 [0.93-1.41],0.1950373362634155
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MILR1,Allergin-1,27198,150,0.85 [0.63-1.14],0.2819655499452752
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24054,130,1.16 [0.99-1.36],0.064740994399949
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MINK1,Misshapen-like kinase 1,24136,133,1.07 [0.90-1.29],0.4393714602720979
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MITD1,MIT domain-containing protein 1,27559,153,1.15 [0.99-1.33],0.0766171242498208
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MKI67,Proliferation marker protein Ki-67,23508,131,0.99 [0.65-1.51],0.964081955813412
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MLLT1,Protein ENL,23315,128,1.11 [0.90-1.38],0.3189507866279845
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MLN,Promotilin,27705,155,1.10 [0.93-1.29],0.2647448991911683
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MME,Neprilysin,27629,155,0.92 [0.77-1.11],0.4031858933027334
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MMP1,Interstitial collagenase,26681,151,0.98 [0.84-1.14],0.7972683076972914
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MMP10,Stromelysin-2,27713,153,0.94 [0.75-1.18],0.6035019629734804
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MMP12,Macrophage metalloelastase,27761,153,0.93 [0.70-1.23],0.6111744149677235
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MMP13,Collagenase 3,27073,151,0.89 [0.57-1.40],0.6260588930465217
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MMP15,Matrix metalloproteinase-15,24191,134,1.02 [0.74-1.40],0.917295555779108
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MMP3,Stromelysin-1,27756,156,1.54 [1.19-2.00],0.0010578642939341
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MMP7,Matrilysin,27196,148,1.37 [0.99-1.88],0.0537837015690749
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MMP8,Neutrophil collagenase,27944,155,1.14 [0.95-1.37],0.1460484403006046
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MMP9,Matrix metalloproteinase-9,27707,155,1.10 [0.88-1.38],0.3898351191437966
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",23424,129,1.21 [0.88-1.66],0.2416313172833799
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MN1,Transcriptional activator MN1,23514,134,0.96 [0.72-1.28],0.7962843070692784
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MNAT1,CDK-activating kinase assembly factor MAT1,23740,131,0.83 [0.56-1.25],0.3733579367602955
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MNDA,Myeloid cell nuclear differentiation antigen,27711,155,1.07 [0.94-1.22],0.2885570839948265
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MOCS2,Molybdopterin synthase catalytic subunit,23679,128,1.20 [0.94-1.54],0.1353607027196189
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MOG,Myelin-oligodendrocyte glycoprotein,27985,155,1.45 [0.93-2.24],0.0985716536687966
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MORC3,MORC family CW-type zinc finger protein 3,24136,133,1.17 [0.70-1.98],0.5482733596201008
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MORF4L1,Mortality factor 4-like protein 1,23740,131,1.16 [0.81-1.65],0.4317910803384832
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MORF4L2,Mortality factor 4-like protein 2,23315,128,0.77 [0.46-1.29],0.3187620484642498
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MORN4,MORN repeat-containing protein 4,23315,128,1.06 [0.87-1.30],0.5655710585571663
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MPHOSPH8,M-phase phosphoprotein 8,27243,152,1.15 [0.95-1.38],0.1500628014216485
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MPI,Mannose-6-phosphate isomerase,27629,155,1.12 [0.96-1.32],0.1556850482588876
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,27841,154,1.26 [1.03-1.54],0.0270286495286289
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MPO,Myeloperoxidase,27756,156,0.81 [0.60-1.10],0.1822616912487051
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MPRIP,Myosin phosphatase Rho-interacting protein,24004,130,1.25 [0.88-1.79],0.2140654527792586
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MRC1,Macrophage mannose receptor 1,24205,134,1.41 [0.79-2.50],0.242634954475057
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MRI1,Methylthioribose-1-phosphate isomerase,23514,134,0.91 [0.72-1.16],0.4558912198295696
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MRPL24,"39S ribosomal protein L24, mitochondrial",23424,129,0.80 [0.50-1.29],0.3571328348371574
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MRPL28,"39S ribosomal protein L28, mitochondrial",24152,133,1.16 [0.81-1.66],0.411401191928653
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MRPL46,"39S ribosomal protein L46, mitochondrial",27073,151,0.97 [0.57-1.65],0.914885652629548
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MRPL52,"39S ribosomal protein L52, mitochondrial",23275,128,1.20 [0.63-2.30],0.5815963469769299
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24152,133,1.11 [0.91-1.36],0.3014804205974701
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MRPS16,"28S ribosomal protein S16, mitochondrial",23508,131,1.16 [0.70-1.93],0.5692922713297488
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MSLN,Mesothelin,27585,155,1.01 [0.79-1.31],0.908443206999893
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MSLNL,Mesothelin-like protein,23514,134,1.08 [0.71-1.64],0.7282485150217027
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MSMB,Beta-microseminoprotein,27657,154,1.05 [0.85-1.29],0.6765681654811944
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MSR1,Macrophage scavenger receptor types I and II,27991,156,1.32 [0.96-1.81],0.0851322903563432
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MSRA,Mitochondrial peptide methionine sulfoxide reductase,27849,154,1.18 [0.97-1.43],0.0965457443815092
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MST1,Hepatocyte growth factor-like protein,23828,128,0.91 [0.71-1.15],0.4222556078222841
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MSTN,Growth/differentiation factor 8,27243,152,1.29 [0.98-1.70],0.0688672872318756
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MTDH,Protein LYRIC,23508,131,1.08 [0.90-1.30],0.3961203392118648
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24136,133,0.47 [0.22-0.99],0.0472889934737252
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,23740,131,1.16 [1.00-1.34],0.0550665285543588
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MTIF3,"Translation initiation factor IF-3, mitochondrial",24066,134,1.13 [0.94-1.36],0.193520153508614
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MTPN,Myotrophin,27243,152,0.90 [0.57-1.42],0.6610895246036355
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MTR,Methionine synthase,23424,129,1.14 [0.91-1.43],0.2628289097119567
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MTSS1,Protein MTSS 1,24066,134,1.10 [0.95-1.28],0.2036245941201137
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MTSS2,Protein MTSS 2,24054,130,1.12 [0.95-1.33],0.1851445290955035
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MTUS1,Microtubule-associated tumor suppressor 1,23740,131,0.76 [0.55-1.04],0.089591669797737
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MUC13,Mucin-13,27073,151,1.26 [0.95-1.68],0.1085183834267958
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MUC16,Mucin-16,27629,155,0.99 [0.92-1.07],0.7698527415809913
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MUC2,Mucin-2,24190,135,0.96 [0.80-1.16],0.6876714585885193
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MUCL3,Mucin-like protein 3,23315,128,1.31 [0.98-1.74],0.0635279092314303
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MVK,Mevalonate kinase,27198,150,1.05 [0.87-1.27],0.6004087624014095
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MXRA8,Matrix remodeling-associated protein 8,23679,128,0.50 [0.29-0.85],0.0108844738692926
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYBPC1,"Myosin-binding protein C, slow-type",24191,134,1.19 [0.93-1.51],0.1612903780544391
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYBPC2,"Myosin-binding protein C, fast-type",23568,133,1.03 [0.85-1.25],0.7471536863099624
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24152,133,1.05 [0.83-1.32],0.6987018016851891
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYDGF,Myeloid-derived growth factor,24191,134,1.15 [0.98-1.35],0.0891666972450196
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYH4,Myosin-4,23424,129,0.97 [0.67-1.41],0.8717084987926887
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYH7B,Myosin-7B,23315,128,0.92 [0.62-1.36],0.6643975359875187
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYH9,Myosin-9,24190,135,1.15 [1.00-1.34],0.0549251799441539
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",23424,129,1.07 [0.72-1.58],0.7379496807598576
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYL3,Myosin light chain 3,23568,133,1.22 [0.97-1.54],0.0868158221151007
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYL4,Myosin light chain 4,23568,133,1.07 [0.80-1.44],0.6376761184678534
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYL6B,Myosin light chain 6B,23514,134,1.09 [0.93-1.28],0.3032450383750255
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",23514,134,0.99 [0.68-1.45],0.9739277995552676
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYO6,Unconventional myosin-VI,24152,133,1.18 [0.81-1.72],0.3802440696288276
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYO9B,Unconventional myosin-IXb,27198,150,1.10 [0.90-1.36],0.3546256301024638
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYOC,Myocilin,27756,156,0.85 [0.63-1.16],0.305668868617989
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYOM1,Myomesin-1,23410,130,0.65 [0.42-1.03],0.066883469889137
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYOM2,Myomesin-2,23424,129,1.08 [0.76-1.53],0.6616147804250283
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MYOM3,Myomesin-3,23679,128,1.06 [0.88-1.27],0.5650925284606122
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MZB1,Marginal zone B- and B1-cell-specific protein,27851,155,1.04 [0.79-1.38],0.7627866038464376
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",MZT1,Mitotic-spindle organizing protein 1,27102,151,1.31 [1.04-1.65],0.0227554138612096
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NAA10,N-alpha-acetyltransferase 10,23424,129,1.32 [0.96-1.83],0.0904688433053434
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NAA80,N-alpha-acetyltransferase 80,23514,134,1.12 [0.98-1.29],0.102946614357888
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NAAA,N-acylethanolamine-hydrolyzing acid amidase,27428,151,1.02 [0.80-1.29],0.869515046528124
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NACC1,Nucleus accumbens-associated protein 1,24054,130,1.21 [0.93-1.59],0.1601889634494738
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NADK,NAD kinase,27752,155,1.13 [0.89-1.42],0.3122706867793593
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NAGA,Alpha-N-acetylgalactosaminidase,23458,131,1.06 [0.81-1.38],0.6659059054583609
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NAGK,N-acetyl-D-glucosamine kinase,23522,133,1.18 [0.89-1.56],0.250918569692672
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,23679,128,0.46 [0.22-0.97],0.0409419143231984
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NAMPT,Nicotinamide phosphoribosyltransferase,27102,151,1.09 [0.86-1.39],0.4769439026764963
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NAP1L4,Nucleosome assembly protein 1-like 4,24025,134,1.06 [0.71-1.57],0.7882388451193068
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NAPRT,Nicotinate phosphoribosyltransferase,24136,133,1.01 [0.61-1.68],0.955831190416188
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NARS1,"Asparagine--tRNA ligase, cytoplasmic",24152,133,1.26 [0.88-1.80],0.2005861716749692
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NBL1,Neuroblastoma suppressor of tumorigenicity 1,27849,154,1.02 [0.59-1.77],0.9322763423539224
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NBN,Nibrin,27198,150,1.12 [0.88-1.43],0.3522053542709157
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NCAM1,Neural cell adhesion molecule 1,27845,154,0.80 [0.48-1.34],0.3956012592915776
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NCAM2,Neural cell adhesion molecule 2,27756,156,0.60 [0.35-1.01],0.0563652509171903
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NCAN,Neurocan core protein,27991,156,1.08 [0.73-1.58],0.7064599750781824
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NCF2,Neutrophil cytosol factor 2,27667,155,1.04 [0.89-1.22],0.6329078840734241
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NCK2,Cytoplasmic protein NCK2,27889,155,1.10 [0.96-1.26],0.1634895848699131
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NCLN,Nicalin,27198,150,1.05 [0.82-1.35],0.6798811587996174
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NCR1,Natural cytotoxicity triggering receptor 1,27664,155,0.80 [0.53-1.19],0.2633152776417381
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24066,134,0.81 [0.49-1.35],0.4210981096257163
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NCS1,Neuronal calcium sensor 1,27985,155,1.10 [0.67-1.81],0.6950704791647155
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NDRG1,Protein NDRG1,27073,151,0.96 [0.78-1.19],0.7243327445988061
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24054,130,0.79 [0.57-1.08],0.1376122542415972
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,23467,131,1.15 [0.72-1.84],0.5491879696552447
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24066,134,1.14 [0.95-1.37],0.1503263094003187
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",27102,151,1.07 [0.91-1.27],0.3993120089809391
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NEB,Nebulin,23424,129,1.08 [0.70-1.66],0.7289640530227162
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NECAP2,Adaptin ear-binding coat-associated protein 2,23424,129,0.93 [0.72-1.21],0.5958620585335168
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NECTIN1,Nectin-1,23508,131,1.30 [0.79-2.13],0.3021300147044271
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NECTIN2,Nectin-2,27707,155,1.58 [0.98-2.54],0.0609374869692365
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NECTIN4,Nectin-4,27849,154,0.83 [0.51-1.36],0.4673286239004727
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,23508,131,1.39 [0.96-2.01],0.0799421828139726
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NEDD9,Enhancer of filamentation 1,23508,131,0.94 [0.56-1.56],0.7992046684501561
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NEFL,Neurofilament light polypeptide,26984,150,1.00 [0.71-1.42],0.9831138066268952
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NEK7,Serine/threonine-protein kinase Nek7,23740,131,1.04 [0.84-1.29],0.7181495563051057
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NELL1,Protein kinase C-binding protein NELL1,27849,154,1.11 [0.79-1.56],0.5402837773231164
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NELL2,Protein kinase C-binding protein NELL2,27889,155,0.75 [0.45-1.25],0.2717735057068613
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NENF,Neudesin,24054,130,1.01 [0.87-1.17],0.9070270420475182
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NEO1,Neogenin,24152,133,1.17 [0.56-2.46],0.6700456785537132
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NEXN,Nexilin,24205,134,1.03 [0.81-1.31],0.7953963287823096
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NFASC,Neurofascin,28040,156,1.01 [0.60-1.69],0.9811073928042204
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NFAT5,Nuclear factor of activated T-cells 5,23508,131,1.01 [0.84-1.22],0.9129823880719068
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",27705,155,1.18 [1.02-1.36],0.0304221804302013
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",27198,150,1.01 [0.79-1.30],0.9145717999507172
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NFE2,Transcription factor NF-E2 45 kDa subunit,23568,133,1.15 [0.92-1.43],0.2212989930014944
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NFIC,Nuclear factor 1 C-type,24152,133,0.98 [0.67-1.44],0.9234124628710584
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NFKB1,Nuclear factor NF-kappa-B p105 subunit,23424,129,1.19 [0.95-1.50],0.1336591982547202
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NFKB2,Nuclear factor NF-kappa-B p100 subunit,23740,131,0.81 [0.56-1.17],0.2582400874504437
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NFKBIE,NF-kappa-B inhibitor epsilon,27102,151,1.24 [0.93-1.65],0.138410771764966
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24066,134,1.08 [0.92-1.27],0.3535556881392983
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NFX1,Transcriptional repressor NF-X1,23424,129,1.07 [0.84-1.37],0.5852157586700973
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NFYA,Nuclear transcription factor Y subunit alpha,23424,129,0.70 [0.42-1.17],0.1724213770204223
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NGF,Beta-nerve growth factor,27559,153,0.80 [0.25-2.62],0.7144553197025054
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NGFR,Tumor necrosis factor receptor superfamily member 16,24191,134,1.07 [0.63-1.82],0.8027242370267976
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NGRN,Neugrin,24136,133,0.83 [0.38-1.83],0.6508315526448982
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NHLRC3,NHL repeat-containing protein 3,23096,127,0.88 [0.52-1.50],0.646084749257995
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NID1,Nidogen-1,27751,154,1.13 [0.79-1.61],0.5141615980929433
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NID2,Nidogen-2,27756,156,1.08 [0.89-1.30],0.4453501478722182
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NINJ1,Ninjurin-1,27102,151,0.84 [0.63-1.13],0.2600750461488512
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NIT1,Deaminated glutathione amidase,23568,133,1.54 [1.07-2.23],0.0217702847006822
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NIT2,Omega-amidase NIT2,24105,134,1.01 [0.81-1.25],0.9607268411747756
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NLGN1,Neuroligin-1,23514,134,1.04 [0.83-1.30],0.7497714217854513
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NLGN2,Neuroligin-2,23410,130,1.01 [0.72-1.42],0.9381551710167064
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NME1,Nucleoside diphosphate kinase A,23508,131,1.14 [0.54-2.42],0.7329760926836613
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NME3,Nucleoside diphosphate kinase 3,27803,154,0.71 [0.37-1.35],0.2938409977693419
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NMI,N-myc-interactor,23969,130,1.10 [0.87-1.37],0.4286836977709634
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,27559,153,0.95 [0.78-1.16],0.6249837781543375
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NMRK2,Nicotinamide riboside kinase 2,23315,128,0.96 [0.64-1.43],0.8256066285951092
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24152,133,1.09 [0.87-1.38],0.4492750990762401
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NOMO1,Nodal modulator 1,27756,156,0.83 [0.46-1.51],0.5480172676618636
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NOP56,Nucleolar protein 56,23424,129,1.01 [0.88-1.18],0.8445546426404552
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NOS1,"Nitric oxide synthase, brain",27073,151,0.91 [0.68-1.21],0.5050972926248212
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NOS2,"Nitric oxide synthase, inducible",23424,129,1.16 [0.78-1.75],0.4651943421120321
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NOS3,"Nitric oxide synthase, endothelial",27073,151,1.23 [0.97-1.55],0.0829870594708043
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NOTCH1,Neurogenic locus notch homolog protein 1,28090,154,0.47 [0.18-1.18],0.1062993873497736
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NOTCH2,Neurogenic locus notch homolog protein 2,24190,135,0.99 [0.47-2.08],0.9809464603650636
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NOTCH3,Neurogenic locus notch homolog protein 3,28090,154,0.57 [0.38-0.86],0.0071454126104063
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NPC2,NPC intracellular cholesterol transporter 2,23783,131,1.55 [0.98-2.44],0.0607566417711101
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NPDC1,Neural proliferation differentiation and control protein 1,27752,155,1.42 [0.91-2.22],0.120181434021736
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NPHS1,Nephrin,23508,131,0.74 [0.44-1.24],0.2536847743895236
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NPHS2,Podocin,23508,131,1.11 [0.96-1.27],0.1568098333183722
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NPL,N-acetylneuraminate lyase,24191,134,1.10 [0.75-1.60],0.6196117611461209
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NPPB,Natriuretic peptides B,27243,152,1.00 [0.90-1.13],0.9374542600747344
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NPPC,C-type natriuretic peptide,27705,155,1.29 [0.94-1.77],0.117646098727469
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NPR1,Atrial natriuretic peptide receptor 1,23424,129,1.09 [0.73-1.62],0.688473783830541
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NPTN,Neuroplastin,27102,151,1.01 [0.85-1.19],0.9070928844290578
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NPTX1,Neuronal pentraxin-1,27756,156,0.72 [0.50-1.04],0.0783019411125451
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NPTX2,Neuronal pentraxin-2,24190,135,0.70 [0.43-1.14],0.1484332966572621
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NPTXR,Neuronal pentraxin receptor,27752,155,0.94 [0.62-1.43],0.775781694825844
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NPY,Pro-neuropeptide Y,27985,155,1.21 [0.98-1.50],0.0730849458205801
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NRCAM,Neuronal cell adhesion molecule,27752,155,0.85 [0.51-1.43],0.5473203897428511
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NRGN,Neurogranin,24205,134,1.19 [0.99-1.42],0.0650726671788425
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NRN1,Neuritin,24152,133,1.10 [0.73-1.67],0.6360827842647765
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NRP1,Neuropilin-1,27892,155,0.60 [0.36-0.98],0.0430857790354884
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NRP2,Neuropilin-2,27756,156,0.82 [0.50-1.34],0.4276429462872488
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NRTN,Neurturin,27198,150,0.84 [0.62-1.15],0.2766070300474292
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NRXN3,Neurexin-3,23514,134,0.92 [0.56-1.50],0.730359870760001
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NSFL1C,NSFL1 cofactor p47,27991,156,1.18 [0.96-1.45],0.1165027477508488
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24191,134,1.13 [0.90-1.41],0.2855252257617212
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NT5C1A,Cytosolic 5'-nucleotidase 1A,24136,133,1.04 [0.63-1.71],0.8914933843446591
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NT5C3A,Cytosolic 5'-nucleotidase 3A,27667,155,1.07 [0.92-1.26],0.3768381282483041
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NT5E,5'-nucleotidase,27849,154,1.03 [0.80-1.32],0.8293852480986733
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NTF3,Neurotrophin-3,27705,155,0.96 [0.63-1.44],0.8284538104834479
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NTF4,Neurotrophin-4,27102,151,0.95 [0.65-1.40],0.8033735599144579
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NTRK2,BDNF/NT-3 growth factors receptor,27752,155,0.78 [0.45-1.36],0.3804570746446845
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NTRK3,NT-3 growth factor receptor,27991,156,0.58 [0.31-1.10],0.0953405796619804
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NTproBNP,N-terminal prohormone of brain natriuretic peptide,27752,155,1.07 [0.92-1.24],0.3874541963065486
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NUB1,NEDD8 ultimate buster 1,27705,155,1.16 [0.98-1.36],0.0813390108980843
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24054,130,1.17 [1.01-1.36],0.0350647451717805
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NUCB2,Nucleobindin-2,27936,155,1.37 [0.95-1.97],0.0938715275145538
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NUDC,Nuclear migration protein nudC,28040,156,1.27 [1.01-1.59],0.0369016317617128
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,23568,133,0.56 [0.26-1.24],0.1529440635610859
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,23424,129,0.72 [0.48-1.07],0.1076423093626489
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NUDT16,U8 snoRNA-decapping enzyme,24024,134,1.12 [0.93-1.34],0.2366718600310298
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],27629,155,0.93 [0.72-1.19],0.553978624195725
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NUDT5,ADP-sugar pyrophosphatase,27756,156,1.16 [0.89-1.51],0.2697358837361163
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NUMB,Protein numb homolog,23508,131,1.23 [1.00-1.51],0.046696291289103
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NUP50,Nuclear pore complex protein Nup50,23424,129,0.73 [0.41-1.30],0.286234927321666
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NXPE4,NXPE family member 4,23424,129,1.01 [0.64-1.61],0.9581903918627902
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NXPH1,Neurexophilin-1,27073,151,1.09 [0.75-1.58],0.666796074783325
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",NXPH3,Neurexophilin-3,23508,131,1.21 [0.69-2.13],0.5058348759460765
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OBP2B,Odorant-binding protein 2b,27473,152,1.15 [0.93-1.43],0.1910976164435877
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OCLN,Occludin,24152,133,1.25 [0.88-1.79],0.2090899647543137
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ODAM,Odontogenic ameloblast-associated protein,27031,151,0.78 [0.57-1.05],0.1064384441045611
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OFD1,Oral-facial-digital syndrome 1 protein,23740,131,1.05 [0.83-1.32],0.6702305224636499
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OGA,Protein O-GlcNAcase,24066,134,1.07 [0.84-1.35],0.5993088979145531
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OGFR,Opioid growth factor receptor,27629,155,1.48 [0.98-2.23],0.0607054861653565
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OGN,Mimecan,27756,156,0.94 [0.66-1.35],0.7461314245937639
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,23740,131,0.98 [0.75-1.29],0.9064794792099384
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OLFM4,Olfactomedin-4,22793,120,1.02 [0.89-1.18],0.7666575859417336
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OLR1,Oxidized low-density lipoprotein receptor 1,27485,154,1.04 [0.83-1.31],0.7172030134133633
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OMD,Osteomodulin,27889,155,0.73 [0.55-0.98],0.0372336802414713
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OMG,Oligodendrocyte-myelin glycoprotein,27629,155,0.98 [0.78-1.22],0.8393638297483671
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OMP,Olfactory marker protein,23410,130,0.81 [0.56-1.18],0.2805364276646592
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OPHN1,Oligophrenin-1,24136,133,1.13 [0.96-1.32],0.1315678183081703
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OPLAH,5-oxoprolinase,23568,133,1.17 [0.93-1.48],0.1871797208181496
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OPTC,Opticin,27629,155,1.15 [0.85-1.55],0.3650203169027176
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ORM1,Alpha-1-acid glycoprotein 1,24157,133,1.65 [0.74-3.67],0.2210173353940098
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OSBPL2,Oxysterol-binding protein-related protein 2,24136,133,0.85 [0.54-1.33],0.4759091118470917
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OSCAR,Osteoclast-associated immunoglobulin-like receptor,27803,154,1.13 [0.74-1.74],0.5731502856513571
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OSM,Oncostatin-M,27576,155,1.07 [0.88-1.29],0.502861790833615
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OSMR,Oncostatin-M-specific receptor subunit beta,27892,155,0.70 [0.36-1.37],0.2966216117449514
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OSTN,Osteocrin,23514,134,1.08 [0.76-1.54],0.648174079885705
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OTOA,Otoancorin,23410,130,0.76 [0.52-1.11],0.1502883570490753
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OTUD6B,Deubiquitinase OTUD6B,24066,134,1.17 [0.89-1.54],0.2659205712280478
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OTUD7B,OTU domain-containing protein 7B,24152,133,1.20 [0.93-1.54],0.1633978461453661
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",23568,133,1.14 [0.90-1.45],0.2605638397886427
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",OXT,Oxytocin-neurophysin 1,27991,156,1.11 [1.00-1.22],0.048810299728675
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",P4HB,Protein disulfide-isomerase,27627,154,1.43 [1.00-2.05],0.0474518468311808
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PACS2,Phosphofurin acidic cluster sorting protein 2,23424,129,1.16 [0.89-1.51],0.2858626411249811
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PADI2,Protein-arginine deiminase type-2,27198,150,1.01 [0.78-1.30],0.932032752952865
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PADI4,Protein-arginine deiminase type-4,27031,151,1.03 [0.85-1.24],0.7830772194533382
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PAEP,Glycodelin,27559,153,0.95 [0.87-1.05],0.3219013674388205
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24152,133,1.07 [0.93-1.21],0.3467704245419548
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",23740,131,1.25 [0.92-1.72],0.157188213679962
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,27243,152,1.09 [0.85-1.40],0.5094615914864329
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PAGR1,PAXIP1-associated glutamate-rich protein 1,23568,133,0.98 [0.68-1.42],0.9347190754859894
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23273,128,1.34 [1.02-1.77],0.0386537496306489
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PAK4,Serine/threonine-protein kinase PAK 4,27073,151,1.15 [0.92-1.44],0.2162562360907494
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PALLD,Palladin,23508,131,0.94 [0.61-1.43],0.7559593621648812
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PALM,Paralemmin-1,23942,134,0.93 [0.53-1.62],0.7917522008590532
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PALM2,Paralemmin-2,24136,133,1.03 [0.66-1.61],0.8919005086357024
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PALM3,Paralemmin-3,23424,129,1.06 [0.86-1.30],0.6025096384482116
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PAM,Peptidyl-glycine alpha-amidating monooxygenase,27938,154,0.99 [0.60-1.65],0.971294158340096
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PAMR1,Inactive serine protease PAMR1,27756,156,0.90 [0.54-1.48],0.6733563546579371
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PAPPA,Pappalysin-1,27198,150,1.02 [0.75-1.37],0.9195851812283536
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PARD3,Partitioning defective 3 homolog,23740,131,0.92 [0.72-1.17],0.4915073344989599
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PARK7,Parkinson disease protein 7,27756,156,1.16 [0.89-1.50],0.2621014642834144
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PARP1,Poly [ADP-ribose] polymerase 1,27705,155,1.03 [0.81-1.33],0.7879307446804388
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PAXX,Protein PAXX,23679,128,1.15 [0.81-1.65],0.4296164398029803
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PBK,Lymphokine-activated killer T-cell-originated protein kinase,23315,128,1.02 [0.59-1.77],0.9460963031373296
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PBLD,Phenazine biosynthesis-like domain-containing protein,27073,151,1.05 [0.79-1.41],0.7194741281330506
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24066,134,1.10 [0.66-1.85],0.7119393723335614
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PCARE,Photoreceptor cilium actin regulator,23410,130,1.08 [0.92-1.28],0.3493512491257253
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,23635,128,0.84 [0.57-1.24],0.3808608517741209
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PCBP2,Poly(rC)-binding protein 2,24152,133,1.17 [0.94-1.48],0.1661098648285497
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PCDH1,Protocadherin-1,27951,156,0.86 [0.44-1.70],0.6619699642904455
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PCDH12,Protocadherin-12,24152,133,0.79 [0.41-1.52],0.4848202071244176
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PCDH17,Protocadherin-17,27752,155,0.73 [0.48-1.12],0.1461966788117831
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PCDH7,Protocadherin-7,24066,134,1.19 [0.77-1.82],0.4310883773286196
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PCDH9,Protocadherin-9,24066,134,0.99 [0.61-1.61],0.978351629548377
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PCDHB15,Protocadherin beta-15,24054,130,0.83 [0.54-1.27],0.3966230186421611
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PCNA,Proliferating cell nuclear antigen,23315,128,1.10 [0.87-1.39],0.4171781460797018
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PCSK7,Proprotein convertase subtilisin/kexin type 7,24054,130,0.84 [0.57-1.23],0.3636198381656735
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PCSK9,Proprotein convertase subtilisin/kexin type 9,28090,154,1.42 [0.99-2.04],0.0549084445692068
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PCYT2,Ethanolamine-phosphate cytidylyltransferase,24066,134,1.15 [0.93-1.43],0.1846717550184147
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDAP1,28 kDa heat- and acid-stable phosphoprotein,24191,134,1.14 [0.96-1.35],0.1237896140325416
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDCD1,Programmed cell death protein 1,27944,155,0.84 [0.59-1.18],0.3177212046922585
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDCD1LG2,Programmed cell death 1 ligand 2,27629,155,0.72 [0.46-1.14],0.1583974425813628
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDCD5,Programmed cell death protein 5,27991,156,1.14 [0.90-1.44],0.2749395905212827
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDCD6,Programmed cell death protein 6,27752,155,1.28 [1.00-1.65],0.0535435237671713
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDCL2,Phosducin-like protein 2,23315,128,0.79 [0.54-1.14],0.2097829025929003
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",23315,128,1.01 [0.75-1.35],0.9511024478582584
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",23424,129,1.01 [0.77-1.32],0.94038914401269
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",23679,128,1.19 [1.00-1.42],0.0449036347611908
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDGFA,Platelet-derived growth factor subunit A,28090,154,1.11 [0.91-1.35],0.3045665271030071
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDGFB,Platelet-derived growth factor subunit B,27889,155,1.13 [0.96-1.34],0.1372543269240541
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDGFC,Platelet-derived growth factor C,27102,151,1.34 [0.85-2.12],0.2117575823596926
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDGFRA,Platelet-derived growth factor receptor alpha,27752,155,0.83 [0.50-1.37],0.4665108329231471
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDGFRB,Platelet-derived growth factor receptor beta,28090,154,0.87 [0.58-1.30],0.4995040740251966
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDIA2,Protein disulfide-isomerase A2,23315,128,1.39 [1.01-1.91],0.0431507215761459
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDIA3,Protein disulfide-isomerase A3,23679,128,0.82 [0.41-1.64],0.5720188504566874
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDIA4,Protein disulfide-isomerase A4,24190,135,1.10 [0.85-1.43],0.4779714832065129
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDIA5,Protein disulfide-isomerase A5,23315,128,1.38 [1.14-1.66],0.0007487015950062
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDLIM5,PDZ and LIM domain protein 5,24152,133,1.10 [0.95-1.26],0.2114926923118315
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDLIM7,PDZ and LIM domain protein 7,27889,155,1.08 [0.96-1.20],0.1981637678696778
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",27102,151,0.98 [0.74-1.30],0.8831611547920302
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDRG1,p53 and DNA damage-regulated protein 1,23514,134,1.14 [0.87-1.50],0.3459313977268575
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,23315,128,0.95 [0.71-1.28],0.7376888984696338
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDZD2,PDZ domain-containing protein 2,23424,129,1.13 [0.87-1.46],0.3713630159035369
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,23508,131,1.20 [0.84-1.71],0.3104630995455449
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PEAR1,Platelet endothelial aggregation receptor 1,28090,154,1.09 [0.58-2.05],0.782973168992716
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PEBP1,Phosphatidylethanolamine-binding protein 1,27756,156,1.13 [0.89-1.42],0.3176903675868452
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PECAM1,Platelet endothelial cell adhesion molecule,27756,156,1.00 [0.62-1.59],0.985662986358534
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PECR,Peroxisomal trans-2-enoyl-CoA reductase,23568,133,1.07 [0.61-1.87],0.8038871881067249
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PENK,Proenkephalin-A,23679,128,1.42 [0.85-2.36],0.1823211955745651
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PEPD,Xaa-Pro dipeptidase,24205,134,1.45 [0.76-2.76],0.2559531411844845
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PER3,Period circadian protein homolog 3,23508,131,1.19 [1.04-1.37],0.010836395618567
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PF4,Platelet factor 4,24062,135,1.12 [0.95-1.31],0.1826969155390944
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PFDN2,Prefoldin subunit 2,27073,151,0.95 [0.73-1.24],0.7095661658731763
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PFDN4,Prefoldin subunit 4,23315,128,1.25 [0.98-1.60],0.068102058303518
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PFDN6,Prefoldin subunit 6,23514,134,0.98 [0.77-1.26],0.8964352614604066
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",27581,155,1.16 [0.97-1.40],0.1082035995505871
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PGA4,Pepsin A-4,24205,134,1.24 [0.96-1.61],0.0960219909113112
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24191,134,1.01 [0.75-1.36],0.9413768848311496
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PGF,Placenta growth factor,28040,156,1.43 [0.97-2.09],0.0688186157773626
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PGLYRP1,Peptidoglycan recognition protein 1,27953,154,1.21 [0.88-1.66],0.2393958917576224
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,23926,131,1.15 [0.68-1.96],0.6023272045298328
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PGLYRP4,Peptidoglycan recognition protein 4,23424,129,0.79 [0.57-1.08],0.142471272478924
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PGM2,Phosphoglucomutase-2,23514,134,0.97 [0.73-1.28],0.8380515591603548
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PGR,Progesterone receptor,23508,131,0.98 [0.83-1.16],0.8051725318140325
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PHACTR2,Phosphatase and actin regulator 2,24152,133,1.11 [0.96-1.29],0.1433833069909945
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PHLDB1,Pleckstrin homology-like domain family B member 1,24066,134,0.86 [0.63-1.17],0.3249903201157974
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PHLDB2,Pleckstrin homology-like domain family B member 2,23315,128,1.16 [0.99-1.35],0.0581975149235496
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,27559,153,1.19 [0.73-1.94],0.496515461424615
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,23679,128,0.98 [0.65-1.46],0.9109879846893882
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PI16,Peptidase inhibitor 16,24205,134,0.81 [0.42-1.59],0.5455020493308271
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PI3,Elafin,27379,152,1.01 [0.77-1.33],0.9354181837849476
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24152,133,1.12 [0.90-1.38],0.3063631636805246
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PIGR,Polymeric immunoglobulin receptor,27397,155,0.79 [0.53-1.16],0.2244693887335715
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,27705,155,1.14 [0.91-1.43],0.2652897011377724
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,27756,156,1.47 [0.87-2.48],0.153823585773262
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,23508,131,1.24 [0.98-1.59],0.0789356584895348
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PILRA,Paired immunoglobulin-like type 2 receptor alpha,27756,156,1.27 [0.90-1.79],0.1806689084084997
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PILRB,Paired immunoglobulin-like type 2 receptor beta,27752,155,1.23 [0.95-1.59],0.1239766177767337
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,23679,128,1.03 [0.80-1.33],0.8217982723208515
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PITHD1,PITH domain-containing protein 1,23273,128,1.12 [0.93-1.34],0.2263811952843513
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PKD1,Polycystin-1,24191,134,0.47 [0.26-0.86],0.0136396576525343
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PKD2,Polycystin-2,23424,129,1.10 [0.84-1.44],0.4709541372058536
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PKLR,Pyruvate kinase PKLR,27801,153,1.11 [0.90-1.36],0.323312622369826
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PKN3,Serine/threonine-protein kinase N3,23740,131,0.95 [0.76-1.18],0.6313874075744224
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLA2G10,Group 10 secretory phospholipase A2,27559,153,0.87 [0.69-1.10],0.2343100319211315
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLA2G15,Phospholipase A2 group XV,27849,154,1.00 [0.58-1.73],0.9964517595829132
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLA2G1B,Phospholipase A2,28040,154,1.26 [0.90-1.77],0.1861088837155333
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLA2G2A,"Phospholipase A2, membrane associated",27669,151,1.11 [0.88-1.39],0.3924161959350484
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLA2G4A,Cytosolic phospholipase A2,27889,155,1.14 [0.97-1.34],0.1082153920625439
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLA2G7,Platelet-activating factor acetylhydrolase,27756,156,1.04 [0.66-1.64],0.8612320883255393
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLAT,Tissue-type plasminogen activator,28000,154,1.08 [0.81-1.44],0.6134832674585291
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLAU,Urokinase-type plasminogen activator,27756,156,0.70 [0.43-1.15],0.1635375671243134
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLAUR,Urokinase plasminogen activator surface receptor,27576,152,0.97 [0.58-1.64],0.9177201459980452
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLB1,"Phospholipase B1, membrane-associated",24136,133,0.86 [0.66-1.12],0.2711053325344381
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",23508,131,1.04 [0.74-1.47],0.8134436239702353
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24136,133,1.12 [0.95-1.33],0.1846737012489382
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLEKHO1,Pleckstrin homology domain-containing family O member 1,24136,133,1.12 [0.89-1.43],0.3305460050354168
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLG,Plasminogen,23605,129,0.84 [0.40-1.76],0.6529191791263808
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLIN1,Perilipin-1,27073,151,1.09 [0.73-1.64],0.6742966228819993
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLIN3,Perilipin-3,27752,155,1.30 [0.96-1.78],0.0936352471886286
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLPBP,Pyridoxal phosphate homeostasis protein,27752,155,1.21 [0.98-1.48],0.0711011730640188
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLSCR3,Phospholipid scramblase 3,24096,133,0.95 [0.72-1.25],0.7085617577031993
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLTP,Phospholipid transfer protein,27991,154,0.68 [0.46-1.01],0.0577763262528001
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLXDC1,Plexin domain-containing protein 1,27102,151,0.87 [0.55-1.36],0.5335060965467316
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLXDC2,Plexin domain-containing protein 2,24136,133,0.66 [0.35-1.25],0.2046050976522275
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLXNA4,Plexin-A4,27705,155,1.18 [0.99-1.41],0.0588380006222772
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLXNB2,Plexin-B2,27956,154,1.16 [0.64-2.13],0.6225247471678599
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PLXNB3,Plexin-B3,27662,155,1.25 [0.94-1.68],0.1302989718200439
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,27611,155,0.99 [0.92-1.07],0.7676395977160251
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PMCH,Pro-MCH,23424,129,0.91 [0.72-1.15],0.4451559169620021
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PMM2,Phosphomannomutase 2,23424,129,1.36 [1.05-1.78],0.0216588733601125
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PMS1,PMS1 protein homolog 1,23514,134,1.16 [0.86-1.57],0.316340240806189
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PMVK,Phosphomevalonate kinase,27028,151,1.17 [1.01-1.35],0.0340729413699394
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PNLIP,Pancreatic triacylglycerol lipase,24205,134,1.16 [0.88-1.52],0.2905281991964852
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PNLIPRP1,Inactive pancreatic lipase-related protein 1,24136,133,1.19 [0.96-1.48],0.1209229105465335
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PNLIPRP2,Pancreatic lipase-related protein 2,27754,153,1.00 [0.95-1.05],0.9122531554435258
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PNMA1,Paraneoplastic antigen Ma1,23568,133,1.12 [0.83-1.49],0.465827213703003
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PNMA2,Paraneoplastic antigen Ma2,23410,130,0.94 [0.63-1.40],0.7628867957016086
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",27198,150,0.91 [0.80-1.03],0.1371845335947878
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PODXL,Podocalyxin,27629,155,0.73 [0.29-1.84],0.5096325681305689
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PODXL2,Podocalyxin-like protein 2,27849,154,1.11 [0.66-1.86],0.7018959726694574
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",POF1B,Protein POF1B,23508,131,1.06 [0.74-1.51],0.7542614216106754
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",POLR2A,DNA-directed RNA polymerase II subunit RPB1,23508,131,1.81 [1.14-2.86],0.0114907271619023
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",27629,155,1.18 [0.81-1.71],0.380632419840165
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",POMC,Pro-opiomelanocortin,23568,133,0.92 [0.72-1.18],0.5026500614189819
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PON1,Serum paraoxonase/arylesterase 1,24205,134,1.41 [0.73-2.71],0.3064357788308283
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PON2,Serum paraoxonase/arylesterase 2,27243,152,0.89 [0.58-1.35],0.5702963670623855
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PON3,Serum paraoxonase/lactonase 3,27889,155,0.67 [0.48-0.93],0.0177028883625687
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",POSTN,Periostin,24190,135,0.69 [0.45-1.06],0.0938143546060491
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPBP,Platelet basic protein,24062,134,1.14 [0.94-1.39],0.1880868434141592
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPCDC,Phosphopantothenoylcysteine decarboxylase,27991,156,1.25 [0.94-1.67],0.1287815440619975
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPIB,Peptidyl-prolyl cis-trans isomerase B,27769,154,1.14 [0.98-1.33],0.0915879160117663
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPIE,Peptidyl-prolyl cis-trans isomerase E,23740,131,0.76 [0.54-1.06],0.1063456221539104
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24190,135,0.99 [0.76-1.30],0.96714185221447
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPL,Periplakin,23508,131,1.18 [0.74-1.90],0.4853189547575792
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPM1A,Protein phosphatase 1A,27102,151,1.21 [0.80-1.83],0.3767517559222026
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPM1B,Protein phosphatase 1B,23508,131,1.06 [0.83-1.36],0.6325290183299157
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPM1F,Protein phosphatase 1F,24191,134,1.05 [0.77-1.44],0.7582337046080012
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPME1,Protein phosphatase methylesterase 1,27629,155,1.15 [0.92-1.45],0.2186794080525473
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24054,130,1.08 [0.89-1.32],0.4361893508645019
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,27849,154,1.16 [1.00-1.34],0.0483000653962458
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,23740,131,1.04 [0.84-1.29],0.718259168450057
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24152,133,1.14 [0.94-1.39],0.174288793016884
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24152,133,0.84 [0.53-1.34],0.4662963161125096
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPP1R2,Protein phosphatase inhibitor 2,27752,155,1.19 [1.00-1.41],0.0542581643137514
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPP1R9B,Neurabin-2,28040,156,1.09 [0.94-1.26],0.2583852861682707
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24066,134,1.03 [0.89-1.18],0.7193960744899447
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPP3R1,Calcineurin subunit B type 1,27559,153,1.25 [0.90-1.75],0.182253654627942
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPT1,Palmitoyl-protein thioesterase 1,23514,134,0.94 [0.75-1.19],0.6075737081097705
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PPY,Pancreatic prohormone,27741,154,1.02 [0.88-1.17],0.8001488382766309
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PQBP1,Polyglutamine-binding protein 1,27102,151,1.07 [0.85-1.36],0.5654224801306018
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRAME,Melanoma antigen preferentially expressed in tumors,23315,128,1.33 [0.72-2.45],0.3649352907723425
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRAP1,Proline-rich acidic protein 1,24190,135,1.07 [0.72-1.58],0.7466361905645877
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRC1,Protein regulator of cytokinesis 1,24054,130,1.21 [0.93-1.57],0.1513373433577187
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRCP,Lysosomal Pro-X carboxypeptidase,27918,152,1.20 [0.77-1.88],0.4225094566002031
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRDX1,Peroxiredoxin-1,26995,147,1.09 [0.93-1.28],0.2927262624507315
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRDX2,Peroxiredoxin-2,23796,131,1.09 [0.84-1.41],0.5221455377379414
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",27198,150,1.05 [0.86-1.29],0.6107909532602729
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRDX5,"Peroxiredoxin-5, mitochondrial",28040,156,1.19 [0.97-1.47],0.1018662498179649
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRDX6,Peroxiredoxin-6,27985,155,1.01 [0.80-1.27],0.9590697487133236
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PREB,Prolactin regulatory element-binding protein,27198,150,1.05 [0.65-1.68],0.8530159774478854
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRELP,Prolargin,27754,153,0.84 [0.46-1.53],0.5622856845077621
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRG2,Bone marrow proteoglycan,24190,135,0.76 [0.55-1.04],0.0818417502799661
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRG3,Proteoglycan 3,24190,135,0.65 [0.48-0.88],0.0051660753968933
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,27198,150,1.22 [0.96-1.55],0.1094974160085276
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,23514,134,1.02 [0.61-1.70],0.9477583626825816
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,27752,155,1.19 [1.00-1.40],0.0474791218029852
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24095,133,1.12 [0.92-1.36],0.2714677717528017
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRKCQ,Protein kinase C theta type,27198,150,0.90 [0.64-1.27],0.5390338134983458
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRKD2,Serine/threonine-protein kinase D2,23424,129,0.78 [0.51-1.18],0.2378215465239533
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRKG1,cGMP-dependent protein kinase 1,23679,128,1.13 [0.98-1.29],0.0841997214580038
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,27102,151,1.19 [0.96-1.47],0.1056397184905738
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRL,Prolactin,27991,156,1.09 [0.92-1.30],0.3317048260505926
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRND,Prion-like protein doppel,24136,133,0.74 [0.54-1.02],0.0686837589063048
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PROC,Vitamin K-dependent protein C,27797,154,1.43 [0.82-2.51],0.2058195436082895
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PROCR,Endothelial protein C receptor,23424,129,1.18 [0.81-1.71],0.3945580670434605
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PROK1,Prokineticin-1,27705,155,1.00 [0.83-1.21],0.971208246395315
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PROS1,Vitamin K-dependent protein S,24239,135,1.75 [0.96-3.20],0.0686763653614043
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRR4,Proline-rich protein 4,23509,128,0.89 [0.70-1.14],0.3712624105552343
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRR5,Proline-rich protein 5,23508,131,0.98 [0.69-1.40],0.9310113902889586
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRRT3,Proline-rich transmembrane protein 3,23568,133,1.28 [0.83-1.99],0.2645864229634085
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRSS2,Trypsin-2,27845,154,1.09 [0.82-1.45],0.5408347979535876
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRSS22,Brain-specific serine protease 4,23508,131,1.03 [0.64-1.64],0.9096092291047876
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRSS27,Serine protease 27,27663,155,0.84 [0.59-1.19],0.3209227215713169
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRSS53,Serine protease 53,24136,133,1.01 [0.66-1.55],0.9698329248496068
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRSS8,Prostasin,27662,153,1.35 [0.96-1.90],0.0801625792740711
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,27073,151,1.13 [0.99-1.30],0.0713683638148199
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRTG,Protogenin,27985,155,0.76 [0.43-1.33],0.3365190604074402
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRTN3,Myeloblastin,27035,151,1.36 [1.05-1.75],0.0197270641459341
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PRUNE2,Protein prune homolog 2,23740,131,0.74 [0.39-1.40],0.3556570105170503
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PSAP,Prosaposin,23959,133,1.41 [0.85-2.36],0.186354932924407
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PSAPL1,Proactivator polypeptide-like 1,24066,134,0.96 [0.70-1.34],0.8257586960050781
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PSCA,Prostate stem cell antigen,24066,134,1.02 [0.95-1.09],0.5769019743434243
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PSG1,Pregnancy-specific beta-1-glycoprotein 1,27559,153,0.93 [0.83-1.05],0.2666832340214097
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PSIP1,PC4 and SFRS1-interacting protein,27705,155,1.12 [0.91-1.37],0.2758741296351653
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PSMA1,Proteasome subunit alpha type-1,27102,151,0.96 [0.70-1.31],0.7864611341897442
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PSMC3,26S proteasome regulatory subunit 6A,23315,128,0.90 [0.51-1.58],0.710924855730048
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PSMD1,26S proteasome non-ATPase regulatory subunit 1,24152,133,0.86 [0.61-1.21],0.3827306668895028
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PSMD5,26S proteasome non-ATPase regulatory subunit 5,23514,134,0.85 [0.61-1.18],0.3234569367646296
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PSMD9,26S proteasome non-ATPase regulatory subunit 9,27629,155,1.14 [0.90-1.44],0.2901165639788119
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PSME1,Proteasome activator complex subunit 1,27520,153,1.12 [0.77-1.63],0.5427305123883691
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PSME2,Proteasome activator complex subunit 2,27427,153,1.32 [0.91-1.93],0.1441158778891147
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PSMG3,Proteasome assembly chaperone 3,27705,155,1.29 [0.99-1.68],0.0551373030021299
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PSMG4,Proteasome assembly chaperone 4,23508,131,1.13 [0.86-1.49],0.3729967386340306
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PSPN,Persephin,27705,155,1.03 [0.90-1.18],0.6618419956095842
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PSRC1,Proline/serine-rich coiled-coil protein 1,27102,151,1.08 [0.85-1.37],0.5308769502646675
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,22817,127,1.15 [0.97-1.36],0.0981031770620632
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",27073,151,0.68 [0.42-1.11],0.1219293600242649
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTGDS,Prostaglandin-H2 D-isomerase,27525,153,1.37 [0.85-2.21],0.1898316498737521
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTGES2,Prostaglandin E synthase 2,23315,130,1.18 [0.87-1.59],0.2935895206454361
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTGR1,Prostaglandin reductase 1,24191,134,1.13 [0.92-1.38],0.254299164942773
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTH,Parathyroid hormone,23514,134,0.96 [0.77-1.18],0.6799434813847614
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,27705,155,0.99 [0.68-1.43],0.9465995180336414
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTK7,Inactive tyrosine-protein kinase 7,27073,151,1.14 [0.78-1.65],0.50084081327933
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTN,Pleiotrophin,27243,152,1.20 [0.91-1.59],0.190944736182427
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTP4A3,Protein tyrosine phosphatase type IVA 3,23508,131,0.88 [0.63-1.24],0.4746450197137291
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,27559,153,1.17 [0.98-1.39],0.0805023741065351
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,27841,154,1.16 [0.98-1.38],0.0813290409783757
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,23462,131,1.16 [0.78-1.73],0.4709335712466432
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTPRB,Receptor-type tyrosine-protein phosphatase beta,24191,134,1.02 [0.58-1.78],0.9574967903312372
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTPRC,Receptor-type tyrosine-protein phosphatase C,24190,135,0.60 [0.29-1.26],0.1785695187615505
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTPRF,Receptor-type tyrosine-protein phosphatase F,28090,154,1.17 [0.72-1.91],0.5254989803240337
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTPRH,Receptor-type tyrosine-protein phosphatase H,24066,134,0.70 [0.49-1.00],0.0493379162757225
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24066,134,1.26 [0.65-2.43],0.4996105936234062
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTPRM,Receptor-type tyrosine-protein phosphatase mu,27661,154,0.63 [0.35-1.14],0.1266194112592493
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,27466,153,1.50 [0.98-2.30],0.064260168186442
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTPRR,Receptor-type tyrosine-protein phosphatase R,24136,133,1.38 [0.89-2.14],0.1492393744243196
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTPRS,Receptor-type tyrosine-protein phosphatase S,28090,154,0.82 [0.46-1.46],0.4982088719738328
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24191,134,0.66 [0.40-1.10],0.1081327169759632
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,23679,128,1.18 [0.89-1.56],0.2428847706604229
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTS,6-pyruvoyl tetrahydrobiopterin synthase,26952,150,0.87 [0.66-1.15],0.3200056018184065
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTTG1,Securin,23740,131,1.16 [0.81-1.66],0.4040370358649185
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PTX3,Pentraxin-related protein PTX3,27705,155,0.93 [0.71-1.23],0.6118749935927366
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PVALB,Parvalbumin alpha,27850,155,1.15 [1.01-1.31],0.0391441310979373
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PVR,Poliovirus receptor,27991,156,1.33 [0.92-1.91],0.1289821027745518
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PXDNL,Peroxidasin-like protein,24054,130,0.94 [0.70-1.28],0.7025977926176223
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PXN,Paxillin,27073,151,0.98 [0.75-1.29],0.9075242159232688
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PYDC1,Pyrin domain-containing protein 1,23568,133,1.03 [0.70-1.51],0.8909497961164409
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PYY,Peptide YY,23424,129,0.99 [0.82-1.19],0.8973725867509678
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",PZP,Pregnancy zone protein,24239,135,0.93 [0.73-1.18],0.5554740287209299
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",QDPR,Dihydropteridine reductase,27621,154,1.26 [0.92-1.73],0.1432355728441433
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",QPCT,Glutaminyl-peptide cyclotransferase,27791,152,0.92 [0.54-1.56],0.7491153079300117
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",QSOX1,Sulfhydryl oxidase 1,23743,131,0.88 [0.56-1.39],0.5869956293518748
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RAB10,Ras-related protein Rab-10,24191,134,1.12 [0.83-1.52],0.4440433433814876
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RAB11FIP3,Rab11 family-interacting protein 3,24191,134,1.09 [0.93-1.27],0.2775385082717918
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RAB27B,Ras-related protein Rab-27B,24191,134,1.20 [0.97-1.49],0.0871408170269445
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RAB2B,Ras-related protein Rab-2B,24054,130,1.16 [0.89-1.51],0.2728164302272547
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RAB33A,Ras-related protein Rab-33A,23424,129,1.02 [0.79-1.31],0.8972186005103229
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RAB37,Ras-related protein Rab-37,27198,150,1.06 [0.90-1.24],0.4965971139375775
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RAB39B,Ras-related protein Rab-39B,23424,129,1.10 [0.94-1.29],0.2477101457694646
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,23410,130,0.99 [0.74-1.33],0.9691483373910612
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RAB44,Ras-related protein Rab-44,24054,130,0.87 [0.57-1.31],0.4976697611699103
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RAB6A,Ras-related protein Rab-6A,27705,155,0.86 [0.64-1.15],0.3046460019142342
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RAB6B,Ras-related protein Rab-6B,27073,151,0.89 [0.65-1.22],0.4759674153029746
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RABEP1,Rab GTPase-binding effector protein 1,23679,128,1.16 [0.93-1.43],0.1868126030075784
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RABEPK,Rab9 effector protein with kelch motifs,27102,151,1.00 [0.79-1.26],0.9987103993277964
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RABGAP1L,Rab GTPase-activating protein 1-like,27198,150,1.19 [0.95-1.50],0.1330578637128165
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RAC3,Ras-related C3 botulinum toxin substrate 3,23514,134,1.00 [0.79-1.26],0.9735088637953372
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RAD23B,UV excision repair protein RAD23 homolog B,27102,151,1.08 [0.80-1.46],0.6211011996086897
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RAD51,DNA repair protein RAD51 homolog 1,23740,131,1.21 [0.95-1.53],0.1181018248125313
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RALB,Ras-related protein Ral-B,23508,131,1.56 [0.93-2.63],0.090490524281535
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RALY,RNA-binding protein Raly,24054,130,0.79 [0.54-1.16],0.2273017560661617
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RANBP1,Ran-specific GTPase-activating protein,23568,133,1.14 [0.83-1.55],0.4140032105304124
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RANBP2,E3 SUMO-protein ligase RanBP2,23410,130,0.79 [0.47-1.34],0.3852958359396982
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RANGAP1,Ran GTPase-activating protein 1,27102,151,0.92 [0.68-1.24],0.5658864551664272
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RAP1A,Ras-related protein Rap-1A,23508,131,1.14 [0.94-1.40],0.189166927510624
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RAPGEF2,Rap guanine nucleotide exchange factor 2,23740,131,1.27 [0.95-1.71],0.1079916738555927
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RARRES1,Retinoic acid receptor responder protein 1,27102,151,1.33 [0.96-1.84],0.0838012461582394
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RARRES2,Retinoic acid receptor responder protein 2,27892,155,1.19 [0.89-1.59],0.2507954985761981
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RASA1,Ras GTPase-activating protein 1,27073,151,0.97 [0.63-1.50],0.8996282148557179
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,23315,128,0.61 [0.42-0.91],0.0141178437804752
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RASSF2,Ras association domain-containing protein 2,27102,151,0.91 [0.70-1.20],0.5104438548419352
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RBFOX3,RNA binding protein fox-1 homolog 3,24152,133,0.98 [0.62-1.53],0.9176955426174352
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RBKS,Ribokinase,27104,152,1.01 [0.77-1.34],0.9214182304347932
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RBM17,Splicing factor 45,24152,133,1.07 [0.86-1.32],0.5596570120393636
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RBM19,Probable RNA-binding protein 19,23424,129,1.01 [0.72-1.43],0.9515378992811856
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RBM25,RNA-binding protein 25,23315,128,0.94 [0.65-1.37],0.7456989994267117
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RBP1,Retinol-binding protein 1,23514,134,0.84 [0.63-1.11],0.2222601236799236
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RBP2,Retinol-binding protein 2,27629,155,1.13 [0.94-1.35],0.187589701946613
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RBP5,Retinol-binding protein 5,27629,155,1.06 [0.82-1.37],0.6488086551850443
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RBP7,Retinoid-binding protein 7,24066,134,1.04 [0.80-1.35],0.7900182971406421
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RBPMS,RNA-binding protein with multiple splicing,23508,131,0.98 [0.76-1.27],0.8812276059828774
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RBPMS2,RNA-binding protein with multiple splicing 2,23568,133,1.13 [0.97-1.33],0.1219744872124542
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RCC1,Regulator of chromosome condensation,24054,130,0.77 [0.52-1.14],0.1933034673392522
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RCOR1,REST corepressor 1,27243,152,1.05 [0.78-1.42],0.7450631770902603
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,23568,133,0.53 [0.24-1.19],0.1259392188890426
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",REEP4,Receptor expression-enhancing protein 4,24152,133,1.05 [0.81-1.36],0.7273671003133872
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",REG1A,Lithostathine-1-alpha,27576,151,1.18 [0.89-1.57],0.2489997957802683
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",REG1B,Lithostathine-1-beta,28090,154,1.09 [0.85-1.39],0.483003440782615
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",REG3A,Regenerating islet-derived protein 3-alpha,28090,154,1.24 [0.99-1.55],0.0558175941723666
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",REG3G,Regenerating islet-derived protein 3-gamma,24054,130,0.90 [0.58-1.38],0.6194568917233666
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",REG4,Regenerating islet-derived protein 4,27803,154,1.33 [0.99-1.79],0.0557913037244321
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RELB,Transcription factor RelB,23508,131,1.19 [0.91-1.55],0.1996697454646823
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RELT,Tumor necrosis factor receptor superfamily member 19L,27756,156,1.47 [0.88-2.45],0.1424917734180983
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",REN,Renin,27752,155,1.16 [0.95-1.42],0.153901979641037
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",REPS1,RalBP1-associated Eps domain-containing protein 1,23508,131,1.04 [0.68-1.59],0.845126485750691
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",REST,RE1-silencing transcription factor,23315,128,1.18 [0.78-1.79],0.4317819783888673
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,27629,155,0.90 [0.65-1.26],0.5504414101611486
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RETN,Resistin,27682,152,1.12 [0.80-1.57],0.4928768344443983
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",REXO2,"Oligoribonuclease, mitochondrial",23424,129,1.13 [0.84-1.51],0.4190536515523571
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RFC4,Replication factor C subunit 4,24054,130,1.39 [0.67-2.88],0.3745429397017661
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RGCC,Regulator of cell cycle RGCC,24152,133,1.11 [0.89-1.38],0.3512023294196592
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,23740,131,1.06 [0.84-1.34],0.6332148722531963
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RGMA,Repulsive guidance molecule A,27991,156,1.55 [0.98-2.44],0.0625206274883428
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RGMB,RGM domain family member B,27991,156,1.30 [0.75-2.27],0.3511815805558492
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RGS10,Regulator of G-protein signaling 10,24152,133,1.08 [0.83-1.42],0.561004314761946
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RGS8,Regulator of G-protein signaling 8,27198,150,0.77 [0.58-1.02],0.0682719465245932
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RHOC,Rho-related GTP-binding protein RhoC,27378,153,1.10 [0.97-1.25],0.1400705874927415
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RICTOR,Rapamycin-insensitive companion of mTOR,23508,131,1.26 [0.98-1.63],0.0765132582694373
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,23679,128,0.87 [0.61-1.25],0.4532926254073434
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RILP,Rab-interacting lysosomal protein,27898,155,1.28 [1.02-1.61],0.0347808005903318
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RILPL2,RILP-like protein 2,24191,134,1.16 [0.98-1.38],0.0845397645514413
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,23424,129,0.95 [0.73-1.23],0.6837979011517652
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RLN1,Prorelaxin H1,24152,133,0.98 [0.84-1.15],0.8428257665582881
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RLN2,Prorelaxin H2,23635,128,1.00 [0.92-1.10],0.9182954484412096
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RNASE1,Ribonuclease pancreatic,24205,134,1.42 [0.75-2.71],0.2839092079852644
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RNASE10,Inactive ribonuclease-like protein 10,23568,133,1.04 [0.74-1.45],0.8358469779093162
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RNASE3,Eosinophil cationic protein,27622,155,0.95 [0.84-1.09],0.4674746975368214
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RNASE4,Ribonuclease 4,23388,128,1.23 [0.66-2.29],0.5181657506263512
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RNASE6,Ribonuclease K6,24021,133,1.41 [0.86-2.31],0.1792746136575596
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RNASEH2A,Ribonuclease H2 subunit A,24152,133,0.90 [0.63-1.27],0.5463341324000817
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RNASET2,Ribonuclease T2,27957,152,1.80 [1.09-2.96],0.0209202867152375
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RNF149,E3 ubiquitin-protein ligase RNF149,23568,133,1.04 [0.60-1.81],0.8831140869650884
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RNF168,E3 ubiquitin-protein ligase RNF168,23508,131,1.29 [0.92-1.80],0.1355284661930345
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RNF31,E3 ubiquitin-protein ligase RNF31,23508,131,1.31 [0.92-1.88],0.1340959463384765
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RNF4,E3 ubiquitin-protein ligase RNF4,23740,131,1.15 [0.92-1.44],0.2052374429730608
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RNF41,E3 ubiquitin-protein ligase NRDP1,27102,151,1.13 [0.92-1.39],0.2444415967892304
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RNF43,E3 ubiquitin-protein ligase RNF43,23740,131,0.90 [0.66-1.23],0.5270134268319471
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RNF5,E3 ubiquitin-protein ligase RNF5,23568,133,1.28 [1.01-1.63],0.0403853435376987
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ROBO1,Roundabout homolog 1,27803,154,0.78 [0.42-1.43],0.4149784086952607
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ROBO2,Roundabout homolog 2,27991,156,0.83 [0.45-1.53],0.549740438685295
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ROBO4,Roundabout homolog 4,23568,133,1.09 [0.43-2.77],0.8617712055656754
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,27752,155,0.97 [0.61-1.53],0.8861748746838367
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RP2,Protein XRP2,27629,155,1.04 [0.74-1.45],0.8318390323981218
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RPA2,Replication protein A 32 kDa subunit,23508,131,1.27 [0.80-2.02],0.3087217691685341
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RPE,Ribulose-phosphate 3-epimerase,23740,131,1.10 [0.88-1.38],0.4030587757087924
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RPGR,X-linked retinitis pigmentosa GTPase regulator,23514,134,0.79 [0.51-1.22],0.2962644564231859
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RPL14,60S ribosomal protein L14,23568,133,0.94 [0.63-1.41],0.7776987591437967
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RPS10,40S ribosomal protein S10,23424,129,1.09 [0.75-1.58],0.6519535794965605
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RRAS,Ras-related protein R-Ras,23514,134,1.03 [0.90-1.16],0.7000305615041551
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RRM2,Ribonucleoside-diphosphate reductase subunit M2,27102,151,1.10 [0.85-1.41],0.4777986545675541
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,27102,151,1.16 [0.94-1.43],0.1712111268548619
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RRP15,RRP15-like protein,23410,130,0.93 [0.77-1.11],0.4084843793106738
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RSPO1,R-spondin-1,27559,153,0.80 [0.54-1.20],0.2855952947691753
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RSPO3,R-spondin-3,27985,155,1.15 [0.71-1.88],0.5679189750475755
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RTBDN,Retbindin,27629,155,1.51 [1.00-2.28],0.0509059890479228
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RTKN2,Rhotekin-2,23424,129,1.14 [0.87-1.51],0.3387565109802173
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24152,133,1.02 [0.85-1.22],0.826707873293189
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RTN4R,Reticulon-4 receptor,27985,155,1.23 [0.82-1.85],0.3204083433524443
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RUVBL1,RuvB-like 1,27102,151,1.01 [0.88-1.16],0.91584670717798
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RWDD1,RWD domain-containing protein 1,27991,156,1.21 [0.97-1.50],0.0884679807462114
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",RYR1,Ryanodine receptor 1,23424,129,0.80 [0.46-1.40],0.4411239443274194
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",S100A11,Protein S100-A11,27527,153,1.15 [0.88-1.50],0.3112122463736607
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",S100A12,Protein S100-A12,27380,154,1.11 [0.92-1.33],0.2654861720408317
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",S100A13,Protein S100-A13,23508,131,1.12 [0.70-1.80],0.6302305082321322
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",S100A14,Protein S100-A14,24152,133,1.12 [0.82-1.53],0.470373419264856
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",S100A16,Protein S100-A16,27031,151,1.13 [0.91-1.40],0.2713586049910922
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",S100A3,Protein S100-A3,24054,130,1.18 [0.89-1.57],0.2485088563432149
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",S100A4,Protein S100-A4,27849,154,1.26 [0.98-1.62],0.0699168076675385
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",S100G,Protein S100-G,24152,133,1.28 [0.91-1.81],0.1621351701782259
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",S100P,Protein S100-P,27243,152,1.15 [0.91-1.45],0.2534725365855923
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SAA4,Serum amyloid A-4 protein,24239,135,0.97 [0.56-1.68],0.909424834825983
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SAFB2,Scaffold attachment factor B2,24152,133,1.58 [0.97-2.59],0.0688614505133521
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SAG,S-arrestin,23410,130,1.13 [0.84-1.51],0.4112735112527774
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SAMD9L,Sterile alpha motif domain-containing protein 9-like,27705,155,1.12 [0.92-1.36],0.2470359343777419
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SAP18,Histone deacetylase complex subunit SAP18,23740,131,0.92 [0.72-1.18],0.5214817740186899
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SARG,Specifically androgen-regulated gene protein,24094,133,1.18 [1.01-1.38],0.0378082666388356
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SART1,U4/U6.U5 tri-snRNP-associated protein 1,23424,129,1.01 [0.65-1.58],0.9546626282316508
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SAT1,Diamine acetyltransferase 1,23424,129,0.76 [0.52-1.11],0.1549873184523495
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SAT2,Thialysine N-epsilon-acetyltransferase,23740,131,0.93 [0.72-1.20],0.56372498772372
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SATB1,DNA-binding protein SATB1,24152,133,0.68 [0.37-1.27],0.2300275119868761
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SBSN,Suprabasin,24143,135,0.98 [0.60-1.59],0.9192229386783064
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCAMP3,Secretory carrier-associated membrane protein 3,27629,155,1.19 [1.01-1.39],0.0394828451591645
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCARA5,Scavenger receptor class A member 5,27991,156,1.03 [0.63-1.68],0.894953412792879
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCARB1,Scavenger receptor class B member 1,27073,151,1.02 [0.81-1.30],0.8487309717650663
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCARB2,Lysosome membrane protein 2,27049,148,1.12 [0.68-1.84],0.6618061557207364
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCARF1,Scavenger receptor class F member 1,28090,154,1.31 [0.95-1.81],0.0987582296439869
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCARF2,Scavenger receptor class F member 2,27991,156,0.81 [0.51-1.29],0.3721330012536282
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCG2,Secretogranin-2,27849,155,1.96 [1.26-3.04],0.0028274780675857
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCG3,Secretogranin-3,27803,154,0.91 [0.59-1.41],0.686223153462791
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCGB1A1,Uteroglobin,27799,154,1.03 [0.81-1.32],0.8089760681016451
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCGB2A2,Mammaglobin-A,23424,129,0.95 [0.54-1.64],0.8432786541825541
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCGB3A1,Secretoglobin family 3A member 1,23679,128,1.15 [0.58-2.26],0.6869767219216127
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCGB3A2,Secretoglobin family 3A member 2,27841,154,0.92 [0.77-1.11],0.3915241032037763
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCGN,Secretagogin,27198,150,1.04 [0.75-1.44],0.8233804728113038
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCIN,Adseverin,23410,130,1.02 [0.81-1.27],0.8845985539482271
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCLY,Selenocysteine lyase,27898,155,1.08 [0.81-1.44],0.5971668926065993
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCN2A,Sodium channel protein type 2 subunit alpha,23410,130,0.63 [0.41-0.97],0.0377966733244139
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCN2B,Sodium channel subunit beta-2,23514,134,0.51 [0.26-0.98],0.0425084939733166
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCN3A,Sodium channel protein type 3 subunit alpha,23514,134,1.04 [0.69-1.59],0.8374353653574855
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCN3B,Sodium channel subunit beta-3,23410,130,1.11 [0.80-1.54],0.5236257701307431
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCN4B,Sodium channel subunit beta-4,23568,133,1.24 [0.84-1.84],0.2750166151121918
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCP2,Non-specific lipid-transfer protein,27102,151,0.83 [0.68-1.02],0.0749335708908251
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCPEP1,Retinoid-inducible serine carboxypeptidase,23472,132,1.05 [0.75-1.47],0.76346285304758
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCRG1,Scrapie-responsive protein 1,24191,134,1.18 [0.64-2.15],0.5954687887446006
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCRIB,Protein scribble homolog,23568,133,1.07 [0.91-1.26],0.4247876675472583
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCRN1,Secernin-1,27705,155,1.20 [0.95-1.52],0.1229348218962677
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SCT,Secretin,23514,134,1.27 [0.88-1.82],0.1980083103520061
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SDC1,Syndecan-1,27752,155,0.98 [0.69-1.39],0.8892341902497903
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SDC4,Syndecan-4,27752,155,1.16 [0.85-1.59],0.3572529705050317
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SDCCAG8,Serologically defined colon cancer antigen 8,24054,130,1.11 [0.96-1.29],0.1683512065739885
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SDHB,Succinate dehydrogenase,24066,134,1.06 [0.84-1.33],0.6444599607660029
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SDK2,Protein sidekick-2,23679,128,0.88 [0.55-1.39],0.5748845102980795
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SEC31A,Protein transport protein Sec31A,23568,133,1.28 [1.02-1.60],0.0338505341954775
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SEL1L,Protein sel-1 homolog 1,23568,133,1.41 [1.00-1.99],0.049592956597284
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SELE,E-selectin,28090,154,0.86 [0.65-1.14],0.2878156054296783
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SELENOP,Selenoprotein P,24239,135,1.40 [0.69-2.83],0.3532193518838251
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SELL,L-selectin,24239,135,0.79 [0.38-1.61],0.5136675923390569
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SELP,P-selectin,27845,154,1.21 [0.95-1.53],0.1240800220591415
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SELPLG,P-selectin glycoprotein ligand 1,27705,155,1.24 [0.75-2.07],0.3992010792507465
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SEMA3F,Semaphorin-3F,27752,155,1.00 [0.57-1.74],0.9940003349891556
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SEMA3G,Semaphorin-3G,23679,128,1.30 [0.90-1.88],0.1684486183623382
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SEMA4C,Semaphorin-4C,27629,155,0.73 [0.42-1.27],0.2628365933198644
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SEMA4D,Semaphorin-4D,27991,156,1.27 [0.79-2.04],0.3243209392207752
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SEMA6C,Semaphorin-6C,23508,131,1.01 [0.54-1.90],0.9681483659442698
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SEMA7A,Semaphorin-7A,28000,154,0.73 [0.42-1.27],0.2695137816674663
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SEPTIN3,Neuronal-specific septin-3,24152,133,1.18 [0.95-1.45],0.1282842686702217
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SEPTIN7,Septin-7,23740,131,0.99 [0.72-1.35],0.9304027875202456
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SEPTIN8,Septin-8,24089,133,1.06 [0.65-1.73],0.8147518911884966
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SEPTIN9,Septin-9,27629,155,0.88 [0.53-1.46],0.6113343480169364
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINA1,Alpha-1-antitrypsin,23773,131,0.29 [0.04-2.34],0.2458988472832569
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINA11,Serpin A11,28090,154,1.07 [0.75-1.52],0.7157976832833399
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINA12,Serpin A12,26950,148,1.10 [0.99-1.23],0.0843735011233369
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINA3,Alpha-1-antichymotrypsin,24139,134,2.33 [0.83-6.55],0.1094942625479346
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINA4,Kallistatin,23783,131,2.42 [1.22-4.78],0.0111656000802113
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINA5,Plasma serine protease inhibitor,23882,130,1.10 [0.67-1.80],0.71869260458607
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINA6,Corticosteroid-binding globulin,24239,135,1.08 [0.48-2.45],0.8466259682392449
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINA7,Thyroxine-binding globulin,24239,135,1.04 [0.44-2.48],0.9256067084131444
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINA9,Serpin A9,27484,155,1.00 [0.83-1.22],0.961440274527763
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINB1,Leukocyte elastase inhibitor,27668,155,1.10 [0.94-1.28],0.2230586647924968
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINB5,Serpin B5,27243,152,1.22 [0.91-1.63],0.1892506879090061
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINB6,Serpin B6,27903,156,1.24 [0.98-1.56],0.0677691410844055
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINB8,Serpin B8,28040,156,1.12 [0.90-1.40],0.3266508616495674
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINB9,Serpin B9,27559,153,1.35 [0.89-2.04],0.1589762003280982
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINC1,Antithrombin-III,24187,134,1.84 [0.60-5.68],0.2859429543091057
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPIND1,Heparin cofactor 2,24187,134,1.24 [0.69-2.24],0.4737222988708103
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINE1,Plasminogen activator inhibitor 1,28090,154,1.11 [0.90-1.36],0.3444148541049161
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINE2,Glia-derived nexin,24191,134,1.03 [0.80-1.33],0.7892955665818915
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINF1,Pigment epithelium-derived factor,23873,131,1.64 [0.87-3.08],0.1274363631404426
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINF2,Alpha-2-antiplasmin,23780,130,1.24 [0.36-4.28],0.7302268496526594
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPING1,Plasma protease C1 inhibitor,24187,134,3.35 [1.42-7.90],0.0056411935776289
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINH1,Serpin H1,23740,131,1.05 [0.92-1.20],0.4440987581211003
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINI1,Neuroserpin,23631,128,0.53 [0.29-0.95],0.0341276918166614
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SERPINI2,Serpin I2,24066,134,0.86 [0.63-1.16],0.3101879397713621
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,27073,151,1.15 [0.92-1.43],0.2165797680886031
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SETMAR,Histone-lysine N-methyltransferase SETMAR,27477,152,0.83 [0.51-1.35],0.4481803504266736
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SEZ6,Seizure protein 6 homolog,23514,134,0.83 [0.47-1.46],0.5151908635737587
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SEZ6L,Seizure 6-like protein,27849,154,1.04 [0.62-1.76],0.8743406225962643
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SEZ6L2,Seizure 6-like protein 2,27629,155,0.64 [0.35-1.15],0.1381375041693784
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SF3B4,Splicing factor 3B subunit 4,27629,155,1.06 [0.88-1.27],0.5666180206021101
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SFRP1,Secreted frizzled-related protein 1,27476,152,0.92 [0.66-1.28],0.6058212946526584
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SFRP4,Secreted frizzled-related protein 4,23679,128,0.64 [0.44-0.95],0.02723938741171
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SFTPA1,Pulmonary surfactant-associated protein A1,27102,151,1.22 [1.00-1.50],0.048417215037087
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SFTPA2,Pulmonary surfactant-associated protein A2,27102,151,1.05 [0.79-1.38],0.7467101237607694
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SFTPD,Pulmonary surfactant-associated protein D,27752,155,1.20 [0.97-1.48],0.1020412067966066
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SGSH,N-sulphoglucosamine sulphohydrolase,23770,131,0.92 [0.68-1.26],0.6113479099556978
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SH2B3,SH2B adapter protein 3,27102,151,1.17 [1.01-1.36],0.0414590965655855
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SH2D1A,SH2 domain-containing protein 1A,27705,155,1.18 [0.94-1.47],0.1545811592476132
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,23410,130,1.03 [0.79-1.34],0.8192915463846746
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SH3BP1,SH3 domain-binding protein 1,24066,134,1.03 [0.74-1.43],0.8651701942850507
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SH3GL3,Endophilin-A3,23611,131,1.00 [0.82-1.21],0.9673501439865804
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SH3GLB2,Endophilin-B2,24136,133,1.14 [0.90-1.46],0.2833676493465595
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SHBG,Sex hormone-binding globulin,24205,134,0.93 [0.69-1.26],0.6480429974962645
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SHC1,SHC-transforming protein 1,23315,128,0.93 [0.80-1.09],0.365245304509184
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SHD,SH2 domain-containing adapter protein D,23374,129,0.86 [0.68-1.08],0.1911727699599008
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SHH,Sonic hedgehog protein,23508,131,1.06 [0.73-1.54],0.7625404883457756
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SHISA5,Protein shisa-5,24190,135,1.42 [0.77-2.61],0.2568847581887125
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SHMT1,"Serine hydroxymethyltransferase, cytosolic",27841,154,1.05 [0.90-1.24],0.519047440910271
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SHPK,Sedoheptulokinase,23740,131,1.07 [0.74-1.55],0.7284226799071793
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SIAE,Sialate O-acetylesterase,27805,154,1.07 [0.79-1.44],0.676212388478248
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SIGLEC1,Sialoadhesin,27889,155,1.13 [0.81-1.56],0.4782450082322845
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SIGLEC10,Sialic acid-binding Ig-like lectin 10,27705,155,0.97 [0.63-1.49],0.8868536718015645
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SIGLEC15,Sialic acid-binding Ig-like lectin 15,27073,151,1.12 [0.96-1.31],0.1509738309896699
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SIGLEC5,Sialic acid-binding Ig-like lectin 5,27756,156,0.95 [0.85-1.06],0.3214999763294307
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SIGLEC6,Sialic acid-binding Ig-like lectin 6,27985,155,0.68 [0.44-1.03],0.0704512898906386
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SIGLEC7,Sialic acid-binding Ig-like lectin 7,27752,155,0.93 [0.56-1.53],0.7648800364743843
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SIGLEC8,Sialic acid-binding Ig-like lectin 8,23568,133,1.35 [0.95-1.93],0.0965612657439391
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SIGLEC9,Sialic acid-binding Ig-like lectin 9,27947,155,1.10 [0.69-1.77],0.6843572878627864
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SIL1,Nucleotide exchange factor SIL1,23568,133,1.06 [0.66-1.71],0.8085480936541087
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,27819,154,1.02 [0.80-1.31],0.8789739944505021
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SIRPB1,Signal-regulatory protein beta-1,27714,152,1.09 [0.79-1.51],0.5988958069697806
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SIRT1,NAD-dependent protein deacetylase sirtuin-1,23508,131,0.97 [0.80-1.19],0.7968541488052997
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SIRT2,NAD-dependent protein deacetylase sirtuin-2,27629,155,1.14 [0.97-1.33],0.1146253936354409
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",27073,151,1.17 [0.93-1.47],0.1771391610619105
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SIT1,Signaling threshold-regulating transmembrane adapter 1,27198,150,1.07 [0.83-1.38],0.6261018968419039
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SKAP1,Src kinase-associated phosphoprotein 1,27507,153,1.04 [0.86-1.26],0.7031312077177855
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SKAP2,Src kinase-associated phosphoprotein 2,27889,155,1.20 [1.05-1.37],0.0086654954549653
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SKIV2L,Helicase SKI2W,23424,129,1.04 [0.70-1.54],0.844408731245076
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLA2,Src-like-adapter 2,24152,133,1.04 [0.88-1.22],0.6578414794345814
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLAMF1,Signaling lymphocytic activation molecule,27198,150,1.00 [0.78-1.27],0.9688805044909884
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLAMF6,SLAM family member 6,27102,151,1.12 [0.77-1.65],0.550616968166276
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLAMF7,SLAM family member 7,27705,155,1.02 [0.79-1.30],0.90271993898611
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLAMF8,SLAM family member 8,27102,151,0.95 [0.73-1.25],0.7307924100462742
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLC12A2,Solute carrier family 12 member 2,23424,129,0.77 [0.40-1.48],0.4246958919723098
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLC13A1,Solute carrier family 13 member 1,24054,130,1.09 [0.86-1.39],0.483505058748805
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLC16A1,Monocarboxylate transporter 1,27073,151,0.89 [0.69-1.15],0.3869581826154579
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLC1A4,Neutral amino acid transporter A,23514,134,0.75 [0.52-1.07],0.1160072955189392
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLC27A4,Long-chain fatty acid transport protein 4,27073,151,1.13 [0.93-1.36],0.2243438059154837
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLC28A1,Sodium/nucleoside cotransporter 1,23315,128,1.00 [0.76-1.32],0.9893740188084362
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLC34A3,Sodium-dependent phosphate transport protein 2C,23315,128,1.04 [0.75-1.45],0.8111493296114308
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLC39A14,Zinc transporter ZIP14,27073,151,1.23 [0.81-1.86],0.3260427148328252
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLC39A5,Zinc transporter ZIP5,27705,155,1.09 [0.85-1.40],0.4838587929621013
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLC44A4,Choline transporter-like protein 4,23514,134,1.03 [0.82-1.30],0.7980232351957381
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLC4A1,Band 3 anion transport protein,24190,135,0.99 [0.70-1.40],0.9554965834016266
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLC51B,Organic solute transporter subunit beta,23424,129,1.11 [0.91-1.36],0.3106140352807003
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,23679,128,1.11 [0.91-1.35],0.314251275681177
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24066,134,1.32 [1.07-1.64],0.0103180590797542
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",23315,128,0.78 [0.55-1.10],0.1511414069137488
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLIT2,Slit homolog 2 protein,27073,151,0.89 [0.66-1.18],0.416119399189639
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLITRK1,SLIT and NTRK-like protein 1,23508,131,1.04 [0.62-1.76],0.8746348159520277
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLITRK2,SLIT and NTRK-like protein 2,27985,155,0.89 [0.61-1.28],0.5249399492063791
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLITRK6,SLIT and NTRK-like protein 6,27243,152,0.93 [0.61-1.42],0.7331362020243728
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLK,STE20-like serine/threonine-protein kinase,23740,131,0.86 [0.67-1.11],0.2405617459936773
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLMAP,Sarcolemmal membrane-associated protein,24066,134,1.17 [0.97-1.42],0.098603120816149
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SLURP1,Secreted Ly-6/uPAR-related protein 1,24004,134,1.30 [0.92-1.86],0.1391762809896302
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SMAD1,Mothers against decapentaplegic homolog 1,27102,151,1.18 [0.98-1.40],0.0741980876027865
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SMAD2,Mothers against decapentaplegic homolog 2,24054,130,1.17 [0.93-1.49],0.1840956098302768
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SMAD3,Mothers against decapentaplegic homolog 3,24054,130,1.13 [0.82-1.56],0.4524043545910379
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SMAD5,Mothers against decapentaplegic homolog 5,27629,155,0.79 [0.41-1.53],0.4880505134221895
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SMARCA2,Probable global transcription activator SNF2L2,27073,151,0.85 [0.69-1.05],0.1427062238873048
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SMC3,Structural maintenance of chromosomes protein 3,23315,128,0.93 [0.67-1.28],0.6491292074380275
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SMNDC1,Survival of motor neuron-related-splicing factor 30,24066,134,1.02 [0.79-1.32],0.8732081851233674
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SMOC1,SPARC-related modular calcium-binding protein 1,27985,155,0.97 [0.64-1.48],0.8942607856500224
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SMOC2,SPARC-related modular calcium-binding protein 2,27889,155,0.92 [0.63-1.32],0.6402890840299096
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SMPD1,Sphingomyelin phosphodiesterase,27855,156,1.13 [0.85-1.50],0.4085908836047029
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SMPD3,Sphingomyelin phosphodiesterase 3,23508,131,1.07 [0.83-1.39],0.591126874490146
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,27849,154,0.99 [0.80-1.24],0.9565614783553804
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24054,130,0.92 [0.73-1.17],0.5094035997199107
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SMS,Spermine synthase,23410,130,1.00 [0.76-1.30],0.9742872711848226
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SMTN,Smoothelin,24093,133,1.12 [0.95-1.31],0.1776435075787109
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SNAP23,Synaptosomal-associated protein 23,27752,155,1.24 [1.04-1.47],0.0146754237714769
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SNAP25,Synaptosomal-associated protein 25,23410,130,1.04 [0.73-1.48],0.8431052721247092
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SNAP29,Synaptosomal-associated protein 29,27849,154,1.17 [1.00-1.37],0.0528904246757101
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SNAPIN,SNARE-associated protein Snapin,24152,133,1.04 [0.78-1.38],0.7794287986041528
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SNCA,Alpha-synuclein,23679,128,1.16 [1.00-1.34],0.0558817845920773
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SNCG,Gamma-synuclein,27559,153,1.00 [0.81-1.25],0.9872133413723858
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",23568,133,0.62 [0.36-1.07],0.084159149828881
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SNRPB2,U2 small nuclear ribonucleoprotein B'',24136,133,0.82 [0.52-1.29],0.389684462905173
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SNU13,NHP2-like protein 1,23424,129,0.80 [0.59-1.09],0.1659603425521253
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SNX15,Sorting nexin-15,23679,128,1.21 [0.90-1.64],0.2070333473457629
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SNX18,Sorting nexin-18,24066,134,0.77 [0.52-1.14],0.1930108312614876
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SNX2,Sorting nexin-2,24054,130,1.20 [0.99-1.45],0.0639325400331709
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SNX5,Sorting nexin-5,23568,133,0.95 [0.55-1.66],0.8619189753622336
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SNX9,Sorting nexin-9,27752,155,1.22 [1.00-1.49],0.0488616275143892
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SOD1,Superoxide dismutase [Cu-Zn],27174,151,1.16 [0.87-1.55],0.2994162904318292
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SOD2,"Superoxide dismutase [Mn], mitochondrial",27756,156,1.00 [0.68-1.46],0.9993332362655108
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SOD3,Extracellular superoxide dismutase,24205,134,0.73 [0.50-1.07],0.1079925477063389
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SORBS1,Sorbin and SH3 domain-containing protein 1,24152,133,1.19 [0.83-1.71],0.3442763267479236
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SORCS2,VPS10 domain-containing receptor SorCS2,27102,151,1.52 [1.02-2.25],0.0396604299238735
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SORD,Sorbitol dehydrogenase,27854,154,0.95 [0.77-1.17],0.6384018939278893
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SORT1,Sortilin,27707,155,1.11 [0.76-1.63],0.592831475780726
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SOST,Sclerostin,27707,155,1.22 [0.85-1.75],0.2860305285535336
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,23514,134,0.72 [0.48-1.09],0.1183329195483104
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SOX2,Transcription factor SOX-2,24112,133,1.25 [0.63-2.49],0.5281517348026105
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SOX9,Transcription factor SOX-9,23514,134,0.91 [0.49-1.68],0.7515102871298415
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24152,133,0.97 [0.55-1.70],0.9033074226156133
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPAG1,Sperm-associated antigen 1,24152,133,1.30 [1.04-1.63],0.023694043187018
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPARC,SPARC,27849,154,1.10 [0.90-1.35],0.3443096831073244
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPARCL1,SPARC-like protein 1,27757,154,1.09 [0.65-1.81],0.75103958990826
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPART,Spartin,23679,128,1.17 [0.95-1.46],0.1402116542159316
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPESP1,Sperm equatorial segment protein 1,24191,134,1.14 [0.63-2.08],0.6609080455308551
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPINK1,Serine protease inhibitor Kazal-type 1,27756,156,1.38 [1.03-1.84],0.0296871590996371
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPINK2,Serine protease inhibitor Kazal-type 2,23679,128,1.22 [0.80-1.87],0.3630017994080292
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPINK4,Serine protease inhibitor Kazal-type 4,27705,155,1.23 [1.00-1.52],0.0514404171152288
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPINK5,Serine protease inhibitor Kazal-type 5,27756,156,0.95 [0.62-1.47],0.8272899079572932
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPINK6,Serine protease inhibitor Kazal-type 6,27985,155,1.39 [1.08-1.80],0.010817646133376
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPINK8,Serine protease inhibitor Kazal-type 8,23424,129,1.17 [0.80-1.72],0.4228579058742105
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPINT1,Kunitz-type protease inhibitor 1,27675,155,0.78 [0.44-1.38],0.3932061650604956
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPINT2,Kunitz-type protease inhibitor 2,27889,155,1.29 [0.92-1.81],0.1426152969310207
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPINT3,Kunitz-type protease inhibitor 3,24066,134,1.03 [0.91-1.18],0.61242492558567
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPOCK1,Testican-1,27559,153,1.00 [0.57-1.78],0.9878242539601396
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPON1,Spondin-1,27803,154,1.11 [0.72-1.71],0.6315351144545094
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPON2,Spondin-2,27620,155,0.89 [0.58-1.35],0.5798465329930961
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPP1,Osteopontin,28043,154,0.87 [0.65-1.17],0.3522608776850258
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",23508,131,1.06 [0.73-1.53],0.764172738150748
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPRING1,SREBP regulating gene protein,23315,128,1.03 [0.77-1.37],0.8581267983426252
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPRR1B,Cornifin-B,23740,131,1.09 [0.92-1.29],0.3117827621220619
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPRR3,Small proline-rich protein 3,24136,133,0.96 [0.76-1.22],0.7583877321784611
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPRY2,Protein sprouty homolog 2,27198,150,1.13 [0.97-1.32],0.1113889004529881
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",23410,130,1.02 [0.61-1.72],0.9298003178035744
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SPTLC1,Serine palmitoyltransferase 1,24136,133,0.76 [0.45-1.27],0.2941719556240278
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SRC,Proto-oncogene tyrosine-protein kinase Src,27802,154,1.10 [0.98-1.25],0.1057966371832503
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SRP14,Signal recognition particle 14 kDa protein,27629,155,1.19 [0.95-1.48],0.1312778267363045
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SRPK2,SRSF protein kinase 2,27705,155,1.11 [0.94-1.31],0.2258821612357788
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SRPX,Sushi repeat-containing protein SRPX,24191,134,0.71 [0.43-1.17],0.1768399967698536
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SSB,Lupus La protein,27073,151,1.05 [0.83-1.32],0.6964111106214519
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",23508,131,1.13 [0.74-1.72],0.5824423972642788
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,27707,155,1.08 [0.94-1.24],0.259122841203909
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,27845,154,1.33 [0.95-1.86],0.0966834086266499
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SSH3,Protein phosphatase Slingshot homolog 3,23315,128,0.67 [0.36-1.24],0.2020051841883847
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SSNA1,Sjoegren syndrome nuclear autoantigen 1,24066,134,1.03 [0.75-1.41],0.8557328896822121
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ST13,Hsc70-interacting protein,23679,128,1.13 [0.84-1.52],0.4343922558196668
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",27629,155,1.03 [0.74-1.42],0.877449188945466
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",28090,154,1.16 [0.71-1.88],0.5581515332540166
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",23508,131,1.18 [0.90-1.55],0.227738441926915
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STAB2,Stabilin-2,24190,135,0.97 [0.55-1.72],0.9121405384680656
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STAM,Signal transducing adapter molecule 1,24054,130,1.19 [0.81-1.77],0.3751139178202257
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STAMBP,STAM-binding protein,27507,153,1.19 [0.95-1.48],0.1230703753380561
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STAT2,Signal transducer and activator of transcription 2,23508,131,1.21 [0.98-1.49],0.081617068629982
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STAT5B,Signal transducer and activator of transcription 5B,27629,155,1.09 [0.98-1.21],0.1183311819533415
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,23315,128,1.11 [0.88-1.40],0.3562526481801055
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STC1,Stanniocalcin-1,27991,156,1.05 [0.75-1.47],0.7850133073619431
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STC2,Stanniocalcin-2,27717,156,1.04 [0.63-1.70],0.8910012527893738
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STEAP4,Metalloreductase STEAP4,23410,130,1.08 [0.88-1.33],0.4518740931769615
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STIP1,Stress-induced-phosphoprotein 1,27717,156,1.12 [0.91-1.39],0.2880797276105153
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STK11,Serine/threonine-protein kinase STK11,27243,152,1.14 [0.94-1.38],0.1950842753428507
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STK24,Serine/threonine-protein kinase 24,27073,151,1.18 [0.94-1.49],0.1521023605019086
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STK4,Serine/threonine-protein kinase 4,27752,155,1.16 [0.99-1.37],0.0647981481518559
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STOML2,"Stomatin-like protein 2, mitochondrial",23315,128,1.00 [0.83-1.21],0.9724012179371212
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STX16,Syntaxin-16,27102,151,1.16 [0.92-1.45],0.2072574017961836
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STX1B,Syntaxin-1B,23514,134,0.96 [0.65-1.42],0.8299079519428536
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STX3,Syntaxin-3,24136,133,1.09 [0.73-1.62],0.6706296656144126
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STX4,Syntaxin-4,27629,155,1.18 [0.97-1.43],0.1061854296922349
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STX5,Syntaxin-5,23508,131,1.54 [1.20-1.97],0.0007726728378954
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STX6,Syntaxin-6,27102,151,1.14 [0.94-1.37],0.1733814955642874
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STX7,Syntaxin-7,23508,131,1.35 [0.98-1.88],0.069847572364309
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STX8,Syntaxin-8,27705,155,1.19 [0.91-1.56],0.2093390290337514
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STXBP1,Syntaxin-binding protein 1,24152,133,1.11 [0.89-1.37],0.3462083908928245
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",STXBP3,Syntaxin-binding protein 3,27102,151,1.00 [0.71-1.39],0.9848964719253868
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SUGP1,SURP and G-patch domain-containing protein 1,24066,134,1.01 [0.67-1.50],0.9755104390178764
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SUGT1,Protein SGT1 homolog,27102,151,1.16 [0.97-1.39],0.1070172686451066
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SULT1A1,Sulfotransferase 1A1,27991,156,1.06 [0.95-1.18],0.3247283149942089
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SULT2A1,Bile salt sulfotransferase,27705,155,0.89 [0.67-1.18],0.4152525782627956
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SUMF1,Formylglycine-generating enzyme,23508,131,1.12 [0.92-1.36],0.2735021282895554
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,27991,156,1.20 [0.92-1.58],0.1826198288571096
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SUOX,"Sulfite oxidase, mitochondrial",24152,133,0.98 [0.75-1.28],0.862660587093327
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SUSD1,Sushi domain-containing protein 1,27243,152,1.34 [0.99-1.81],0.0587153618482577
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SUSD2,Sushi domain-containing protein 2,27756,156,0.85 [0.52-1.39],0.5149890322241113
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SUSD4,Sushi domain-containing protein 4,24054,130,0.83 [0.56-1.22],0.3366787417273066
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SUSD5,Sushi domain-containing protein 5,23536,127,1.24 [0.76-2.04],0.39186853263652
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SV2A,Synaptic vesicle glycoprotein 2A,23514,134,0.97 [0.74-1.27],0.8354824224771906
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SWAP70,Switch-associated protein 70,24066,134,0.97 [0.62-1.53],0.9075844816256986
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SYAP1,Synapse-associated protein 1,23679,128,1.37 [1.03-1.82],0.0307327833033391
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,23410,130,0.95 [0.71-1.28],0.745560164454791
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SYT1,Synaptotagmin-1,24136,133,1.25 [0.88-1.76],0.2075106950980307
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",SYTL4,Synaptotagmin-like protein 4,24191,134,1.10 [0.88-1.37],0.3964261522195637
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,23740,131,1.12 [0.96-1.31],0.1484389498295387
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TACC3,Transforming acidic coiled-coil-containing protein 3,27629,155,1.14 [1.01-1.29],0.0390076585085872
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TACSTD2,Tumor-associated calcium signal transducer 2,24604,141,1.07 [0.65-1.78],0.7896311833634849
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TADA3,Transcriptional adapter 3,24054,130,1.20 [0.79-1.83],0.3853149091684733
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TAFA5,Chemokine-like protein TAFA-5,27629,155,1.26 [0.85-1.87],0.2436661757615753
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TAGLN3,Transgelin-3,23315,128,0.97 [0.73-1.28],0.8310372106173407
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TALDO1,Transaldolase,24093,133,0.99 [0.70-1.42],0.9736564294974618
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TANK,TRAF family member-associated NF-kappa-B activator,27198,150,1.06 [0.86-1.31],0.5613736311567168
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TAP1,Antigen peptide transporter 1,23740,131,0.74 [0.51-1.05],0.0929220484188815
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TARBP2,RISC-loading complex subunit TARBP2,27073,151,1.19 [1.00-1.43],0.0547837749078069
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",23514,134,0.98 [0.79-1.21],0.8443408340624532
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24054,130,1.38 [0.91-2.09],0.1262204948609158
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TAX1BP1,Tax1-binding protein 1,24136,133,1.14 [0.89-1.47],0.2934234221036208
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TBC1D17,TBC1 domain family member 17,27073,151,0.96 [0.69-1.32],0.7819162168345075
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TBC1D23,TBC1 domain family member 23,27629,155,1.12 [0.96-1.31],0.1608138330781764
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TBC1D5,TBC1 domain family member 5,27705,155,1.16 [0.99-1.37],0.0742387013817808
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TBCA,Tubulin-specific chaperone A,23679,128,1.14 [0.94-1.38],0.1732913888887423
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TBCB,Tubulin-folding cofactor B,27559,153,1.11 [0.96-1.29],0.1419947073407571
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TBCC,Tubulin-specific chaperone C,27559,153,1.15 [0.97-1.37],0.1153145320403454
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TBL1X,F-box-like/WD repeat-containing protein TBL1X,27102,151,1.13 [0.95-1.34],0.1672160245993253
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TBR1,T-box brain protein 1,23514,134,1.22 [0.92-1.61],0.1601309445352713
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TCL1A,T-cell leukemia/lymphoma protein 1A,27513,153,1.04 [0.89-1.21],0.5991637494892992
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TCL1B,T-cell leukemia/lymphoma protein 1B,27243,152,1.06 [0.90-1.25],0.4903623138246468
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TCN1,Transcobalamin-1,23701,132,1.08 [0.66-1.78],0.7533943118361522
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TCN2,Transcobalamin-2,28043,154,1.23 [0.78-1.96],0.3728261653119713
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TCOF1,Treacle protein,24191,134,0.75 [0.43-1.33],0.3279671560402193
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TCP11,T-complex protein 11 homolog,23740,131,0.99 [0.75-1.30],0.9167825916428856
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TCTN3,Tectonic-3,24191,134,1.09 [0.62-1.92],0.7625496578869903
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TDGF1,Teratocarcinoma-derived growth factor 1,27073,151,0.99 [0.89-1.10],0.8227966150221984
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TDO2,"Tryptophan 2,3-dioxygenase",23514,134,0.93 [0.59-1.46],0.7576721624666265
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TDP1,Tyrosyl-DNA phosphodiesterase 1,24054,130,1.08 [0.87-1.34],0.4976018542501467
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TDRKH,Tudor and KH domain-containing protein,27073,151,1.10 [0.93-1.30],0.2513557631526774
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TEF,Thyrotroph embryonic factor,23424,129,1.47 [1.09-1.98],0.0111617281927229
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TEK,Angiopoietin-1 receptor,27849,154,0.72 [0.38-1.36],0.3163352626314825
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TERF1,Telomeric repeat-binding factor 1,23508,131,1.23 [0.72-2.11],0.4460699283718052
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TET2,Methylcytosine dioxygenase TET2,23694,131,0.91 [0.75-1.10],0.3374743932975454
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TEX101,Testis-expressed protein 101,23514,134,1.11 [0.74-1.69],0.6071718043920551
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TEX33,Testis-expressed protein 33,23740,131,0.89 [0.57-1.39],0.6066252453180629
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TF,Serotransferrin,24239,135,0.74 [0.36-1.53],0.4167618198214229
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TFAP2A,Transcription factor AP-2-alpha,23410,130,0.88 [0.65-1.20],0.4246533386049401
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TFF1,Trefoil factor 1,27616,155,0.97 [0.80-1.18],0.7802884620941327
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TFF2,Trefoil factor 2,27841,154,1.03 [0.81-1.31],0.7857179194392861
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TFF3,Trefoil factor 3,27709,155,1.16 [0.95-1.42],0.1480128140578017
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TFPI,Tissue factor pathway inhibitor,27661,154,1.28 [0.84-1.95],0.2499504161772908
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TFPI2,Tissue factor pathway inhibitor 2,27758,154,0.88 [0.61-1.29],0.5199284846540453
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TFRC,Transferrin receptor protein 1,27852,155,1.06 [0.75-1.48],0.7552410046016678
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TG,Thyroglobulin,24054,130,0.99 [0.86-1.14],0.8876855207508741
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TGFA,Protransforming growth factor alpha,27705,155,1.15 [0.87-1.53],0.333801806134183
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TGFB1,Transforming growth factor beta-1 proprotein,27994,156,1.53 [1.08-2.17],0.0160379808008135
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TGFB2,Transforming growth factor beta-2 proprotein,24054,130,0.92 [0.67-1.27],0.6168396878047953
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TGFBI,Transforming growth factor-beta-induced protein ig-h3,27571,151,1.54 [0.92-2.59],0.1038380342015185
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TGFBR1,TGF-beta receptor type-1,23508,131,0.96 [0.45-2.05],0.9201565181473113
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TGFBR2,TGF-beta receptor type-2,27849,154,1.15 [0.72-1.82],0.5632588731761687
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TGFBR3,Transforming growth factor beta receptor type 3,28090,154,1.53 [0.97-2.39],0.0646993933784656
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TGM2,Protein-glutamine gamma-glutamyltransferase 2,27709,155,1.20 [0.99-1.44],0.0566125155596457
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TGOLN2,Trans-Golgi network integral membrane protein 2,24205,134,1.27 [0.66-2.43],0.4785171983058796
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",THAP12,52 kDa repressor of the inhibitor of the protein kinase,23273,128,0.89 [0.72-1.09],0.2534162464218213
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",THBD,Thrombomodulin,27752,155,1.30 [0.78-2.18],0.3147597944969432
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",THBS2,Thrombospondin-2,27756,156,1.01 [0.68-1.51],0.941792515197319
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",THBS4,Thrombospondin-4,27751,154,0.78 [0.57-1.06],0.1154723864123146
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",THOP1,Thimet oligopeptidase,27619,154,1.44 [0.93-2.24],0.1000184460182728
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",THPO,Thrombopoietin,27243,152,1.45 [1.00-2.09],0.0480571585647164
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",THRAP3,Thyroid hormone receptor-associated protein 3,23424,129,0.98 [0.85-1.13],0.8002264770431183
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",THSD1,Thrombospondin type-1 domain-containing protein 1,23320,131,1.43 [0.93-2.20],0.1054134487198048
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",THTPA,Thiamine-triphosphatase,24017,130,1.17 [0.97-1.41],0.0997629101511569
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",THY1,Thy-1 membrane glycoprotein,27991,156,0.86 [0.51-1.45],0.5733115541366918
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TIA1,Nucleolysin TIA-1 isoform p40,26933,150,1.10 [0.98-1.24],0.1148708416162125
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TIE1,Tyrosine-protein kinase receptor Tie-1,28090,154,0.95 [0.68-1.33],0.7688802546791287
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",27021,151,1.13 [0.84-1.51],0.4287217475680743
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,23740,131,0.86 [0.53-1.40],0.5502008766169999
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,27845,154,1.26 [0.92-1.73],0.1580024010587137
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24191,134,1.21 [0.81-1.81],0.3468143275238626
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24136,133,1.09 [0.90-1.32],0.3903286577541137
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TIMP1,Metalloproteinase inhibitor 1,27429,154,1.30 [0.79-2.14],0.2939537240279888
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TIMP2,Metalloproteinase inhibitor 2,24191,134,0.58 [0.26-1.29],0.183574538807537
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TIMP3,Metalloproteinase inhibitor 3,27889,155,1.04 [0.94-1.15],0.4620875930093061
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TIMP4,Metalloproteinase inhibitor 4,27756,156,1.13 [0.80-1.59],0.4890071517382496
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TINAGL1,Tubulointerstitial nephritis antigen-like,27658,155,1.24 [0.67-2.29],0.5007375233520082
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TJAP1,Tight junction-associated protein 1,27849,154,1.18 [0.99-1.40],0.0651017230086578
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TJP3,Tight junction protein ZO-3,23410,130,0.85 [0.56-1.29],0.4341165722695749
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TK1,"Thymidine kinase, cytosolic",23740,131,1.29 [0.95-1.75],0.0998311863813366
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TLR1,Toll-like receptor 1,23508,131,1.15 [0.61-2.16],0.6583190768720266
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TLR2,Toll-like receptor 2,23740,131,2.22 [1.12-4.38],0.0217963913457303
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TLR3,Toll-like receptor 3,28040,156,0.97 [0.77-1.22],0.8041275683971271
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TLR4,Toll-like receptor 4,23508,131,1.06 [0.58-1.93],0.851891796416535
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,23514,134,1.22 [0.92-1.61],0.1751098638274135
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TMED1,Transmembrane emp24 domain-containing protein 1,23740,131,0.69 [0.48-0.98],0.0377407412771868
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TMED10,Transmembrane emp24 domain-containing protein 10,23424,129,1.02 [0.76-1.39],0.8758719888761617
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TMED4,Transmembrane emp24 domain-containing protein 4,23424,129,1.09 [0.83-1.44],0.52704573850966
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TMED8,Protein TMED8,24066,134,1.10 [0.93-1.29],0.2557836673754002
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TMEM106A,Transmembrane protein 106A,24054,130,0.99 [0.78-1.26],0.9567961618573748
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TMEM132A,Transmembrane protein 132A,23568,133,1.20 [0.94-1.53],0.1501110482008886
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TMEM25,Transmembrane protein 25,24152,133,0.87 [0.58-1.28],0.4758691830716968
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TMOD4,Tropomodulin-4,23315,128,1.20 [0.82-1.75],0.3426225156564241
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TMPRSS11B,Transmembrane protease serine 11B,23410,130,0.71 [0.54-0.94],0.015454031855723
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TMPRSS11D,Transmembrane protease serine 11D,24089,133,1.00 [0.64-1.56],0.9986460732712524
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TMPRSS15,Enteropeptidase,27629,155,1.05 [0.90-1.23],0.5198963510297622
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TMPRSS5,Transmembrane protease serine 5,27429,152,0.87 [0.60-1.27],0.4720014303882618
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TMSB10,Thymosin beta-10,27756,156,1.12 [0.94-1.34],0.2100406746966435
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNC,Tenascin,27845,154,1.15 [0.85-1.55],0.3552265139818095
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNF,Tumor necrosis factor,27197,148,1.13 [0.82-1.56],0.4531103456218879
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24066,134,0.96 [0.68-1.36],0.8205324453009655
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,27198,150,0.68 [0.45-1.04],0.0733282211998832
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,23679,128,1.16 [0.90-1.50],0.2431543102290626
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,27559,153,1.26 [0.82-1.93],0.2970109272711656
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,27559,153,1.07 [0.76-1.49],0.7015798990060582
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,27808,153,1.07 [0.81-1.43],0.6245342083668872
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,28040,156,1.27 [0.88-1.84],0.2066459195447509
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,27754,153,1.34 [0.85-2.11],0.2123735507185455
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,27849,154,1.31 [0.87-1.96],0.195227865146853
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,27803,154,1.01 [0.65-1.57],0.9573048249501848
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,27198,150,1.18 [0.84-1.66],0.3355340479850501
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,27803,154,1.31 [0.82-2.10],0.2586626115442887
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,23679,128,0.83 [0.54-1.27],0.3882273066003504
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,27985,155,1.58 [1.03-2.44],0.0372786151677637
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,27756,156,1.04 [0.62-1.72],0.8929319665787123
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,27756,156,0.89 [0.58-1.36],0.588907675946535
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,27991,156,0.99 [0.59-1.68],0.9788969395427672
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,27994,156,0.96 [0.65-1.42],0.8494011291203727
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,27559,153,0.90 [0.68-1.18],0.4352867788528117
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,27991,156,0.91 [0.66-1.25],0.5486743294377507
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,27559,153,0.81 [0.55-1.19],0.284564994867218
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFSF10,Tumor necrosis factor ligand superfamily member 10,28040,156,1.21 [0.72-2.04],0.4803808916450541
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFSF11,Tumor necrosis factor ligand superfamily member 11,27705,155,0.88 [0.70-1.11],0.2877264219360221
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFSF12,Tumor necrosis factor ligand superfamily member 12,28040,156,1.33 [0.84-2.12],0.2296398541219676
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFSF13,Tumor necrosis factor ligand superfamily member 13,27889,155,1.23 [0.72-2.09],0.4473146836113151
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,28043,154,0.62 [0.36-1.07],0.0851215433757
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFSF14,Tumor necrosis factor ligand superfamily member 14,27559,153,1.14 [0.89-1.45],0.2963144613346157
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNFSF8,Tumor necrosis factor ligand superfamily member 8,24190,135,0.80 [0.50-1.28],0.3608598986426278
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNIP1,TNFAIP3-interacting protein 1,24136,133,1.11 [0.92-1.34],0.2616443741367246
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNN,Tenascin-N,24190,135,0.88 [0.60-1.28],0.4967938848229883
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNNI3,"Troponin I, cardiac muscle",27243,152,1.03 [0.87-1.23],0.7022398407336631
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNPO1,Transportin-1,23740,131,1.05 [0.66-1.67],0.8459259945110348
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNR,Tenascin-R,27559,153,0.71 [0.51-1.00],0.0477023198981379
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TNXB,Tenascin-X,27756,156,0.85 [0.49-1.47],0.560518215911066
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24191,134,1.12 [0.91-1.38],0.2988709885740989
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TOP1,DNA topoisomerase 1,24066,134,0.93 [0.80-1.08],0.3406375909415171
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TOP1MT,"DNA topoisomerase I, mitochondrial",23315,128,0.95 [0.67-1.34],0.7700231145719979
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TOP2B,DNA topoisomerase 2-beta,23508,131,1.12 [0.91-1.38],0.2821753256630649
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TOR1AIP1,Torsin-1A-interacting protein 1,23568,133,1.00 [0.73-1.36],0.9872857166089792
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TP53,Cellular tumor antigen p53,27102,151,1.17 [0.84-1.62],0.3599485629192455
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TP53BP1,TP53-binding protein 1,23508,131,0.95 [0.78-1.15],0.5999989651374911
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TP53I3,Quinone oxidoreductase PIG3,23161,126,1.08 [0.79-1.49],0.6234200304371303
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TP53INP1,Tumor protein p53-inducible nuclear protein 1,27243,152,0.98 [0.63-1.52],0.9176081572992064
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TP73,Tumor protein p73,23514,134,0.67 [0.41-1.09],0.1065317178945334
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TPBGL,Trophoblast glycoprotein-like,23514,134,0.97 [0.65-1.43],0.8594010046317041
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TPD52L2,Tumor protein D54,23679,128,1.15 [0.98-1.35],0.0974688084516944
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TPK1,Thiamin pyrophosphokinase 1,24191,134,1.11 [0.61-2.00],0.7308870385043893
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TPM3,Tropomyosin alpha-3 chain,23424,129,1.27 [0.92-1.76],0.1457393298055253
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TPMT,Thiopurine S-methyltransferase,27102,151,0.98 [0.81-1.20],0.8796902535700726
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TPP1,Tripeptidyl-peptidase 1,27571,152,1.10 [0.81-1.49],0.5535952856043875
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TPPP2,Tubulin polymerization-promoting protein family member 2,23740,131,0.99 [0.81-1.21],0.9018826288388913
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TPPP3,Tubulin polymerization-promoting protein family member 3,27073,151,0.68 [0.44-1.04],0.0767178171137683
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TPR,Nucleoprotein TPR,23424,129,0.68 [0.44-1.04],0.077102072406451
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TPRKB,EKC/KEOPS complex subunit TPRKB,23315,128,1.06 [0.83-1.36],0.635622946448654
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TPSAB1,Tryptase alpha/beta-1,27993,154,1.05 [0.80-1.37],0.7272182030234218
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TPSD1,Tryptase delta,24152,133,0.80 [0.49-1.30],0.3609259343917098
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TPSG1,Tryptase gamma,23508,131,0.89 [0.47-1.70],0.7270966165856754
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TPT1,Translationally-controlled tumor protein,27198,150,0.76 [0.58-1.00],0.0530412127165165
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TRAF2,TNF receptor-associated factor 2,27705,155,1.10 [0.91-1.34],0.3347591180297893
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TRAF3,"TNF receptor-associated factor 3, Isoform 2",23508,131,1.27 [0.86-1.88],0.2241027065999693
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,23424,129,0.77 [0.51-1.16],0.2087350054609672
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,23740,131,1.05 [0.86-1.27],0.6269456831176574
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TREH,Trehalase,24190,135,1.15 [0.92-1.44],0.2134666275838475
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TREM2,Triggering receptor expressed on myeloid cells 2,27754,153,0.94 [0.71-1.24],0.6471502216804068
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TREML1,Trem-like transcript 1 protein,24205,134,1.23 [0.91-1.66],0.1847267700494936
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TREML2,Trem-like transcript 2 protein,27756,156,1.02 [0.67-1.55],0.9342100224110276
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TRIAP1,TP53-regulated inhibitor of apoptosis 1,27985,155,1.24 [1.00-1.54],0.0516818537095966
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TRIM21,E3 ubiquitin-protein ligase TRIM21,27705,155,0.94 [0.79-1.12],0.4573916274709486
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TRIM24,Transcription intermediary factor 1-alpha,23693,131,1.11 [0.87-1.42],0.3951782787274513
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24066,134,1.13 [0.97-1.31],0.1294472596112388
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TRIM26,Tripartite motif-containing protein 26,23315,128,1.07 [0.81-1.42],0.6172368356236035
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TRIM40,E3 ubiquitin ligase TRIM40,23514,134,0.90 [0.71-1.14],0.3852570415299845
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TRIM5,Tripartite motif-containing protein 5,27705,155,1.19 [1.01-1.40],0.0412262054178227
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TRIM58,E3 ubiquitin-protein ligase TRIM58,24054,130,1.05 [0.86-1.27],0.6461223326674645
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TRPV3,Transient receptor potential cation channel subfamily V member 3,23424,129,1.25 [0.96-1.63],0.0967192573746969
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TSC1,Hamartin,23508,131,1.01 [0.82-1.26],0.9170213955213736
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TSC22D1,TSC22 domain family protein 1,24152,133,1.19 [0.96-1.49],0.1165069229579313
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TSHB,Thyrotropin subunit beta,27752,155,1.05 [0.88-1.25],0.5912544157380741
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TSLP,Thymic stromal lymphopoietin,27243,152,1.04 [0.83-1.31],0.7266030646146249
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TSNAX,Translin-associated protein X,23424,129,1.19 [0.79-1.80],0.40554172856293
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TSPAN1,Tetraspanin-1,27243,152,0.95 [0.60-1.49],0.808383846929934
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TSPAN15,Tetraspanin-15,23424,129,0.87 [0.61-1.25],0.447590643115109
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TSPAN7,Tetraspanin-7,23410,130,1.01 [0.84-1.21],0.912708281399256
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TSPAN8,Tetraspanin-8,24066,134,1.04 [0.89-1.22],0.6019158072288109
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TSPYL1,Testis-specific Y-encoded-like protein 1,23508,131,0.99 [0.66-1.50],0.9717019753573312
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TST,Thiosulfate sulfurtransferase,27026,151,1.10 [0.91-1.32],0.338133667163648
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TTF2,Transcription termination factor 2,23514,134,0.90 [0.63-1.27],0.5427480722911578
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TTN,Titin,23424,129,1.12 [0.90-1.40],0.3219770260974283
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TTR,Transthyretin,23970,132,3.12 [1.62-6.03],0.0006788360421145
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TUBB3,Tubulin beta-3 chain,23410,130,0.69 [0.37-1.26],0.2260224514778606
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TWF2,Twinfilin-2,24190,135,1.11 [0.91-1.34],0.3107799028474695
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TXK,Tyrosine-protein kinase TXK,23740,131,0.93 [0.74-1.18],0.5609859138510991
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TXLNA,Alpha-taxilin,27559,153,1.17 [0.99-1.37],0.0629899912505555
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TXN,Thioredoxin,23797,132,1.28 [0.93-1.76],0.1291260160828233
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TXNDC15,Thioredoxin domain-containing protein 15,27849,154,1.21 [0.72-2.02],0.4763411555563779
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TXNDC5,Thioredoxin domain-containing protein 5,27991,156,1.17 [0.95-1.43],0.1357615491576569
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TXNDC9,Thioredoxin domain-containing protein 9,24136,133,1.05 [0.78-1.43],0.7481834603349418
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TXNL1,Thioredoxin-like protein 1,23361,130,1.05 [0.89-1.24],0.5326613990054037
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",27756,156,1.12 [0.83-1.51],0.4551669489442801
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TYMP,Thymidine phosphorylase,27571,154,1.09 [0.88-1.34],0.43134307624352
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TYRO3,Tyrosine-protein kinase receptor TYRO3,27752,155,0.93 [0.57-1.54],0.7838756564213292
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",23508,131,1.44 [1.08-1.92],0.0121652238021925
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UBAC1,Ubiquitin-associated domain-containing protein 1,27629,155,1.17 [0.79-1.73],0.4423256751812424
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UBE2B,Ubiquitin-conjugating enzyme E2 B,24054,130,1.65 [1.03-2.65],0.0361088512165196
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24191,134,1.20 [0.93-1.56],0.1673275899650794
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,23508,131,1.12 [0.86-1.45],0.4007507718048206
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UBQLN3,Ubiquilin-3,23424,129,0.96 [0.64-1.42],0.8296829362786355
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UBXN1,UBX domain-containing protein 1,23679,128,1.12 [0.88-1.43],0.338321187269501
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24066,134,1.10 [0.98-1.24],0.1027762227282558
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UGDH,UDP-glucose 6-dehydrogenase,23424,129,0.97 [0.82-1.16],0.7613420591475811
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UHRF2,E3 ubiquitin-protein ligase UHRF2,23424,129,0.71 [0.41-1.24],0.2262434003026295
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ULBP2,UL16-binding protein 2,27559,153,1.01 [0.68-1.48],0.9702047759140554
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UMOD,Uromodulin,28009,154,0.88 [0.68-1.14],0.3403970266771087
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UNC5D,Netrin receptor UNC5D,23508,131,1.29 [0.73-2.30],0.3811830745703942
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UNC79,Protein unc-79 homolog,23315,128,1.09 [0.82-1.45],0.5582141272899164
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UNG,Uracil-DNA glycosylase,24054,130,1.06 [0.66-1.72],0.8023397394200542
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UPB1,Beta-ureidopropionase,24191,134,0.96 [0.80-1.15],0.6434720410268429
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UPK3A,Uroplakin-3a,23410,130,0.82 [0.58-1.17],0.2754243737152299
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UPK3BL1,Uroplakin-3b-like protein 1,23699,131,0.99 [0.73-1.34],0.935252193987584
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UROD,Uroporphyrinogen decarboxylase,23679,128,1.18 [0.93-1.49],0.1780242443715044
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UROS,Uroporphyrinogen-III synthase,23514,134,1.02 [0.81-1.29],0.859420042367389
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",USO1,General vesicular transport factor p115,27629,155,1.18 [1.00-1.38],0.043554222078125
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",USP25,Ubiquitin carboxyl-terminal hydrolase 25,24054,130,1.22 [0.97-1.53],0.0931618777923281
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",USP28,Ubiquitin carboxyl-terminal hydrolase 28,24136,133,0.75 [0.45-1.23],0.2489856546091089
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",USP47,Ubiquitin carboxyl-terminal hydrolase 47,23424,129,1.05 [0.87-1.26],0.6427336544098293
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",USP8,Ubiquitin carboxyl-terminal hydrolase 8,27243,152,1.15 [1.00-1.33],0.0547104855323104
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",UXS1,UDP-glucuronic acid decarboxylase 1,27102,151,1.07 [0.83-1.39],0.5854574234234333
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VAMP5,Vesicle-associated membrane protein 5,27243,152,1.08 [0.84-1.38],0.5603434709475439
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VAMP8,Vesicle-associated membrane protein 8,23508,131,1.12 [0.93-1.35],0.2365286706370782
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VASH1,Tubulinyl-Tyr carboxypeptidase 1,27705,155,1.08 [0.91-1.28],0.38770219736577
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VASN,Vasorin,27303,151,0.95 [0.56-1.60],0.8355736243282501
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VASP,Vasodilator-stimulated phosphoprotein,24205,134,1.08 [0.86-1.35],0.5061785210157324
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,27629,155,0.87 [0.43-1.77],0.7070230634872654
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VAV3,Guanine nucleotide exchange factor VAV3,23410,130,1.08 [0.91-1.28],0.3573486340838538
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VCAM1,Vascular cell adhesion protein 1,27797,154,0.74 [0.43-1.28],0.281456534422552
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VCAN,Versican core protein,27991,156,1.15 [0.72-1.85],0.5467481504639353
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VCPKMT,Protein-lysine methyltransferase METTL21D,23315,128,0.94 [0.76-1.15],0.5419550991857774
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VEGFA,Vascular endothelial growth factor A,27947,155,1.11 [0.87-1.40],0.4052844093952074
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VEGFB,Vascular endothelial growth factor B,23508,131,1.59 [0.90-2.81],0.1070183669218625
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VEGFC,Vascular endothelial growth factor C,27849,154,1.15 [0.89-1.48],0.2847153853875013
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VEGFD,Vascular endothelial growth factor D,27990,155,0.90 [0.59-1.37],0.6285648378581152
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VGF,Neurosecretory protein VGF,24152,133,1.45 [0.86-2.45],0.168378823708271
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VIM,Vimentin,27243,152,1.07 [0.94-1.22],0.3086279288110084
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VIPR1,Vasoactive intestinal polypeptide receptor 1,23568,133,0.96 [0.50-1.84],0.8946243862205061
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VIT,Vitrin,24191,134,1.63 [1.07-2.47],0.0219375838543282
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VMO1,Vitelline membrane outer layer protein 1 homolog,27629,155,1.19 [0.95-1.49],0.1242196563057877
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VNN1,Pantetheinase,24205,134,1.09 [0.87-1.37],0.4431668224814425
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VNN2,Vascular non-inflammatory molecule 2,27629,155,1.29 [0.93-1.77],0.1242622471028698
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VPS28,Vacuolar protein sorting-associated protein 28 homolog,23740,131,1.21 [0.96-1.52],0.1096690174270454
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VPS37A,Vacuolar protein sorting-associated protein 37A,27629,155,1.18 [0.99-1.41],0.0668726809568144
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VPS4B,Vacuolar protein sorting-associated protein 4B,24054,130,1.08 [0.91-1.29],0.3664704284873227
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VPS53,Vacuolar protein sorting-associated protein 53 homolog,27629,155,1.10 [0.92-1.32],0.2983758520167866
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VSIG10,V-set and immunoglobulin domain-containing protein 10,24054,130,0.66 [0.39-1.12],0.1209462812673772
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,23424,129,0.67 [0.39-1.17],0.1623452529862461
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VSIG2,V-set and immunoglobulin domain-containing protein 2,24054,130,1.09 [0.81-1.47],0.5681633697263662
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VSIG4,V-set and immunoglobulin domain-containing protein 4,27717,156,1.67 [1.19-2.34],0.0030640871022802
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,27711,155,1.16 [0.93-1.44],0.1909033998687825
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VSNL1,Visinin-like protein 1,24136,133,0.94 [0.59-1.49],0.7951683788509143
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VSTM1,V-set and transmembrane domain-containing protein 1,27073,151,1.07 [0.80-1.44],0.6440548646665853
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VSTM2B,V-set and transmembrane domain-containing protein 2B,23740,131,1.01 [0.68-1.50],0.9598408280536516
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,27243,152,0.83 [0.63-1.09],0.1786215174064541
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,27991,156,1.24 [1.02-1.50],0.0315964311161083
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VTCN1,V-set domain-containing T-cell activation inhibitor 1,27102,151,1.05 [0.69-1.62],0.8129934934993815
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,23679,128,1.06 [0.80-1.41],0.6638790665365044
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VWA1,von Willebrand factor A domain-containing protein 1,27936,155,0.80 [0.58-1.12],0.1978312541518897
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VWA5A,von Willebrand factor A domain-containing protein 5A,23315,128,0.90 [0.71-1.14],0.382642710685138
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VWC2,Brorin,27465,152,1.16 [0.80-1.67],0.4447305112782678
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VWC2L,von Willebrand factor C domain-containing protein 2-like,24152,133,0.96 [0.67-1.36],0.7990434613287734
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",VWF,von Willebrand factor,28090,154,0.94 [0.78-1.15],0.5614099343856442
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",WARS,"Tryptophan--tRNA ligase, cytoplasmic",27756,156,1.04 [0.71-1.51],0.8429623813138606
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",WAS,Wiskott-Aldrich syndrome protein,27198,150,0.91 [0.73-1.13],0.3973112659959293
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",WASF1,Wiskott-Aldrich syndrome protein family member 1,27243,152,1.10 [0.94-1.28],0.219985332289989
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",WASF3,Wiskott-Aldrich syndrome protein family member 3,27073,151,1.09 [0.92-1.30],0.3296825502488029
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",WASHC3,WASH complex subunit 3,24136,133,1.08 [0.87-1.33],0.4790841039109457
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",WASL,Neural Wiskott-Aldrich syndrome protein,23508,131,1.14 [0.89-1.44],0.2990856231096391
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",WDR46,WD repeat-containing protein 46,24054,130,1.13 [0.74-1.72],0.5746578813177772
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",WFDC1,WAP four-disulfide core domain protein 1,23579,129,1.04 [0.76-1.40],0.8182910484324926
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",WFDC12,WAP four-disulfide core domain protein 12,27948,154,1.19 [0.96-1.48],0.1088964878364874
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",WFDC2,WAP four-disulfide core domain protein 2,26330,148,1.30 [0.91-1.87],0.1543375661890319
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",27477,152,0.87 [0.61-1.24],0.4455659511312516
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",27803,154,0.75 [0.49-1.14],0.1792529086044734
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",WIF1,Wnt inhibitory factor 1,27985,155,0.94 [0.62-1.41],0.7566412450294165
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",WNT9A,Protein Wnt-9a,27198,150,1.30 [0.79-2.12],0.2990028877034264
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,27559,153,1.33 [1.03-1.71],0.0275167727715641
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",XCL1,Lymphotactin,27985,155,1.02 [0.79-1.31],0.8833565047176342
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",XG,Glycoprotein Xg,27948,154,0.97 [0.59-1.59],0.9002453036789148
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",XIAP,E3 ubiquitin-protein ligase XIAP,23508,131,1.14 [0.86-1.51],0.3543829513227677
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",XPNPEP2,Xaa-Pro aminopeptidase 2,27849,154,1.07 [0.91-1.25],0.4272463185951634
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",XRCC4,DNA repair protein XRCC4,27073,151,1.08 [0.74-1.57],0.6992560453847969
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",YAP1,Transcriptional coactivator YAP1,24136,133,1.11 [0.59-2.07],0.749197403021097
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24066,134,1.11 [0.99-1.24],0.0792136417623171
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",YES1,Tyrosine-protein kinase Yes,27629,155,1.12 [0.98-1.27],0.0908485615253849
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",YJU2,Splicing factor YJU2,24054,130,1.29 [0.79-2.09],0.3060049193776167
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",YOD1,Ubiquitin thioesterase OTU1,23424,129,1.17 [0.90-1.52],0.2366026664372524
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",YTHDF3,YTH domain-containing family protein 3,27198,150,1.08 [0.91-1.28],0.3875182272648646
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",YWHAQ,14-3-3 protein theta,23679,128,1.12 [0.89-1.41],0.3307772023270021
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",YY1,Transcriptional repressor protein YY1,23508,131,0.93 [0.51-1.69],0.8014048705465888
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ZBP1,Z-DNA-binding protein 1,23508,131,1.16 [0.81-1.67],0.4103738330439673
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ZBTB16,Zinc finger and BTB domain-containing protein 16,27102,151,1.25 [1.03-1.51],0.025753620091224
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ZBTB17,Zinc finger and BTB domain-containing protein 17,27243,152,1.11 [0.81-1.53],0.5233760464499724
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ZCCHC8,Zinc finger CCHC domain-containing protein 8,23424,129,0.87 [0.65-1.18],0.3816471043043431
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ZFYVE19,Abscission/NoCut checkpoint regulator,24066,134,1.11 [0.92-1.33],0.2666506578592353
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ZHX2,Zinc fingers and homeoboxes protein 2,24136,133,0.69 [0.37-1.29],0.2489379493112159
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ZNF174,Zinc finger protein 174,23508,131,1.10 [0.74-1.64],0.6282840397844776
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ZNF75D,Zinc finger protein 75D,23740,131,0.98 [0.74-1.29],0.8741543574559534
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ZNF830,Zinc finger protein 830,24054,130,0.81 [0.64-1.03],0.081721421572379
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ZNRD2,Protein ZNRD2,24066,134,1.22 [0.97-1.53],0.0907277930989126
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24054,130,0.92 [0.68-1.25],0.60460029764537
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ZP3,Zona pellucida sperm-binding protein 3,23568,133,1.00 [0.94-1.07],0.9090272946333025
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ZP4,Zona pellucida sperm-binding protein 4,23315,128,0.94 [0.55-1.59],0.8142247625327503
Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",ZPR1,Zinc finger protein ZPR1,23410,130,0.88 [0.72-1.08],0.2096967328405227
